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Abstract 
 
The overarching aim of this thesis was to explore psychological 
wellbeing among a treatment seeking population of trans individuals. 
Specifically, psychopathology and quality of life were studied as key dimensions 
of psychological wellbeing. The thesis begins with a proposed model of 
predictors of psychological wellbeing derived from a review of the literature, 
which includes social support, interpersonal problems, body dissatisfaction, 
self-esteem, experiences of transphobia, non-suicidal self-injury (NSSI), age 
and gender. Study 1 proceeds then to focus specifically on levels of perceived 
social support and its relationship to psychological wellbeing. Study 2 assesses 
interpersonal problems. Study 3 investigates prevalence rates of NSSI. Drawing 
on the findings from the previous three studies, Study 4 subsequently tests an 
amended model of predictors. In terms of the methodology employed across 
the studies, a cross-sectional questionnaire survey was conducted using 
standardised measures, a large sample of trans individuals recruited from a 
national gender identity clinic (GIC), and a matched control group of non-trans 
(hereafter referred to as cisgender) individuals. Throughout, consideration was 
given to differences between trans women and trans men as well as how trans 
individuals compare to cisgender individuals, with regards to each of the 
variables tested. The thesis concludes with a revised model of predictors, in 
addition to recommendations for preventing the development of poor 
psychological wellbeing and interventions for improving poor psychological 
wellbeing among the trans population. 
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Chapter 1: Introduction 
 
 
1.1 Introduction 
 
This introduction chapter will have three parts. The first section will 
introduce the field of transgender by addressing the terminology, epidemiology, 
treatment, and mental health issues. The second part will discuss and review 
the available literature investigating psychological wellbeing in this population. 
The third part will outline the aims of this thesis and each of the empirical 
chapters within it, before concluding the chapter. 
 
One of the foremost and essential issues to address before introducing this 
thesis is the terminology used. This includes the specific terminology selected 
for use in this thesis situated in the wider context of terminology, and its 
diversity within trans research. While lay or non-medical terms are 
acknowledged, precedence is given to terminology from a clinical standpoint as 
this is most pertinent to the research presented here. An overview of changes 
to diagnostic criteria and critique of previous and current diagnoses is given. 
Following on from terminology, epidemiology is considered, specifically 
prevalence rates of Transsexualism. Due to the clinical nature of this body of 
research, a description of the treatment pathway provided by Gender Identity 
Clinics (GICs) in the United Kingdom and the typical transitional journey of 
patients is then provided. Variability within and exceptions to this course are 
emphasised. The first section is concluded with a discussion of key mental 
health issues relevant to this population. 
 
Having established the context behind this thesis, the chapter moves on to the 
rationale underpinning the research. The concept of psychological wellbeing is 
explored and an operational definition supplied. Subsequently, the existing 
literature on psychological wellbeing among trans individuals is considered, 
compared and critiqued. This review section focuses predominantly on 
depression and, to a lesser extent, on general psychopathology and quality of 
life, which reflects the availability of the literature. A summary of the 
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methodological and theoretical shortcomings, and gaps in the research follows, 
some of which this thesis endeavours to address. This leads onto the general 
rationale, culminating in the overarching aims of this thesis, a proposed model 
of predictors of psychological wellbeing, and an outline of empirical chapters. 
 
1.2 Part 1: Introduction to transgenderism 
 
1.2.1 Terminology and language within transgender research 
 
1.2.1.1 Terminology used in this thesis 
 
Before expanding on the history and diversity of language used across 
this field, the specific terms applied within this thesis are discussed. For ease of 
reading, the shorthand trans is used broadly, hereafter, to refer to those who 
are transgender, transsexual, or who experience gender dysphoria. Depending 
on journal requirements, some chapters have rephrased trans individuals as 
‘individuals with gender dysphoria’ in their published form. Though for 
consistency within this thesis, the term trans is observed here. When 
differentiating trans individuals by gender, the terms trans women and trans 
men are used. Individuals who are assigned a male sex at birth but later identify 
as female are referred to as trans women. Conversely, individuals who are 
assigned a female sex at birth but later identify as male are referred to as trans 
men. From the outset, it was recognised that describing individuals by their 
natal sex serves to discredit their experienced gender identity (Winters, 2006) 
and using the denotations male-to-female (shorthand: MtoF) or female-to-male 
(FtoM) are better suited to medical discourse. Avoiding MtoF and FtoM labels 
and instead placing the emphasis on a person’s gender identity was considered 
to be more humanising, and less rigid in relation to a person’s transitional 
status. To differentiate between non-trans and trans individuals, the term 
cisgender is used to refer to those who have continually experienced a gender 
identity congruent to their birth sex and who do not, and have never, identified 
themselves as transgender. The participants who took part in this research are 
more specifically described in Chapter 2. 
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1.2.1.2 The meaning of ‘transgender’ 
 
The umbrella terms ‘transgender‘ and ‘trans‘, by nature, are broad and 
all-inclusive, and are intended to capture a diverse group of individuals who 
cross or transcend the social and cultural binary of gender (Bockting, 2009). 
According to Whittle (2000), transgender encapsulates a political and social 
community of individuals, transsexuals, cross-dressers (previously identified as 
transvestites), and gender variant individuals who may identify as drag queens, 
drag kings, butch lesbians, mannish women, or passing women (individuals 
who outwardly appear feminine and who are unlikely to be recognised as a 
trans person). Transgender applies to those who express gender in non-
traditional ways, irrespective of whether or not they continue to identify as their 
birth sex (Whittle, 2000). Two important notes should be acknowledged. First, 
not all individuals within this broad and heterogeneous group self-identify as 
transgender, which may be irrespective of whether or not they have received 
any form of gender-related treatment (Bouman, 2014). Second, though 
individuals who fall under these umbrella terms may express their sexuality in 
unconventional and non-conforming ways, gender identity is independent of 
sexual orientation (Ahmad et al., 2013). In the TranZnation report by Couch and 
colleagues (Couch et al., 2007), while participants classified themselves as 
transgender, they expressed their gender identity in a variety of ways, including 
traditional female and male terms; phrases related to transition (e.g., ‘currently 
female’; ‘post-op transsexual’); queer/cultural references (e.g., ‘genderqueer 
transboi’); presentation style (e.g., ‘butch’); crossdressing (e.g., ‘crossdresser 
and tranny’); and gender and sexuality (e.g,. ‘bi-gendered’; ‘androgynous’). A 
fifth of participants used more than one term to describe their gender identity 
and terms could vary depending on context (Couch et al., 2007). Generally, the 
gender identities of trans individuals may fall outside the traditional binary 
framework of gender, and are negotiated in relation to transition, social 
connections, and generational factors, often resisting medical discourse (Hines, 
2006). The diversity and fluidity of self-definition illustrated here presents a 
challenge when it comes to research, an issue that will be discussed in more 
depth later in the chapter.  
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1.2.1.3 Diagnostic criteria: Changes and challenges 
 
The social, political and medical climate in the transgender field is 
constantly evolving, which is reflected in the changes to diagnostic criteria. How 
the experience of being trans is defined and diagnosed has not only political 
and social ramifications, but importantly affects how people are perceived by 
others and how people perceive themselves. Despite reforms, the validity and 
usefulness of diagnostic criteria remain contested. Those contributing to the 
debate include medical professionals, sociologists, political groups (in particular 
transgender advocacy groups), and the lesbian, gay, bisexual, and transgender 
(LGBT) community (Drescher, 2014). This section aims to outline changes in 
diagnostic criteria and draw attention to the shortfalls. 
 
The two prevailing classification systems are the World Health Organization’s 
(WHO) International Statistical Classification of Diseases and Related Health 
Problems (ICD) and the American Psychiatric Association's (APA) Diagnostic 
and Statistical Manual of Mental Disorders (DSM). Regrettably, these manuals 
are not revised simultaneously and so far, have not reached a consensus. 
Nonetheless, changes within both the ICD and DSM have spurred controversy, 
criticism and praise (Bouman, Bauer, Richards, & Coleman, 2010). 
 
For an adult to meet the current criteria for a diagnosis of Transsexualism 
(F64.0), according to the ICD-10, they must express the desire to live and be 
accepted as a member of the opposite sex, usually accompanied by the wish to 
make his or her body as congruent as possible with the experienced sex 
through surgery and cross-sex hormones. This transsexual identity must have 
been present persistently for a minimum of two years and not be a symptom of 
another mental disorder or a chromosomal abnormality (WHO, 1992). 
 
Under the new edition of the DSM (DSM-V), while the DSM-V states that 
Gender Dysphoria should not be viewed as a mental disorder and that the 
manual’s intention is to avoid stigma, it continues to categorise it as such. 
However, there are several positive changes. The diagnosis has been 
separated from sexual dysfunctions and paraphilic disorders, and is now 
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positioned in its own chapter. Furthermore, subtyping in relation to sexual 
orientation has been eliminated. The specific term of Gender Dysphoria assigns 
the pathology within the dysphoria, as opposed to within the gender identity 
(Bouman & Richards, 2013). Language such as ‘incongruence’ and ‘alternative 
gender’ are chosen over ‘cross-gender identification’ and ‘other sex’, in order to 
recognise the variation in individuals’ experiences. The new post-transition 
specifier recognises that some individuals when living full-time in their 
experienced gender will cease to fulfil the criteria for Gender Dysphoria and is 
intended to preserve access to ongoing treatment, for which, in some countries, 
individuals must retain a diagnosis (APA, 2013). 
 
Both diagnoses, Gender Dysphoria and Transsexualism, are situated at the end 
of a theoretical continuum of cross-gender identification (Zucker & Lawrence, 
2009), referring only to extreme gender dysphoria (Kreukels et al., 2012). While 
Gender Dysphoria was launched as a new diagnostic term, it is also referred to 
as a symptom of distress regarding physical sex characteristics and/or their 
associated social roles (Winters, 2006). Depending on the intensity of this 
distress, some individuals may wish to transition from one point on a notional 
gender scale to another. The most common direction is from a man to a woman 
(people known as trans women), or from a woman to a man (people known as 
trans men) (Ahmad et al., 2013; Wylie et al., 2014). The distress intrinsic to 
gender dysphoria may be focused around anatomy, physiology, and/or being 
perceived and treated as someone of a sex with which the person does not 
identify (Bouman, Bauer, Richards, & Coleman, 2010). However, these 
diagnostic labels do not apply to all trans individuals, for a multitude of reasons, 
as some people will not identify themselves either as a man or as woman 
(Ahmad et al., 2013; Bouman & Richards, 2013; Davies et al., 2013; Wylie et 
al., 2014). 
 
Similar to the DSM-V (APA, 2013), it is expected that the forthcoming edition of 
the ICD (ICD-11), due to be released in 2017, will present a new diagnostic 
term to include those who fall outside of the traditional gender binary (Drescher, 
Cohen-Kettenis, & Winter, 2012). The WHO working group has recommended 
that the ICD-11 replace Transsexualism with Gender Incongruence (Drescher 
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et al., 2012) and remove it from mental and behavioural disorders. Gender 
incongruence denotes the incongruence between a person’s gender identity 
and their assigned sex and/or congenital primary and secondary sex 
characteristics (Meyer-Bahlburg, 2010). 
 
1.2.1.4 Historical perspective 
 
Historically, Transsexualism, under the DSM-III (APA, 1980), was first 
placed within Psychosexual Disorders. It later moved to Disorders Usually First 
Evident in Infancy, Childhood or Adolescence in the DSM-III-R (APA, 1987), 
and then shifted to the amended class of Sexual and Gender Identity Disorders 
in the DSM-IV (APA, 1994). The DSM-III-R’s Transsexualism diagnosis 
excluded individuals who did not desire sex reassignment surgery (APA, 1987). 
In the DSM-IV, previously differentiated diagnoses became amalgamated under 
the new term Gender Identity Disorder (APA, 1994). The DSM-IV-TR modified 
supporting text only, rather than the diagnostic criteria, referencing subtypes 
related to sexual orientation (APA, 2000).  
 
A contradiction within the diagnosis Gender Identity Disorder was that it implied 
that cross-gender identification was intrinsically disordered or deficient (Wilson, 
2002) and that it was the gender identity rather than the body that needed to be 
treated or corrected (Winters, 2006). Therefore, rather than facilitating 
treatment, the diagnosis of GID made it possible to deny sex reassignment 
surgery under claims that it was cosmetic and elective (Winters, 2006). Those 
who were well-adjusted, who did not need treatment, or who had successfully 
completed sex reassignment treatment were equally cast as mentally 
disordered (Winters, 2006).  
 
The ambiguity and conflicting language within the DSM-III was criticised for 
conflating social non-conformity with mental illness and misrepresenting 
ordinary gender expressions as deviant (Winters, 2006). Illogically, behaviours 
considered normal for cisgender men and women, such as dress and 
mannerisms, were deemed pathological and symptomatic of mental illness for 
trans individuals (Wilson, 2002). This emphasis of social non-conformity was 
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then sustained through to the DSM-IV-TR (Winters, 2006). A further inadequacy 
of the language used, for example ‘discomfort’ and ‘aversion’, was that it 
euphemistically and inappropriately referred to the distress and pain many 
individuals suffer (Winters, 2006). It is important to note that it is now widely 
accepted that much of the distress experienced by trans individuals stems from 
other’s people attitudes, as described by the Meyer’s minority stress theory 
(Meyer, 1995, 2003). This theory emphasises how the stress experienced by 
particular minority groups (such as lesbian, gay, bisexual and trans people) is 
primarily due to the relationship between minority and dominant values, which 
results in conflicts within the social environment (Meyer, 1995, 2003). These 
conflicts can create a hostile, transphobic environment, leading to lifelong 
harassment, discrimination and abuse of trans individuals (Marshal et al., 2008; 
Meyer, 2003). 
 
One of the major problems of the DSM, by its nature/purpose a manual for 
categorising mental disorders, is that it by continuing to include Gender Identity 
Disorder (or some variant), it encourages the medical profession and wider 
society to view the trans experience as a mental illness. Despite this position, 
the majority of professionals emphasis that Transsexualism/Gender Dysphoria 
should not be regarded as a mental disorder (Ahmad et al., 2013). Many have 
called for the diagnosis to be declassified from the DSM (e.g., Ault & Brzuzy, 
2009), in the same way Asperger’s Syndrome was dropped in the release of the 
DSM-V. This does not deny that the challenges of unmanaged gender 
dysphoria and social stigma may lead to mental health problems (Ahmad et al., 
2013). There is much agreement that this categorisation perpetuates the stigma 
attached to individuals diagnosed with this condition (Bouman et al., 2010) and 
creates barriers to social legitimacy and civil rights (Winters, 2006). However, 
the central argument for the decision is that it preserves the need and 
legitimacy of trans-specific care (Bouman et al., 2010; Bouman & Richards, 
2013). This is a prominent issue in countries, such as the United States and 
Canada, where access to healthcare and health insurance may be more difficult 
in its absence (Bouman et al., 2010). The DSM-V’s failure to declassify the 
diagnosis as a mental disorder demonstrates that the moral and scientific 
argument that gender dysphoria is a natural variation in the human condition 
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has been superceded by fears that declassification will affect access to 
treatment (Bouman & Richards, 2013). 
 
Arguably the most important (and controversial) change within the DSM-IV was 
the introduction of clinically significant distress or impairment criterion. Critics 
have opposed the distress criterion, arguing that it is vague, inadequately 
differentiated, open to interpretation, and not unique to the diagnosis (Bouman 
et al., 2010; Winters, 2006; Zucker, 2005). What the DSM failed to 
acknowledge is that not all distress experienced is inherent to the condition 
(though undoubtedly it can be); social stigma can play a significant, causal role 
in distress (Bouman et al., 2010; Winters, 2006). While distress generated from 
both sources are not easily differentiated (Bouman et al., 2010), it is in fact, not 
necessarily meaningful for diagnostic purposes (Bouman et al., 2010). The 
distress criterion also creates a problem whereby the needs of trans individuals 
who are resilient and receive appropriate care are presented as less valid than 
those who are outwardly distressed (Bouman & Richards, 2013). Many 
individuals who attend GICs are not distressed (Bouman & Richards, 2013), 
whereas others may function well in social and occupational terms, yet still 
experience distress (Bouman et al., 2010). Unsurprisingly, appeals were made 
to remove the distress criterion (Bouman et al., 2010), however, these have not 
been heeded in the DSM-V. 
 
1.2.2 Epidemiology: Prevalence of Transsexualism 
 
There is considerable variation in reports of prevalence data regarding 
Transexualism, for example from 0.45 (Wålinder, 1971) to 23.6 (Tsoi, 1988) in 
100,000 people. This wide margin is likely influenced by geographical origin of 
the studies; duration and methods of data collection (approximations, primary 
care, and third parties being weaker sources than gender clinics); changing 
diagnostic (and therefore inclusion) criteria; eligibility parameters; and 
development of gender services (Arcelus et al., in press). More recent meta-
analytical evidence reports a prevalence rate of 4.6 in 100,000 for 
Transsexualism (6.8 for trans women and 2.6 for trans men), with a trans 
women to trans men ratio of 2.6 to 1 (Arcelus et al., in press). Importantly, time 
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analysis found an increase in reported prevalence over the last 50 years 
(Arcelus et al., in press). This clear trend of increasing prevalence over time 
could be attributed to the growing societal acceptance towards trans individuals 
(Kuyper & Wijsen, 2014). 
 
It should be noted here that epidemiological evidence is largely derived from 
clinical data. Clinical research is unlikely to identify or include trans individuals 
who feel unable to ‘come out’, perhaps as a result of their family background or 
societal factors (Arcelus et al., in press); those who do not have the opportunity 
to transition due to a lack of available care (Arcelus et al., in press); or those 
who actively choose to socially transition without assistance or treatment 
through GIC services, some of whom use self-prescribed cross-sex hormones 
or private services (Davies et al., 2013; Mepham, Bouman, Arcelus, Hayter, & 
Wylie, 2014). For this reason, it is hypothesised that the true prevalence of 
Transsexualism, not captured here, is likely to be higher. 
 
In addition to greater societal tolerance, the increase in the reported prevalence 
of trans individuals may also be a reflection of changing healthcare systems 
and expanding availability of treatment. This could suggest an important need 
for healthcare services to be aware of the increase in demand so that 
individuals, who wish to, can access the treatment pathway. 
 
1.2.3 The treatment pathway 
 
For the subgroup of individuals who do wish to seek treatment, in order 
to change social gender role with cross-sex hormones and gender-related 
surgeries, some countries provide GIC services. GIC services, through 
multidisciplinary teams, offer specialist assessment and treatment, which may 
include evaluation and diagnosis; psychological therapies; speech and 
language therapy; endocrinology; referral for electrolysis; referral for sex 
reassignment surgery; and follow-up care (Ahmad et al., 2013; Coleman et al., 
2012; Wylie et al., 2014). In the UK, the general order of gender treatment is to 
begin with reversible interventions when appropriate, such as social gender role 
change, carefully followed by irreversible ones (Ahmad et al., 2013), which may 
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differ from other countries where there is a requirement for regular 
psychodynamic psychotherapy as a part of the treatment (Manieri et al., 2014). 
In the UK, all GICs are tertiary services which are nationally commissioned 
through NHS England and free at the point of access for all British citizens. 
Referrals to GICs are predominantly made by primary care services. 
Outstanding medical or psychological conditions are stabilised before 
physiological treatment is started, with the understanding that some conditions 
are due to gender dysphoria itself and/or the pressures of transition, in which 
case they are likely to be alleviated through appropriate gender-related 
treatment (Ahmad et al., 2013). 
 
The assessment process usually requires two or three assessment 
appointments with two different clinicians. In some clinics, such as the 
Nottingham National Centre for Gender Dysphoria, a third meeting (or network 
meeting) with both clinicians, the trans individual and someone who is close to 
him/her and has known the individual for many years, is also organised as part 
of the assessment. As part of this stage, the trans individual is required to 
provide evidence of social gender role change, including change of name, plus 
two items of official documentation, such as their passport and driving licence. 
Following this, the two independent gender specialists reach a diagnosis. If the 
diagnosis is that of Transsexualism (F64.0, WHO, 1992) and the patient is 
ready to enter the treatment pathway, the trans individual will be informed about 
all elements of the treatment process. If cross-sex hormones are prescribed, 
consent will be sought and side effects and associated risks will be discussed in 
depth, as well as organising physical examination and blood tests.  
 
The period of social gender role transition, typically a two-year phase, which is 
sometimes referred to as the Real Life Experience (RLE) or just Life 
Experience, requires patients to enter full social and occupational adaption to 
their experienced gender role (Davies et al., 2013; Wylie et al., 2014). Some 
trans individuals will have progressed through social transition to varying 
degrees (including completely), prior to their attendance at a GIC service 
(Ahmad et al., 2013). Once in the transitional period, cross-sex hormone 
treatment is usually initiated, if appropriate. Meaningful social or occupational 
22 
engagement such as employment, voluntary work, or education, is typically a 
prerequisite to enter into the treatment programme as it is important that the 
individual experiences life as their experienced gender in full (Ahmad et al., 
2013). The occupational requirement serves to facilitate interaction in the 
acquired social gender role within social and professional domains, with the 
potential added benefit of assisting financial independence (Davies et al., 
2013). Success of social transition is not reliant on an individual’s ability to 
‘pass’ but rather that the trans person thrives in their newly acquired social 
gender role and that there is no evidence of emerging mental health problems 
(Bouman & Richards, 2013).  
 
Eligibility for sex reassignment surgery follows a successful period of social 
gender role transition (Bockting, Coleman, & De Cuypere, 2011; Coleman et al., 
2012; Wylie et al., 2014). Genital surgery is contingent upon the patient living 
typically 12-24 months full time in their experienced gender role, with the 
relevant documentation. It requires two written recommendations, though the 
validity and ethical implications of this has been challenged (Bouman et al., 
2014). However, chest reconstructive surgery may be considered following a 
minimum of six months of cross-sex hormone treatment. Physical treatments, 
such as cross-sex hormone treatment and gender-related surgery, are not 
desired by or necessary for all trans individuals as part of their transition: for 
some these options can alleviate their dysphoria whereas for others changes in 
gender role and expression are sufficient (Bockting et al., 2011; Bockting, 
2008). Follow-up care is provided for those who have completed their gender 
role transition and/or undergone sex reassignment surgery (SRS). 
 
The role of the gender clinician, throughout the transitional process, is not only 
to provide support and prescribe hormones but also to assess any mental 
health problems the trans individual may have or may develop. Evidence 
suggests that mental health problems are more prevalent in this population than 
the general cisgender population (e.g., Claes et al., 2015; Davey, Bouman, 
Arcelus, & Meyer, 2014; Heylens et al., 2014), therefore professionals who 
work with trans individuals need to be aware of possible mental health issues.  
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1.2.4 Mental health issues 
 
1.2.4.1 Depression 
 
 
Depressive disorders have been recognised as a risk among trans 
individuals. While there is some clinical evidence to show a low prevalence of 
depressive disorders (e.g., Bodlund & Kullgren, 1996; Cole, O’Boyle, Emory, & 
Meyer, 1997; Gómez-Gil, Trilla, Salamero, Godás, & Valdés, 2009; Hepp, 
Kraemer, Schnyder, Miller, & Delsignore, 2005; Hoshiai et al., 2010; Landén, 
Wålinder, & Lundström, 1998; Levine & Solomon, 2009), others have found 
rates as high as 60% of trans individuals reporting a lifetime history of an 
affective disorder (Heylens et al., 2014). Further, the psychometric data on 
depression tends to reveal a greater number of individuals who experience 
depressive symptoms (e.g., Clements-Nolle, Marx, Guzman, & Katz, 2001; 
Nuttbrock et al., 2013; Rotondi, Bauer, & Scanlon, 2011; Rotondi, 2012). These 
high rates of depressive symptoms are not surprising given that individuals with 
gender dysphoria often present with a number of well-known risk factors for 
depression including poor self-esteem, social isolation and suicide ideation 
(e.g., Fitzpatrick, Euton, Jones, & Schmidt, 2005; Haas et al., 2011; Nemoto, 
Bödeker, & Iwamoto, 2011; Simon, Zsolt, Fogd, & Czobor, 2011). Given that 
there is mixed evidence in the depression literature relating to this population, a 
more detailed review is provided in Part 2 of this chapter. 
 
1.2.4.2 Non-suicidal self-injury (NSSI) 
 
There is relatively little research on NSSI among trans individuals 
compared to the literature on depression and on suicide. However, anecdotal 
reports provided by clinicians suggest a high prevalence of NSSI (Gapka & Raj, 
2003). Among trans adults presenting to services, 2-9% report self-injury to 
genitals and breasts (Dixen, Maddever, Van Maasdam, & Edwards, 1984) 
whereas among children and adolescents experiencing gender dysphoria, 21% 
report a history of self-mutilation (Spack et al., 2012). NSSI may be seen as a 
coping mechanism for dysphoria. If individuals were to undergo gender 
reassignment treatment to alleviate their dysphoria, the need for such coping 
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mechanisms may be reduced. However, there has been little exploration into 
the link between treatment/transition and NSSI. 
 
1.2.4.3 Suicide 
 
Suicide is disproportionately high among trans individuals compared to 
the cisgender population (e.g., Mathy, 2002), even among those receiving 
hormone treatment (e.g., Van Kesteren, Asscheman, Megens, & Gooren, 1997) 
and those who have undergone SRS (e.g., Dhejne et al., 2011; Pfäfflin & 
Junge, 1998). In one follow-up study, not only was there an increased risk of 
suicide attempts among sex-reassigned persons compared to cisgender 
controls, the mortality rate due to suicide was also significantly higher (Dhejne 
et al., 2011). Early research found that 19 to 25% of trans individuals seeking 
SRS reported a previous suicide attempt (Dixen et al., 1984). Later research 
among self-identified trans individuals suggests this rate is even higher, with 
between one quarter to two thirds having made a previous suicide attempt (e.g., 
Clements-Nolle et al., 2001; Clements-Nolle, Marx, & Katz, 2006; Grossman & 
D’Augelli, 2007; Kenagy & Bostwick, 2005). Evidence suggests that trans 
women especially are at risk (e.g., Van Kesteren et al., 1997), with one study 
reporting the risk of mortality by suicide for hormone-treated trans women as six 
times that of the cisgender population (Asscheman et al., 2011). Interestingly, 
the authors found no significant differences in mortality by death between 
hormone-treated trans men and cisgender individuals (Asscheman et al., 2011), 
though this could be influenced by the smaller number of trans men studied. It 
is well documented that attempted suicide in this population is associated with 
mental health difficulties and transphobic victimisation (e.g., Clements-Nolle et 
al., 2006; Grossman & D’Augelli, 2007; Mathy, 2002). This link between suicide 
and transphobia could account for the high rate of suicidality continuing post-
treatment as social stigma and associated discrimination often persists. 
 
The risk identified in these three areas of depression, NSSI, and suicide, 
indicate that trans individuals are likely to present with poorer psychological 
wellbeing than the cisgender population. However, psychological wellbeing is 
more than the presence or absence of mental health problems.  
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1.3 Part 2: Psychological wellbeing  
 
1.3.1 Defining psychological wellbeing 
 
Psychological wellbeing is a multidimensional concept; it is not merely 
the absence of mental illness but the presence of wellness (Ryff & Singer, 
1996). This perspective is advocated by Greenspoon and Saklofske (2001) who 
recommend a dual approach to psychological health that integrates both 
positive indicators, such as subjective wellbeing, and negative indicators, such 
as psychopathology. Traditionally, emphasis has been placed on 
psychopathology, which can be seen in the wealth of research on mental health 
problems among trans individuals, whereas more recent literature has valued 
positive indicators. The two are not opposing points on a continuum and there 
is a need to recognise the value of studying them simultaneously (Greenspoon 
& Saklofske, 2001). 
 
Quality of life is one positive indicator of psychological wellbeing. While the 
literature lacks a unifying definition, there is general agreement that quality of 
life is subjective in nature, can be viewed as a global perception of happiness 
underpinned by various domains of life, and is determined by how well 
expectations correspond with reality (Anderson & Burckhardt, 1999) Therefore, 
quality of life can be understood as an individual’s own perception of happiness 
or satisfaction with life domains that he/she attributes importance to (Oleson, 
1990). From a health perspective, quality of life is also considered to indicate 
one’s emotional, social, physical, and functional wellbeing (Aaronson, 1988; 
Fallowfield, 1990). 
 
1.3.2 Psychological wellbeing among the trans population: A review 
 
As psychological wellbeing is directly associated with mental health 
problems and quality of life, the following review will focus on these dimensions 
in order to give a satisfactory overview of the available literature on 
psychological wellbeing among the trans population. Presented are evidence 
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on rates of depressive disorders and symptoms; levels of both psychopathology 
and depression derived from psychometric tests; and reports of quality of life 
among trans individuals. 
 
1.3.2.1 Prevalence of depressive disorders and symptoms 
 
Studies looking at rates of depression among trans individuals have 
given very different prevalent rates, varying from 1% (Hoshiai et al., 2010) to 
60% (Heylens et al., 2014). It is likely that some of the discrepancies in the 
literature are due to the role of treatment/transition not being accounted for, as 
the rates of mental health problems may vary depending where people are in 
the transitional process. Stage of treatment is known to impact psychological 
wellbeing (e.g., Heylens, Verroken, De Cock, T’Sjoen, & De Cuypere, 2014; 
Keo-Meier et al., 2015; Smith, Van Goozen, Kuiper, & Cohen-Kettenis, 2005). 
For example, Gómez-Gil and colleagues from Barcelona found that 31% of 
individuals without hormone treatment experienced depressive symptoms 
compared to just 8% of those with hormone treatment (Gómez-Gil et al., 2012); 
however, it should be noted that the two groups in this study were not matched. 
Furthermore, some authors have speculated that simply the initiation of 
treatment and anticipation of undergoing SRS can contribute to an 
improvement in mood and alleviate emotional distress (e.g., Blanchard & 
Steiner, 1983; Gómez-Gil et al., 2012). It is therefore possible that the reports of 
lower prevalence rates (e.g., Bodlund & Kullgren, 1996; Hepp et al., 2005; 
Hoshiai et al., 2010; Landén et al., 1998) may be due specifically to assessing 
individuals who are seeking treatment and perhaps closer to achieving their 
goals of realigning the body with their gender identity. Even those measured at 
baseline (pre-treatment) (e.g., Bodlund & Kullgren, 1996) may exhibit lower 
levels of distress as they have a certain level of functioning to actively pursue 
treatment and to present to services, and are likely anticipating their desired 
treatment. Linked to this issue, measuring current depressive disorders may 
contribute to the low prevalence rates reported. Measuring lifetime history of 
depressive disorders, which includes experiences prior to treatment, is likely to 
give a different picture. This issue is highlighted in a major study that compiled 
data across four European countries where current affective disorders were 
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present in 27% of those with a diagnosis of GID seeking SRS (Heylens et al., 
2014). This rate rose to 60% when lifetime prevalence of affective disorders 
was included. This is supported by other research which similarly reveals higher 
rates of depression from data on lifetime prevalence of depression (e.g., Hepp 
et al., 2005; Levine & Solomon, 2009). 
 
The conflicting evidence highlighted above may also result from several 
methodological problems in the literature. One of the complications in 
attempting to integrate the available evidence is that there is variation between 
reporting of depressive symptoms (e.g., Budge, Adelson, & Howard, 2013), 
depressive episodes (e.g., Pitts, Smith, Mitchell, & Patel, 2006), and 
mood/affective disorders (e.g., Hoshiai et al., 2010), which likely contributes to 
the inconsistencies between studies. 
 
A further issue is that the reputability of the existing evidence of depression in 
this population is weakened by a lack of control groups (e.g., Landén et al., 
1998). In one of the few studies to provide a comparison group of cisgender 
individuals, depressive disorders were significantly more common in trans 
university students than in their cisgender peers (Lai, Chiu, Gadow, Gau, & 
Hwu, 2010). However, among such studies where comparisons are made to the 
cisgender population, either the control groups are not matched to the trans 
groups (e.g., Haraldsen & Dahl, 2000; Simon et al., 2011) or secondary data is 
relied upon (e.g., Sanchez & Vilain, 2009).  
 
An additional potential confounder in the research is reporting bias. The 
presence of a mental health problem, such as depression, is not necessarily a 
contraindication to hormone or surgical treatment but must be effectively 
managed prior to or alongside gender treatment (Coleman et al., 2012; Wylie et 
al., 2014). However, if individuals perceive that disclosure of significant mental 
health difficulties may hinder their access to treatment, clinical assessments 
(and also self-report measures) may be subject to underreporting of 
depression. 
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In terms of representativeness and generalisability to other trans groups, an 
important note is that clinic-based studies include only those who present to 
clinical services seeking transition-related care (Zucker & Lawrence, 2009). 
Therefore, evidence of depression derived from clinic-based research is likely 
to be skewed by particular types of trans individuals, namely those who have 
access to clinical services and are both motivated and capable of seeking 
treatment (Eklund, Gooren, & Bezemer, 1988), and may misrepresent the 
psychological wellbeing of the broader population of trans individuals. It is 
possible that clinic-based studies miss those who have greater difficulties in 
their psychological wellbeing as these patients may be unlikely to be accepted 
onto a treatment programme, approved for SRS, or even ask to be referred to 
gender services. These issues may account for the much higher rate of 
depression identified in an online survey which reported that 59% of self-
identified trans men and 49% of trans women had been told by their doctor they 
were suffering from depression (Pitts, Smith, Mitchell, & Patel, 2006). Those 
who do not have the opportunity of appropriate treatment (more likely to be 
captured by internet surveys or community-based studies) may suffer poor 
psychological wellbeing as a result of unmanaged gender dysphoria. Accessing 
treatment can be problematic owing to the general lack of gender services, 
inadequate funding, reliance on referrals from local mental health services, and 
availability of psychological, endocrinological, and surgical expertise (Bouman 
& Richards, 2013). On the other hand, if Transsexualism is considered an 
extreme sense of gender dysphoria, sufficiently intense to require treatment, 
those who present to services (and in clinical research) may in fact have poorer 
psychological wellbeing than those captured in community-based studies which 
tap into the wider trans population, including those who do not desire or need 
gender treatment to live whole, well-adjusted lives. 
 
In addition to structured clinical assessments, there is a wealth of evidence on 
depressive symptoms derived from psychometric measures. Although several 
different psychometric instruments have been employed to investigate levels of 
depression among trans individuals, a majority of studies have used the Centre 
for Epidemiological Studies Depression Scale (CES-D; Radloff, 1977) which 
offers a cutoff score to indicate clinical depression. Approximately two thirds of 
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trans women and trans men were categorised as depressed on the CES-D 
(Clements-Nolle et al., 2001; Nuttbrock et al., 2013; Rotondi, Bauer, & Scanlon, 
2011; Rotondi, Bauer, Travers, et al., 2011), though in several cases the 
number of participants scoring in the clinical range was nearer 50% (Clements-
Nolle et al., 2001; Gonzalez, Bockting, Beckman, & Durán, 2012; Nemoto et al., 
2011; Sanchez, Finlayson, Murrill, Guilin, & Dean, 2010). The Patient Health 
Questionnaire 9 (PHQ-9; Spitzer, Kroenke, & Williams, 1999) also revealed 
relatively high levels of depressive symptoms: 35% of trans women reported 
moderate to severe levels of depressive symptoms (Bazargan & Galvan, 2012). 
Compared to trans individuals who present to GICs seeking treatment (e.g., 
Gómez-Gil et al., 2009; Landén et al., 1998), levels of depressive symptoms 
among trans individuals within the community appear much higher (e.g., 
Bazargan & Galvan, 2012; Pitts, Couch, Mulcare, Croy, & Mitchell, 2009).  
 
In contrast, evidence generated from some of the alternative depression 
instruments, including the Minnesota Multiphasic Personality Inventory (MMPI; 
Butcher, Dahlstrom, Graham, Tellegen, & Kreammer, 1989), Hospital Anxiety 
and Depression Scale (HADS; Zigmond & Snaith, 1983) and Symptom 
Checklist 90 (SCL-90; Derogatis, 1977), tend to show scores in the normal 
range among trans individuals (e.g., Gómez-Gil, Vidal-Hagemeijer, & Salamero, 
2008; Gómez-Gil et al., 2012; Hunt, Carr, & Hampson, 1981; Simon et al., 
2011). However, these studies specifically investigated individuals seeking sex 
reassignment surgery. As emphasised previously, the anticipation or actual 
acceptance for treatment is likely to skew these findings. If individuals were 
later denied the treatment they sought and expected, this would likely have a 
major impact on their levels of distress. 
 
With regard to gender differences, there are further conflicting results. Some 
studies have found no evidence of significant gender differences in depression 
(e.g., Gómez-Gil et al., 2008; Gorin-Lazard et al., 2012; Haraldsen & Dahl, 
2000), whereas others suggest that trans women experience much higher 
levels of depression than trans men (e.g., Clements-Nolle et al., 2001; Couch et 
al., 2007; Hepp et al., 2005; Smith et al., 2005). Contradictions are even found 
within studies, for example Hepp et al. (2005) found that while there were no 
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gender differences in scores on the HADS, clinical assessments revealed that 
20% of trans women had a current mood disorder compared no trans men. 
Though this study had very small sample sizes, it highlights how different 
measurement tools can affect the results. One potential explanation as to why 
trans women may be more vulnerable to depression is that the social 
implications, particularly through childhood and adolescence, are more severe 
for trans women (e.g., Devor, 2004): feminine behaviour in natal males is far 
less tolerated and incurs greater reproach than masculine behaviour in natal 
females. Consequently, greater difficulties in finding acceptance, compared to 
trans men, may increase the risk of depression among trans women. 
 
An additional consideration, with regards to measurement, is that self-report 
measures apply different thresholds to clinical assessment: high depression 
scores on psychometric measures are not necessarily equivalent to clinical 
diagnoses (e.g., Caracciolo & Giaquinto, 2002). Though some measures 
include a clinical range or cutoff score (e.g., CES-D; Radloff, 1977), individuals 
who experience symptoms classed as ‘moderate’ or ‘severe’ may not 
necessarily fulfil sufficient criteria for a diagnosis of depression (Gómez-Gil et 
al., 2012). This can create discrepancies in the literature, however evidence of 
subclinical distress is still valuable. If trans individuals report levels of 
depressive symptoms, not represented by diagnosis, that are disproportionately 
higher compared to the cisgender population, it is important to be aware of this 
risk.  
 
1.3.2.2 Evidence of psychopathology 
 
Depression is one aspect of psychopathology, however a number of 
studies have assessed global psychopathology among trans individuals (e.g., 
Cole et al., 1997; Fisher et al., 2013; Greenberg & Laurence, 1981; Haraldsen 
& Dahl, 2000; Simon et al., 2011; Tsushima & Wedding, 1979). The Symptom 
Checklist 90 (SCL; Derogatis, 1977) and the Minnesota Multiphasic Personality 
Inventory (MMPI; Butcher, Dahlstrom, Graham, Tellegen, & Kreammer, 1989), 
two of the most commonly used measures of psychopathology, tend to produce 
similar findings that levels of global psychopathology are not significantly 
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different from the cisgender population, even when considering trans groups at 
varying stages of treatment (e.g., Cole et al., 1997; Fisher et al., 2013; 
Greenberg & Laurence, 1981; Haraldsen & Dahl, 2000; Simon et al., 2011; 
Tsushima & Wedding, 1979). Importantly, when compared to psychiatric 
groups, trans individuals show significantly lower levels of psychopathology 
(Greenberg & Laurence, 1981; Haraldsen & Dahl, 2000). However, unlike the 
literature on depression, where a considerable proportion of the evidence 
comes from non-clinical data, the evidence on psychopathology is almost 
exclusively clinical, specifically recruiting SRS applicants. Since the rigorous 
selection process for SRS is likely to exclude those with severe 
psychopathology (e.g., Ross & Need, 1989), this may explain the findings of 
low psychopathology (Haraldsen & Dahl, 2000). In addition, those studies that 
include post-SRS individuals (e.g., Ross & Need, 1989) may be biased by the 
exclusion of drop-outs. This is important to note as higher levels of 
psychopathology are associated with drop-out from treatment (Smith et al., 
2005). This could create bias and misrepresentation in the data. 
 
As highlighted previously, the initiation of treatment is known to not only 
alleviate gender dysphoria, but also to reduce concurrent psychopathology. 
This is observed in the prospective study by Heylens et al (2014) where scores 
relating to anxiety, depression, interpersonal sensitivity, and hostility, were 
significantly reduced when measured following treatment. Moreover, at pre-
treatment testing, scores of psychopathology among trans individuals were 
significantly higher compared to general population norms, whereas at post-
treatment these scores reflected similar levels of psychopathology to general 
population norms. Similar findings were reported by Smith et al. (2005), but only 
in relation to trans women: levels of psychopathology remained higher among 
trans men at post-treatment testing. Interestingly, the authors speculate 
possible reporting bias at post-treatment when individuals responses may be 
influenced by relief and a desire to downplay negative experiences, thus 
reducing cognitive dissonance after life –changing, irreversible surgery. In what 
may be considered a more rigorous study (one that included an age-matched 
cisgender control group), there is a different picture. Auer et al. (2013) found 
that trans individuals, even when receiving hormone treatment, reported greater 
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levels of psychopathology, compared to matched cisgender controls. However, 
having hormone treatment is, for many, not the end of their gender journey but 
a step closer to having a more congruent body and physical appearance. Many 
individuals may need additional steps (socially and physically) towards their 
desired gender, before their psychological wellbeing improves in a marked way. 
Two studies that specify their participants were living full-time in their desired 
gender role at the time of study found low levels of psychopathology 
(Greenberg & Lawrence, 1981; Simon et al., 2011). Assessing trans individuals 
who live full-time in their desired gender role is likely to influence levels of 
psychopathology as those who have the opportunity to do so (encountering less 
social barriers or perhaps living in spite of these) are likely to experience 
greater psychological wellbeing by having a more congruent self. 
 
1.3.2.3 Quality of life literature 
 
Having examined the negative indicators of psychological wellbeing 
(depression and psychopathology), the focus shifts now to the literature on 
quality of life among the trans population. Quality of life can be defined as a 
person’s emotional, social, physical, and functional wellbeing (Aaronson, 1988; 
Fallowfield, 1990), and their subjective satisfaction or happiness in various 
domains of life (Oleson, 1990). Much of the evidence that will be discussed 
comes from self-report quality of life measures, such as the Short Form 36 
Health Survey. Perhaps due to the need to justify such major and life-changing 
intervention, the majority of the literature is occupied by the relationship 
between gender reassignment treatment and quality of life (e.g., Ainsworth & 
Spiegel, 2010; Murad et al., 2010; Weyers et al., 2009; Wierckx et al., 2011). 
There appears to be consensus among the evidence that gender reassignment 
treatment has a vital impact on quality of life: many trans individuals report 
significant improvements to quality of life (e.g., Lawrence, 2003; Parola et al., 
2010; Rakic, Starcevic, Maric, & Kelin, 1996), scoring highly overall on quality 
of life measures following SRS (e.g., Weyers et al., 2009; Wierckx et al., 2011). 
In fact, in a meta-analysis, pooling 1833 trans individuals who underwent SRS, 
80% reported an improvement in quality of life (Murad et al., 2010). While one 
study reported no differences in quality of life between SRS and non-SRS 
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groups (Motmans, Meier, Ponnet, & T’Sjoen, 2012), it was unclear whether or 
not non-SRS participants in this particular study actually desired surgical 
treatment. As mentioned previously, not all trans individuals desire SRS and 
many go on to live fulfilled lives without additional treatment, which could 
account for these contrasting findings. 
 
Despite generally positive evidence regarding quality of life (at least post-
treatment) in this population, there is a distinct lack of clarity in several studies 
on how improvement to quality of life is defined and measured. Specifically, it is 
unclear whether post-SRS individuals are comparing their own experiences or 
being compared to others who are pre-SRS, with or without hormone treatment. 
There is also further reason to interpret these findings with caution. Several 
studies are weakened by their reliance on retrospective reports, in the absence 
of baseline (pre-SRS) data (e.g., Johansson, Sundbom, Höjerback, & Bodlund, 
2010; Lawrence, 2003; Parola et al., 2010; Rakic et al., 1996). Subjective 
reports or participant recall may be distorted by memory or attempts to make 
post-SRS experiences appear more favourable to reduce cognitive dissonance 
(e.g., Johansson et al., 2010; Lawrence, 2003; Smith et al., 2005). It would not 
be easy for individuals to openly express regret over a life-changing and 
irreversible procedure (Johansson et al., 2010). However, some argue that 
post-SRS data is less susceptible to social desirability bias; when collecting 
data pre-SRS, participants might feel they need to respond a specific way in 
order to receive treatment and be accepted for SRS (Gorin-Lazard et al., 2012; 
Lawrence, 2003). 
 
More importantly, very few studies include cisgender control groups resulting in 
a lack of understanding as to how the quality of life of trans individuals (whether 
they are pre/post treatment or somewhere in between) compares to that of 
cisgender individuals. The limited evidence that suggests quality of life among 
trans individuals, specifically trans men, is lower than the cisgender population 
typically relies on unmatched secondary data (e.g., Motmans, Meier, Ponnet, & 
T’Sjoen, 2012; Newfield, Hart, Dibble, & Kohler, 2006). Whilst one study 
recruited cisgender individuals as a control group, the findings lack reliability 
given the small sample sizes, particularly with only including three trans men 
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(Kuhn et al., 2009). A replication study with higher numbers of both trans and 
cisgender participants would be useful to verify Kuhn et al.’s findings. 
 
With regards to differences in gender, there is no clear trend in the limited 
evidence available. Some studies show no differences between trans women 
and trans men (e.g., Gorin-Lazard et al., 2012; Parola et al., 2010), whereas 
others suggest trans men experience lower quality of life than trans women 
(e.g., Johansson et al., 2010). One explanation of why the evidence is mixed 
could be that trans women and trans men have different experiences of and 
responses to treatment and that reports of quality of life may differ depending 
on where they are in their gender journey. For example, ‘bottom surgery’ for 
trans men (e.g., phalloplasty) is very complex, requires several operations, and 
carries a high risk of complications, in comparison to ‘bottom surgery’  for trans 
women (e.g., vaginoplasty). This could by one reason why, at post-treatment, 
trans women show greater improvement to quality of life than trans men 
(Johansson et al., 2010). Generally, it is difficult to draw any firm conclusions on 
gender differences when these studies are based on such small sample sizes 
and present conflicting evidence. 
 
Aside from treatment and to a far lesser extent gender, scarcely any other 
factors have been explored in relation to what influences trans individuals’ 
quality of life. One recent exception to this, however, identified family support 
and being in employment or education as factors linked to higher quality of life 
among pre-SRS trans individuals (Gómez-Gil, Zubiaurre-Elorza, de Antonio, 
Guillamon, & Salamero, 2014). As will be discussed shortly, there are further 
factors to consider that would valuably expand on the work of Gómez-Gil and 
colleagues. 
 
1.3.3 Why might trans individuals be more vulnerable to poor psychological 
wellbeing? 
 
While there is variation in the literature, the trans population generally 
appears vulnerable to diminished psychological wellbeing. When exploring why 
this might be the case, there are two salient causes that warrant discussion 
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(though these are not exclusive): the distress at the core of gender dysphoria 
and the distress due to the social stigma. As mentioned earlier in the chapter, 
those with gender dysphoria may experience distress arising from incongruent 
anatomy and physiology, such as the presence of unwanted genitals or 
sensation of inappropriate hormones (Bouman et al., 2010). Additionally, many 
trans individuals must negotiate the social challenges of being perceived and 
treated as the gender they were assigned at birth and not the gender they 
identify with (Bouman et al., 2010). 
 
Independent of body-related distress, an ongoing challenge is living with the 
pervasive social stigma that is attached to gender-non-conformity and 
consequent incidents of transphobia (Couch et al., 2007). The frequency and 
severity of discrimination and violence experienced by trans individuals are 
widely reported (e.g., Clements-Nolle et al., 2006; Grant et al., 2011; Kenagy & 
Bostwick, 2005; Lombardi, Wilchins, Priesing, & Malouf, 2002; Mizock & Lewis, 
2008). In a more immediate sense, this intolerance and transphobia can extend 
to family attitudes, leading to outright rejection or a lack of support from loved 
ones (Koken, Bimbi, & Parsons, 2009). Disclosure and living openly as trans (or 
being perceived as gender non-conforming) exposes individuals to transphobia, 
whether this is intolerance and hostility at an individual level or the systematic 
discrimination of policies and practices that exclude or undermine trans 
experiences and expressions (Bouman et al., 2010). According to Meyer’s 
(Meyer, 1995, 2003) minority stress theory, the minority status of trans 
individuals results in greater exposure to psychosocial stressors (prejudice, 
discrimination and victimisation) and consequently, adverse health outcomes. 
Among the lesbian, gay, and bisexual (LGB) population, there is clear evidence 
that minority stressors, specifically homophobic experiences, hostile 
heterosexist environments and stigma consciousness, predict poorer 
psychological wellbeing (e.g., Kelleher, 2009; Lewis, Derlega, Clarke, & Kuang, 
2006; Lewis, Derlega, Griffin, & Krowinski, 2003). Similarly, evidence in the 
trans literature suggests that the impact of stigma and transphobia are likely to 
play a causal role in the high risk of depression (e.g., Nemoto et al., 2011), self-
injurious behavior (e.g., Gapka & Raj, 2003), and suicide (e.g., Clements-Nolle 
et al., 2006; Maguen & Shipherd, 2010).  
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1.3.4 Factors linked to trans psychological wellbeing 
 
So far, the literature assessing levels of psychological wellbeing has 
been examined and some explanations as to why trans individuals can be at 
risk of poor wellbeing have been considered. Currently, less is known about 
what factors may be associated with psychological wellbeing among this 
population. However, a selection of potential factors that emerge from the 
literature will now be discussed.  
 
1.3.4.1 Social support 
 
Social support is one factor that may have beneficial effects for trans 
individuals’ wellbeing, for example family support has been linked to higher 
quality of life among SRS applicants (Gómez-Gil et al., 2014). Other 
researchers have speculated that support from family members may protect 
transgender individuals from harmful societal prejudice and discrimination 
(Koken et al., 2009). Similarly, positive reactions to disclosure from work 
colleagues can buffer against stress generated by transgender identity (Law, 
Martinez, Ruggs, Hebl, & Akers, 2011). However, where social support is less 
available (e.g., Ryan, Russell, Huebner, Diaz, & Sanchez, 2010) or perhaps 
has been lost through disclosure/transition (e.g., Koken et al., 2009), poor 
psychological wellbeing is likely to be experienced. Importantly, inadequate 
social support, particularly family support, has been identified as a risk factor for 
poor prognosis following SRS (Ross & Need, 1989), though this evidence is 
based on a very small sample size. While the general literature on the 
beneficial effects of social support for mental wellbeing is extensive (e.g., 
Dumont & Provost, 1999; Hinson Langford, Bowsher, Maloney, & Lillis, 1997; 
Shumaker & Brownell, 1984), there are important gaps in the trans literature. 
For example, in contrast to what is known about family support, levels of 
support from friends and partners, and how this relates to psychological 
wellbeing, is one area that is relatively unexplored. 
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1.3.4.2 Interpersonal functioning 
 
One factor which is notably under studied in the trans literature is 
interpersonal functioning. Secure and fulfilling interpersonal relationships are 
considered a crucial component to people’s happiness and emotional wellbeing 
(e.g., Berscheid & Peplau, 1983). Therefore, difficulties in relating to others and 
being able to seek and utilise social support (interpersonal problems) are likely 
to negatively affect psychological wellbeing. This has been demonstrated in the 
general literature: interpersonal problems are implicated in both the 
development and maintenance of depression and other mental health problems 
(e.g., Arcelus, Haslam, Farrow, & Meyer, 2013; Barrett & Barber, 2007; 
Eberhart & Hammen, 2006; Ravitz, Maunder, & McBride, 2007). Though 
interpersonal problems have not yet been measured among the trans 
population, given the strong evidence from the literature on the general 
population, interpersonal problems are likely to predict poor psychological 
wellbeing. 
 
1.3.4.3 Transphobia  
 
The impact of transphobic experiences on psychological wellbeing has 
attracted considerable attention. There is consistent evidence that severity of 
depression, among both trans women and trans men, is strongly associated 
with exposure to transphobia (e.g., Bazargan & Galvan, 2012; Couch et al., 
2007; Nemoto et al., 2011; Nuttbrock et al., 2010; Rotondi, Bauer, & Scanlon, 
2011; Rotondi, Bauer, Travers, et al., 2011; Sugano, Nemoto, & Operario, 
2006). In fact, transphobia may play a causal role in depression. Recent 
research found dose-response type correlations between transphobia and 
major depression among trans women during adolescence (Nuttbrock et al., 
2010). In this particular study, where the evidence for causality diminished 
among later life stages, it was speculated that with age comes reduced 
exposure to transphobia and/or the development of more effective coping 
mechanisms. Furthermore, trans women who reported modifying their 
behaviour due to fear of stigma were more likely to be depressed than trans 
women who didn't modify their behavior (Couch et al., 2007). This suggests that 
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the impact of trying to conform to social norms, in order to avoid transphobia, 
and consequently being unable to reveal their true selves, is likely to impair 
trans individuals’ psychological wellbeing. The literature regarding transphobia 
as a predictor of depression is relatively convincing, however less is known 
about the link to other areas of psychological wellbeing, for example the impact 
of such experiences on quality of life. 
 
1.3.4.4 NSSI 
 
Section 1.2.4.2 briefly reviewed the limited research into NSSI in the 
trans population (e.g., Dixen et al., 1984; Gapka & Raj, 2003) and suggested 
that trans individuals may be more likely to engage in self-injurious behaviour 
than cisgender individuals as a means to cope with their distress. The general 
literature has identified associations between NSSI and a range of indicators of 
poor psychological wellbeing, including low self-esteem, emotional distress, 
anxiety, and depression (e.g., Laye-Gindhu & Schonert-Reichl, 2005; Skegg, 
2005). Therefore, it is expected that NSSI could be a predictor of poor 
psychological wellbeing among trans individuals. 
 
1.3.4.5 Self-esteem 
 
Among the cisgender population, low self-esteem is known to predict 
poorer psychological wellbeing as indicated by less positive and more negative 
affect; greater severity of stress; depression and anxiety; and suicide ideation 
(e.g., Brown, Andrews, Harris, Adler, & Bridge, 1986; Juth, Smyth, & Santuzzi, 
2008; Karatzias, Chouliara, Power, & Swanson, 2006; Orth, Robins, & Roberts, 
2008; Wild, Flisher, & Lombard, 2004). Low self-esteem among trans 
individuals has been well documented in the literature (Clements-Nolle et al., 
2006; Erich, Tittsworth, Dykes, & Cabuses, 2008; Schrock, Holden, & Reid, 
2004; Skrapec & MacKenzie, 1981). Evidence to date has shown that self-
esteem in this group is related to stage of transition (Wolfradt & Neumann, 
2001); experiences of transphobia (Iantaffi & Bockting, 2011); positive trans 
identity (Iantaffi & Bockting, 2011); disclosure and being ‘out’ to others (e.g., 
Erich, Tittsworth, Dykes, & Cabuses, 2008; Strain & Shuff, 2010); and family 
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acceptance (Ryan et al., 2010). While the link between self-esteem and 
psychological wellbeing in the trans population has not yet been studied, it is 
expected that self-esteem plays a vital role in the psychological wellbeing of 
trans individuals, perhaps even to a greater degree than among the cisgender 
individuals. 
 
1.3.4.6 Body image 
 
For many trans individuals, the core source of distress is their body and 
how congruent their body is with their gender identity (Bandini et al., 2013). This 
is reflected in reports of trans individuals showing greater levels of 
dissatisfaction with their overall appearance and all body features compared to 
cisgender individuals (e.g., Becker, et al., 2015). As expected, body 
dissatisfaction is higher in relation to sex-specific body features, such as 
genitalia and androgen-responsive characteristics, than body features that are 
less connected with natal sex, such as facial characteristics and body shape 
(Becker, et al., 2015). Yet, body image generally improves with treatment 
(Fisher et al., 2014). Those trans individuals without hormone treatment or pre-
SRS demonstrate poorer body image than those receiving hormone treatment 
or post-SRS (Bandini et al., 2013; Fisher et al., 2014). This can be seen as an 
indication of body image improving as the body becomes more closely aligned 
with the person’s gender identity. Though it tends not to be directly measured in 
research, poor body image would be expected to affect trans individuals’ 
psychological wellbeing, particularly among those who have not yet completed 
their desired treatment. Due to the body being the focal point for dysphoria, 
poor body image or high body dissatisfaction is likely to be linked to increased 
depressive symptoms, greater psychopathology and poorer quality of life. 
Though one study found that body uneasiness reported by trans individuals 
was not linked to scores of general psychopathology (Bandini et al., 2013), 
there is a general lack of evidence in this area and this particular finding has not 
be supported or refuted. 
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1.3.4.7 Age 
 
A demographic factor that may influence the psychological wellbeing of 
trans individuals is age. Though little research has investigated the effects of 
age in this population, there is some evidence to suggest that younger trans 
individuals are more vulnerable to greater mental health difficulties (Heylens et 
al., 2014) and poorer quality of life (Newfield et al., 2006). One explanation, 
proposed by Nuttbrock et al. (2010), suggests that as trans individuals become 
older, they are able to develop more effective coping mechanisms to manage 
distress and may experience less transphobia (which is known to adversely 
affect wellbeing). 
 
1.3.4.8 Gender 
 
A further demographic factor to consider, in relation to psychological 
wellbeing, is gender. As highlighted in section 1.3.2, though several studies 
have explored potential gender differences in this area, there are inconsistent 
findings both within and between studies. Some report no evidence of 
significant gender differences in levels of depression (e.g., Gómez-Gil et al., 
2008; Gorin-Lazard et al., 2012; Haraldsen & Dahl, 2000) or in quality of life 
(e.g., Gorin-Lazard et al., 2012; Parola et al., 2010). In contrast, other evidence 
shows that trans women have higher levels of depression than trans men (e.g., 
Clements-Nolle et al., 2001; Couch et al., 2007; Hepp et al., 2005; Smith et al., 
2005), yet trans men report lower quality of life compared to trans women, and 
report less improvement in quality of life following treatment (e.g., Johansson et 
al., 2010). These contradictions may be in part due to the use of small sample 
sizes and differences in methodology. Illustrating this point, one study reported 
similar depression scores across gender groups on the HADS, but marked 
differences in rates of mood disorders when measured by clinical assessments 
(Hepp et al., 2005). Given the contradictory evidence to date and weak 
methodology often applied, further exploration of gender differences (or 
similarities) in trans psychological wellbeing is needed. 
 
41 
1.4 Part 3: This thesis 
 
1.4.1 Overarching aims 
 
With a view to advancing clinical knowledge and addressing the gaps in 
the existing literature, the endpoint of this research was to have produced a 
model of predictors of psychological wellbeing. As highlighted at the outset, 
psychological wellbeing is a multidimensional concept. Therefore, it was 
essential to measure different aspects of wellbeing, including psychopathology, 
quality of life and life satisfaction. One difficulty was that there is no single 
agreed definition of quality of life. Some researchers propose that quality of life 
relates to emotional, social, physical, and functional wellbeing (e.g., Aaronson, 
1988; Fallowfield, 1990), whereas others suggest it is happiness and 
satisfaction across domains of life (e.g., Oleson, 1990). Each of these 
definitions were considered useful and so within this thesis, quality of life was 
measured according to the first definition and life satisfaction was included in its 
own right. There has been such scarce research into life satisfaction among 
trans populations that the above review of the literature pertains only to 
evidence on psychopathology and quality of life. 
 
In order to achieve this aim of formulating a model, the research began 
comparing trans individuals with cisgender individuals, either replicating 
previous research in a more specific sample or testing new variables. To gain a 
deeper understanding, trans women and trans men were examined separately 
or gender entered as a variable. At the same time, associations between 
predictive factors and psychological wellbeing variables were identified. This 
preliminary work enabled the testing of predictors in Study 4 and the final 
model, underpinned by the combination of previous findings.  
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Figure 1.1. Proposed model of predictors and outcomes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.4.2 Outline of empirical chapters 
 
Study 1. Social support and psychological wellbeing among trans individuals: A 
comparison of patients with matched controls 
Aims: 
− To test whether trans individuals report lower levels of social support 
and psychological wellbeing compared to their cisgender peers. 
− To examine gender differences in social support. 
− To investigate whether social support predicts psychological wellbeing. 
 
 
 
 
Psychological Wellbeing 
↑ Psychopathology 
↓ Quality of life 
↓ Life satisfaction 
↓ Social Support 
↑ Interpersonal Problems 
↑ Experiences of Transphobia 
↑ NSSI 
↓ Self-Esteem 
↑ Body Dissatisfaction 
↓ Age 
Gender 
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Study 2. Interpersonal functioning among treatment seeking trans individuals  
Aims:  
− To investigate whether trans individuals report greater interpersonal 
problems compared to cisgender controls. 
− To test whether trans men and trans women differ in relation to 
interpersonal problems. 
− To assess whether interpersonal problems, if found, remain after 
controlling for depression. 
 
Study 3. Self-injury among trans individuals and matched controls: Prevalence 
and associated factors 
Aims: 
− To examine prevalence of current NSSI among trans individuals on the 
treatment pathway. 
− To compare trans adults who currently engage in NSSI to trans and 
cisgender groups with no history of NSSI, with regards to 
psychopathology, body satisfaction, self-esteem, social support, and 
age. 
 
Study 4. Predictors of psychological wellbeing among trans individuals 
Aims: 
- To cross-sectionally test a model of potential predictors of 
psychological wellbeing among treatment seeking individuals with a 
diagnosis of Transsexualism. 
- To replicate findings from existing research that shows trans individuals 
experience greater psychopathology, increased interpersonal problems, 
higher body dissatisfaction, lower quality of life, and lower self-esteem, 
compared to cisgender individuals. 
- To test which factors significantly predict levels of psychopathology 
(including depression) among trans individuals. 
- To test which factors significantly predict quality of life. 
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- To examine whether self-esteem and social support act as mediators in 
any significant effects of predictors on psychopathology, depression or 
quality of life. 
 
1.4.3 Conclusion: Where are the gaps in the literature? 
 
This review spans three decades of literature on psychological wellbeing 
among trans individuals. There are three main areas where the current 
literature on psychological wellbeing is lacking. Firstly, it is apparent in this 
review that the literature predominantly focuses on depression, with less 
investigation of global psychopathology, and even less into quality of life. 
Where quality of life is explored, it tends to only be in terms of SRS outcomes 
(e.g., Gorin-Lazard et al., 2013; Lawrence, 2003; Rakic et al., 1996; Wierckx et 
al., 2011); little is known about factors, other than treatment, that may affect 
quality of life among trans individuals. However, quality of life is an essential 
component of psychological wellbeing. Secondly, the existing literature primarily 
focuses on prevalence rates; less investigation is granted to predictors of 
psychological wellbeing in this population, though a few (transphobia, social 
support, body image, and self-esteem) have been illustrated here. Where these 
factors are considered, the analysis tends to be limited to correlations and lacks 
detail on what factors predict psychological wellbeing. Thirdly, common 
methodological issues weaken the usefulness of the data: matched control 
groups are scarce; assumptions are often made on small sample sizes; trans 
women and trans men are not always differentiated; and non-clinical studies 
include self-identified individuals who may not fulfil the criteria for a diagnosis of 
Transsexualism. In summary, it is clear that there is a need for more rigorous 
investigation into the factors which predict psychological wellbeing in this 
population. 
  
45 
Chapter 2: Methodology 
 
2.1 Introduction 
 
While the specifics of the method are discussed with respect to each 
study in the subsequent chapters, this chapter will describe the generic protocol 
employed within this thesis. It will detail the design, participants, recruitment 
process, procedure and ethical considerations. It will also outline the 
psychometric measures that were considered and provide a rationale for those 
that were selected.  
2.2 Design 
 
A single, large-scale questionnaire design was considered the most 
suitable approach, in light of the nature of the research questions and principle 
aim to build a model of predictors of psychological wellbeing. Identifying 
predictors of psychological wellbeing using a cross-sectional design was the 
first step in testing the model (Figure 1.1). Collecting data at one time-point 
allowed scope for a wide number of measures (and predictors) to be 
administered and tested, without creating too big a burden on participants’ time.  
2.3 Participants 
 
2.3.1 Eligibility criteria 
 
2.3.1.1 Clinical participants 
 
Clinical participants were eligible to participate if they were attending a 
gender identity clinic (GIC) and had received a clinician-formed diagnosis of 
Transsexualism, according to ICD-10 criteria (WHO, 1992). A requirement of 
the GIC was that two independent gender clinicians, who were experienced in 
the field, had both independently assessed the individual and reached an 
agreement regarding their diagnosis. The ICD-10 is the leading medical 
classification manual in the UK and by ensuring participants had a diagnosis, 
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the study would be replicable and could be compared to existing clinical 
evidence. Individuals who did not fulfil the diagnostic criteria or who had not yet 
been diagnosed were not invited to participate. Those who had a diagnosis of 
Transsexualism and were on the treatment pathway were recruited to the study 
regardless of stage of treatment or transition. A further condition was that 
participants were aged 18 or older as the focus of the research was 
psychological wellbeing in trans adults. 
 
2.3.1.2 Control participants 
 
Cisgender participants, discussed hereafter as control participants, were 
considered eligible to take part if they did not identify themselves as trans and 
did not experience gender dysphoria, and were also over the age of 18. It was 
made clear on the information sheet that the research was interested in 
comparing the psychological wellbeing of trans people to those who are 
cisgender, and that individuals were invited to take part as the control group for 
this purpose. The phrasing used in materials for control participants (such as 
the information sheet, Appendix VI) was adapted for a lay audience. 
Specifically, the term ‘non-transgender’ was used instead of ‘cisgender’ and 
‘trans’ was expanded to ‘transgender’. Under the section “why have I been 
chosen?”, the control information sheet stated: “We are looking for people aged 
between 18 and over, who do not identify as transgender and who do not feel 
they have (or have ever had) gender dysphoria (a condition where you 
experience your gender identity as different to the sex you were born with), to 
take part in the control sample.” The understanding of information sheet was 
checked during the pilot of the control questionnaire pack.  
 
Given that the focal point of the research was psychological wellbeing, 
neither group was screened for any diagnoses of significant mental health 
problems. Rather, measuring levels of psychopathology was an integral part of 
the research. Neither were any participants excluded on the basis of culture, 
religious background, or socio-economic status. The inclusion of an age- and 
gender- matched control group allowed direct comparisons to be made 
between trans and control individuals. 
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2.3.2 Recruitment procedure 
 
2.3.2.1 Clinical participants 
 
All individuals who attended a national NHS GIC in the UK over the 
course of one year were invited to take part in the study. Clinicians were briefed 
on the purpose of the research and asked to identify individuals who fulfilled the 
eligibility criteria from their caseload. Clinicians then dispensed questionnaire 
packs to potential participants at their next appointment following the start of 
data collection. Given that one of the major objectives of this thesis was to test 
a model of predictors of psychological wellbeing (Chapter 6), the sample size 
was guided by Cohen’s d table (Cohen, 1992) which states that, in order to 
achieve a medium effect size and power of 0.8 when using multiple regression 
analysis with eight independent variables, 107 participants are needed. 
 
2.3.2.2 Control participants 
 
A convenience sample of control participants were recruited through a 
University campus as well as social networking websites and local charities and 
voluntary organisations. Psychology undergraduates were invited to participate 
through a departmental research participation scheme. The scheme allowed 
students to earn course credits through participating in psychological research. 
This was an optional scheme and students retained the same rights as all study 
participants. Students were emailed a summary of the research and informed 
that it would involve completing a battery of questionnaires. If students chose to 
participate, they received credits equivalent to 45 minutes of research 
participation. They could either collect a paper version of the questionnaire 
pack from the researcher or follow a weblink to an online version through the 
recruitment email. The scheme provided access to a large pool of younger 
participants, however it was necessary to recruit a broader and more diverse 
sample and therefore social networking websites were used in conjunction. This 
involved advertising a brief description of the study and the weblink to the 
online survey, with permission, on groups’ and individuals’ webpages on 
popular social networking websites. In order to increase recruitment of older 
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participants, local charities and voluntary organisations which were known to 
have older adult members were approached. Permission to recruit members for 
the research was granted by the persons overseeing the organisations. 
Individual members were approached face-to-face or via email by the 
researcher, informed about the nature of the study and what would be required, 
and invited to participate. Again, both paper and online versions of the 
questionnaire pack were offered. In all cases, snowballing techniques were 
applied so that those who participated were encouraged to invite others who 
they thought might be interested to participate and pass on details about how to 
do so. Over a duration of six months, control data were collected until they 
could be satisfactorily matched to the clinical data on age and gender identity. 
2.4 Procedure 
 
A questionnaire pack containing an information sheet, consent form, a 
background questionnaire, and battery of carefully selected self-report 
measures was constructed in both paper (Appendix IV & VII) and online 
formats. Demographic questions specific to the clinical sample (such as 
hormone status and items measuring transphobia) were omitted from the 
background questionnaire for the control sample. The online version was 
created using the programme Bristol Online Surveys and replicated the paper 
version in terms of content and structure. When piloted prior to the study, the 
questionnaire packs took approximately 30 to 45 minutes to complete. Clinical 
participants were invited to complete the paper version at home and return it to 
the clinic by post, using a pre-paid addressed envelope provided. One hundred 
and ten clinical participants returned questionnaire packs, six of which had to 
be discounted due to substantial amounts of missing data (for example where 
entire measures were not completed). This produced a response rate of 
approximately 40%. A total of 160 control participants took part, of which 104 
were matched by age and gender to the clinical sample. First, gender matching 
was performed using clinical participants’ gender identity as opposed to their 
birth sex, which has been recommended in the literature (e.g., Auer et al., 
2013). This matching process was designed to reflect how trans individuals 
desire to be treated as the gender they experience and adopt social and 
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occupational roles that align with that gender identity. Second, age matching 
was conducted and where ages could not be matched exactly, the next 
participant closest in age was selected. Following this process, statistical tests 
were performed to ensure the mean ages of the clinical and control group did 
not significantly differ (z= 5250, p=.358).  
2.5 Ethical considerations 
 
Ethical approval for the procedures applying to clinical participants was 
granted from Coventry and Warwickshire NHS Research Ethics Committee 
(Appendix I).  Loughborough University Ethical Committee approved 
procedures applying to control participants (Appendix I). All participants were 
informed of the overarching research aims and procedures via a Participant 
Information Sheet (Appendix II). Informed consent was sought from all 
participants: those who completed a paper version signed a written consent 
form (Appendix III) and those who completed an online version selected a box 
that indicated their consent on the first webpage of the survey before 
proceeding.  Participants were assured that all their responses would be 
confidential and for control participants, anonymous as well. Participants were 
made aware that their involvement was entirely voluntary and that they retained 
the right to withdraw from the project at any time up until publication and were 
not required to give a reason for withdrawal. Clinical participants were also 
assured that choosing whether or not to participate, or later withdrawing from 
the research, would in no way affect any aspect of care they received at the 
gender clinic. Written consent forms and completed paper questionnaire packs 
were stored separately in locked filing cabinets at Nottingham Gender Clinic 
and all data were entered onto a password-protected computer. Numerical 
codes were assigned to each dataset, in place of participants’ names, to 
preserve confidentiality. Participants were informed that their data would be 
stored in accordance with Loughborough University guidelines and the Data 
Protection Act 1998.  
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2.6 Measures 
 
2.6.1 Background questionnaire (demographic data) 
 
A background questionnaire enabled collection of data on participants’ 
age, gender identity, ethnic origin, employment status, civil status, and living 
situation (Appendix IV & VII). Additional items specific to the clinical group 
were: age of coming out as trans to others, age of transition, age of first referral 
to a gender clinic, current stage of treatment, use of hormone treatment, and 
sex reassignment surgery (SRS) undergone (type and date of surgery). Stage 
of treatment was categorised into assessment, Real Life Experience (RLE) and 
post-surgery (having undergone at least on form of gender surgery). Response 
options to use of hormone treatment were: current use, previous use, or none 
at all. 
 
2.6.2 Selection process for measures 
 
During the process of selecting the most appropriate measures for the 
questionnaire pack, several aspects were considered. First, the measure 
needed to have face validity and suitably align with how the corresponding 
variable was operationally defined in this thesis. Second, evidence of 
satisfactory psychometric properties of the measure must be available. Third, 
the measure had to include access to copyright. Finally, measures that had 
previously been used both in clinical (or ideally trans) and non-clinical adult 
populations were prioritised. Often original measures had been revised and/or 
shortened and where they retained good psychometric properties, this newer or 
shorter version was chosen. The length of each measure was particularly 
important as data were collected at one time-point and there was a risk of over-
burdening participants by measuring several factors at once. Selecting 
psychometrically sound measures and, where possible, those that had 
previously been applied to trans groups, would allow for the potential of 
comparing the data to existing international research. In this section, for each 
variable of interest, several measures that were considered for inclusion are 
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described before providing a justification of why one measure was chosen 
above the others.  
 
2.6.3 Psychological wellbeing 
 
As discussed in the previous chapter, psychological wellbeing is a 
multidimensional construct. Therefore, to build a comprehensive assessment, 
three areas were investigated (levels of psychopathology, quality of life, and life 
satisfaction), necessitating three different instruments. 
 
2.6.3.1 Psychopathology 
 
Hospital Anxiety and Depression Scale – Depression (HADS-D; Zigmond & 
Snaith, 1983) 
 
The HADS comprises seven items that relate to depression and seven 
that relate to anxiety (Zigmond & Snaith, 1983). However, the depression 
subscale can be used in isolation (e.g., Falavigna et al., 2012). An example 
item is “I still enjoy the things I used to enjoy” to which the responses range 
from 1 ‘definitely as much’ to 4 ‘hardly at all’. A depression score is calculated 
by the sum of all 7 responses. Scores can range from 0 to 21 and severity is 
determined as scores between 0 and 7 indicating a normal range, 8-10 mild, 
11-14 moderate, and 15-21 severe. Physical symptoms of depression are not 
included in the scale. The HADS is widely used, with one literature review 
identifying over 700 papers that referred to the measure (Bjelland, Dahl, Haug, 
& Neckelmann, 2002). Though not intended as a diagnostic tool, the scale 
produces clinically meaningful results and is sensitive to changes in response 
to therapeutic and pharmacological intervention (Herrmann, 1997). In a review 
study, specificity and sensitivity for the HADS-D was similar to that achieved by 
the General Health Questionnaire and reliability was high in both samples of the 
general population and clinical groups (Bjelland et al., 2002). The HADS-D has 
also demonstrated a strong correlation with the Beck Depression Inventory 
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(Falavigna et al., 2012) and has been used widely with trans participants (e.g., 
Gómez-Gil et al., 2012; Hepp et al., 2005). 
 
Centre of Epidemiological Studies Depression (CES-D; Radloff, 1977) 
 
The CES-D is a 20-item measure of depressive symptomatology across 
nine symptom groups including: sadness, loss of interest, appetite, sleep, 
concentration, guilt, tiredness, movement, and suicidal ideation (Radloff, 1977). 
Respondents rate how often they have experienced a symptom, such as 
“nothing made me happy” or “I was tired all the time”, in the previous two 
weeks: not at all/less than one day, 1-2 days, 3-4 days, 5-7 days, or nearly 
every day for two weeks. Scores range between 0 and 60 and scores over 16 
are indicative of depressive symptoms. Internal consistency, test-retest 
reliability and construct validity are reportedly good among groups of both 
healthy and physically unwell participants (Devins et al., 1988; Knight, Williams, 
McGee, & Olaman, 1997). In addition, the CES-D is commonly used in 
research with trans individuals (e.g., Clements-Nolle et al., 2001; Nuttbrock et 
al., 2013a; Rotondi, Bauer, & Scanlon, 2011; Rotondi, Bauer, Travers, et al., 
2011). 
 
Minnesota Multiphasic Personality Inventory 2 (MMPI-2; Butcher, Dahlstrom, 
Graham, Tellegen, & Kreammer, 1989) 
 
The MMPI-2 (Butcher et al., 1989) is an extensive 576-item measure of 
psychopathology that spans ten clinical subscales and uses a true/false 
response format. The subscales are: hypochondria, depression, hysteria, 
psychopathic deviate, paranoia, psychasthenia, schizophrenia, hypomania, 
social introversion and masculinity/femininity. Example items include “I find it 
hard to keep my mind on a task or job” and “much of the time I feel as if I have 
done something wrong or evil”. Raw scores are transformed into T scores 
whereby higher scores are indicative of poorer psychological functioning. T 
scores of 65 and above represent presence of psychopathology in the clinical 
range. The MMPI-2 has been translated and adapted internationally (e.g., 
Butcher, 1996) and has previously been used with trans individuals (e.g., de 
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Vries, Kreukels, Steensma, Doreleijers, & Cohen-Kettenis, 2011; Gómez-Gil et 
al., 2008; Keo-Meier et al., 2015; Miach, Berah, Butcher, & Rouse, 2000) as 
well as in clinical and non-clinical adults (e.g., Butcher, 2010). However, some 
authors have cited major structural problems and theoretical concerns, 
including overlap of scales, inadequate validation of scoring, and questionable 
norms (e.g., Helmes & Reddon, 1993). 
 
Symptom Checklist-90-Revised (SCL-90-R; Derogatis, 1977)  
 
The SCL-90-R is a multidimensional instrument which assesses 
psychological functioning and symptoms of psychopathology (Derogatis, 1977). 
It consists of 90 items divided into nine primary symptom dimensions – 
somatisation, obsessive-compulsive, interpersonal sensitivity, depression, 
anxiety, hostility, phobic anxiety, paranoid ideation, and psychoneuroticism. A 
five-point likert scale is used to indicate how much a particular problem has 
distressed or bothered the respondent during the previous seven days: 0 = not 
at all, 1 = a little bit, 2 = moderately, 3 = quite a bit, and 4 = extremely. Higher 
scores indicate greater psychological distress. “Feeling hopeless about the 
future” and “hearing voices that other people do not hear” are two examples of 
items. Calculating the total mean produces the Global Severity Index (GSI) 
score which indicates overall psychological distress. The SCL-90-R has good 
construct validity and reliability for its nine dimensions and GSI score across a 
multitude of non-psychiatric and psychiatric samples and populations (e.g., 
Derogatis & Unger, 2010). It also has high convergent validity with the MMPI 
(Derogatis, Rickels, & Rock, 1976) and has been used frequently with trans 
populations (e.g., Colizzi, Costa, & Todarello, 2014; Haraldsen & Dahl, 2000; 
Udeze, Abdelmawla, Khoosal, & Terry, 2008).   
 
Rationale for choice of measure 
 
In relation to psychopathology, four measures were compared before 
concluding that the SCL-90-R was most suitable. Both specific measures that 
focus solely or primarily on depression and broader measures that evaluate 
psychopathology across a range of dimensions were considered. In the 
54 
literature presented in the introduction chapter, the HADS-D (Zigmond & Snaith, 
1983) and CES-D (Radloff, 1977) were frequently used to assess depressive 
symptomatology among trans individuals (e.g., Gómez-Gil et al., 2012; 
Nuttbrock et al., 2013; Rotondi et al., 2011). These both are empirically 
validated in clinical and non-clinical populations (e.g., Bjelland et al., 2002; 
Devins et al., 1988), relatively short, and offer a cut-off or range that indicates 
severe levels of depression. However on reflection, rather than limiting the 
investigation to depression, it was decided that testing psychopathology on a 
broader level could produce a more complete picture of psychological 
wellbeing. In the introduction, it was highlighted that trans individuals can 
experience a range of mental health problems (e.g., Heylens et al., 2014) and 
measuring general psychopathology could reflect that. Yet, given the 
importance of depression as illustrated by the trans literature (e.g., Heylens et 
al., 2014; Rotondi, 2012a; Weinrich, Atkinson, McCutchan, & Grant, 1995), it 
was deemed desirable to use an instrument that incorporated items on 
depressive symptoms, in addition to satisfactorily covering other areas of 
psychopathology. Again drawing on measures frequently seen in the literature 
examined in the introduction chapter, two such instruments were therefore 
reviewed: the Minnesota Multiphasic Personality Inventory 2 (MMPI-2; Butcher 
et al., 1989) and Symptom Checklist 90 Revised (SCL-90-R; Derogatis, 1977). 
 
On review, the MMPI-2 was ruled out due to two major concerns. First, the 
masculinity/femininity subscale was regarded as problematic in that it involves 
stereotypical gender-based assumptions relating to socio-economic status, 
intelligence and education which veer away from psychological symptoms. 
Second, it was considered too great in length, containing 576 items and 
reportedly taking 60-90 minutes to complete. Even the shortened version of the 
MMPI-2 stands at 180 items (Dahlstrom & Archer, 2000) which was considered 
excessive for the scope of this study. In contrast, the SCL-90-R was judged a 
superior measure of psychopathology since it covers a broad range of 
psychological symptoms, is much shorter than the MMPI, and demonstrates 
good psychometric properties (e.g., Derogatis et al., 1976; Derogatis & Unger, 
2010). One of the key advantages of the SCL-90-R is that it offers both a broad 
and narrow view of psychological wellbeing. Specifically, it can provide an 
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indication of global psychological distress as well as pinpoint distress in certain 
areas, such as depression, anxiety, and obsessions/compulsions, therefore 
offering versatility beyond depression-only measures. Furthermore, the SCL-
90-R is appropriate for use in community samples (e.g., Olsen, Mortensen, & 
Bech, 2004) as well as those with medical or psychiatric conditions (e.g., 
Shannahoff-Khalsa et al., 1999); has been utilised in more than 2000 published 
clinical studies; and has been translated into approximately 30 languages 
(Derogatis & Unger, 2010). An additional benefit is that the SCL-90-R is 
currently included in the routine psychometric assessment of some GIC’s in the 
UK (Gillott & Wylie, 2008), used by European Network for the Investigation of 
Gender Incongruence (ENIGI; Kreukels et al., 2012), and has been used widely 
across the trans literature (e.g., De Cuypere et al., 2006; Fischer et al., 2010; 
Haraldsen & Dahl, 2000; Simon et al., 2011; Smith et al., 2005). For these 
reasons, the SCL-90-R was chosen for this study. 
 
2.6.3.2 Quality of life 
 
Quality of Life Scale (QOLS; Flanagan, 1978) 
 
The QOLS was developed from the results of a national survey in the 
United States designed to identify the most important domains of quality of life 
(Flanagan, 1978). The scale originally contained 15 items which related to five 
domains of quality of life: physical and material wellbeing; relationships with 
other people; social and civic activities; personal development; and recreation. 
An additional item relating to independence was later introduced after 
investigating the usefulness of the QOLS with patients with chronic illness 
(Burckhardt, Woods, Schultz, & Ziebarth, 1989). Example items include 
“socialising – meeting other people” and “health – being physically fit and 
vigorous”. Satisfaction with each item is rated from 1 (terrible) to 7 (delighted), 
therefore higher scores can be interpreted as higher quality of life. The QOLS 
has since been applied frequently in physical health research and its reliability 
has been validated across different adult non-psychiatric patient groups (e.g., 
Neumann & Buskila, 1997; Wahl, Burckhardt, Wiklund, & Hanestad, 1998). 
However, it has yet to be used among trans populations. 
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World Health Organization Quality of Life (WHOQOL; Group, 1998b) 
 
The WHOQOL is designed to assess quality of life cross-culturally, thus 
eliminating the need for translations and adaptations (The WHOQOL Group, 
1998b). The full scale contains 100 items but has been shortened to 26 items in 
the WHOQOL-BREF (The WHOQOL Group, 1998a). The measure 
encompasses four domains of quality of life: physical health, psychological, 
social relationships and environment. Each domain yields a mean score. Higher 
scores reflect a higher quality of life. An example item is “how much do you 
enjoy life?” to which the responses range from 1 ‘not at all’ to 5 ‘an extreme 
amount’. In an expansive study conducted across 23 countries, involving both 
healthy participants and those with physical and mental health conditions, the 
WHOQOL-BREF demonstrated good to excellent psychometric properties 
(Skevington, Lotfy, & O’Connell, 2004). The instrument has also previously 
been used in trans research (e.g., Gómez-Gil et al., 2014). 
 
Short Form 36-Item Health Survey Version 2 (SF36; Ware & Sherbourne, 1992) 
 
This 36-item instrument assesses functional quality of life across eight 
subscales: physical functioning, role limitations due to physical problems, bodily 
pain, general health perceptions, vitality, social functioning, role limitations due 
to emotional problems, and mental health (Ware & Sherbourne, 1992). Scores 
for each item are summed to produce subscale scores for each health concept 
which are then converted to a zero-100 scale. Higher scores are indicative of 
higher quality of life. Items typically relate the question to the past four weeks 
and response formats vary either asking participants to rate the frequency or 
severity of given problem. For example, “during the past four weeks, how much 
of the time has your physical health or emotional problems interfered with your 
social activities (like visiting friends, relatives, etc.)?” to which participants can 
respond all of the time, most of the time, some of the time, a little of the time or 
none of the time. There are two summary scores calculated by the mean of four 
related subscales: the Mental Health Component Summary score (MHCS, 
consisting of subscales: vitality, social functioning, role limitations due to 
emotional problems, and mental health) and the Physical Health Component 
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Summary score (PHCS, consisting of subscales: bodily pain, physical 
functioning, role limitations due to physical problems, and general health 
perceptions). The SF-36v2 has undergone extensive psychometric testing and 
been replicated across diverse patient populations (Ware & Gandek, 1998). 
Internal consistency and discriminant validity are high and reliability coefficients 
range from .65 to .94 (McHorney, War, Lu, & Donal Sherbourne, 1994), though 
in the majority of studies they exceed .80 (Ware & Gandek, 1998). It is 
designed for clinical use and includes eight of the most commonly measured 
health concepts (Ware & Gandek, 1998). The SF-36v2 differs from the SF-36 
only in terms of format, making the instrument more user-friendly. 
 
Rationale for choice of measure 
 
Regarding quality of life, three measures were examined prior to 
selecting the SF-36v2. Most importantly, a measure was needed that reflected 
the operational definition of quality of life applied in this study (see Chapter 1). 
Quality of life measures in general have been criticised for over-emphasising 
health and not adequately considering the influence of other life domains 
(Anderson & Burckhardt, 1999). Therefore, several measures that include 
affective and interpersonal domains in addition to health were considered: the 
QOLS, the WHOQOL, and the SF36v2. These three instruments are 
multidimensional, subjective and can be applied to the general population 
rather than being disease-specific. The QOLS was ruled out first as it has 
predominantly been used in populations with chronic illness, has not previously 
been used with trans participants, and appears less psychometrically robust 
than the other two measures (e.g., Burckhardt & Anderson, 2003). While the 
original WHOQOL is relatively long, and would therefore be unsuitable for this 
study, the WHOQOL-BREF is a much shorter version which remains similarly 
reliable and valid (The WHOQOL Group, 1998a). The WHOQOL-BREF and 
SF36v2 were very similar in terms of utility, however the SF36v2 offered two 
advantages and was hence used in this study. First, the scoring yields a 
composite score relating to psychological wellbeing (independent of physical 
health) which corresponded fittingly with the principle aims of this study. 
Second, the SF-36v2 has been used more frequently in studies of trans 
58 
populations than the WHOQOL-BREF (e.g., Motmans, Meier, Ponnet, & 
T’Sjoen, 2012; Newfield et al., 2006; Wierckx et al., 2011), and is currently 
being used by ENIGI (Kreukels et al., 2012). Further justification for excluding 
the WHOQOL-BREF was that one particular item, “are you able to accept your 
bodily appearance?”, presented a problem in this study, as treatment seeking 
trans participants are likely to have high levels of dysphoria in relation to their 
body which could skew the data on this measure. Overall, the SF36v2 was a 
clear choice. 
 
2.6.3.3 Life satisfaction 
 
Satisfaction With Life Scale (SWLS; Diener, Emmons, Larsen, & Griffin, 1985) 
 
The SWLS (Diener et al., 1985) is a brief 5-item measure of global life 
satisfaction. Respondents are asked to rate how strongly they agree with 
statements, such as “if I could live my life over, I would change almost nothing”, 
on a 7-point Likert scale, where 1 equals strongly disagree and 7 equals 
strongly agree. Higher scores are indicative of higher life satisfaction. The 
SWLS demonstrates good convergent validity with other measures of 
subjective wellbeing, such as the SCL-90-R and General Health Questionnaire 
(Arrindell, Meeuwesen, & Huyse, 1991; Pavot & Diener, 1993). While it shows 
temporal stability, it also exhibits sufficient sensitivity to detect change during 
clinical intervention (Pavot & Diener, 1993). The SWLS has been translated into 
several different languages and its psychometric properties, including high 
reliability, were retained across cultures (e.g., Gouveia, Milfont, da Fonseca, & 
de Miranda Coelho, 2009). The SWLS has been applied to non-psychiatric 
samples (e.g., Arrindell et al., 1991), including trans individuals (e.g., Erich et 
al., 2008). 
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Personal Wellbeing Index-Adult (PWI; Cummins, Eckersley, Pallant, Van Vugt, 
& Misajon, 2003) 
 
This instrument is constructed in two parts. The first item, which is 
analysed separately, asks respondents to rate their satisfaction with life as a 
whole. The following eight items, which may be analysed as a global mean 
score or as individual variables, assess satisfaction in different quality of life 
domains. These domains include standard of living, health, achievements in 
life, personal relationships, personal safety, community/connectedness, future 
security, and spirituality/religion. They are theoretically embedded and serve to 
deconstruct the single item “satisfaction with life as a whole.” Participants rate 
their answers on a scale from zero to 10 where zero indicates being completely 
dissatisfied, five indicates a neutral response feeling neither satisfied nor 
dissatisfied, and ten indicates being completely satisfied. All data are then 
standardised into units of a zero to 100 point distribution, so that higher scores 
represent higher life satisfaction. Originally, the PWI was created from the 
Comprehensive Quality of Life Scale (Cummins, McCabe, Romeo, & Gullone, 
1994), which was abandoned due to methodological flaws. The International 
Wellbeing Group was subsequently established with the primary purpose of 
developing the PWI into a valid cross-cultural measure and to provide 
normative data (The International Wellbeing Group, 2006). This organisation 
has been largely successful with the PWI demonstrating good reliability, validity 
and sensitivity across diverse cultural populations (e.g., Lau, Cummins, & 
McPherson, 2005) and different age groups (e.g., Casas et al., 2012). Although 
the PWI has not yet been validated in clinical samples, it has been judged to be 
psychometrically sound in non-clinical samples (e.g., Lau et al., 2005). To date, 
it has also not been used in trans populations. 
 
Rationale for choice of measure 
 
Two measures of life satisfaction were reviewed and, despite being very 
similar, the PWI was chosen. One of the main reasons for preferring the PWI 
was that the SWLS uses five items to measure global life satisfaction, it was 
thought that a similar result could be achieved with the first, independent item 
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on the PWI. Thus the PWI was a more economical yet similarly validated choice 
for this study. Additionally, some of the items of the SWLS are sensitive to age 
which could potentially distort data (Hultell & Gustavsson, 2008). As life 
satisfaction has not been extensively studied within trans populations, it was not 
considered a major drawback that the PWI has not yet been administered to 
trans individuals. 
 
2.6.4 Transphobia 
 
Background of measurement and rationale 
 
Due to the lack of standardised measurement of transphobia, this section 
does not review in detail a selection of well-known questionnaires (as has been 
the procedure for all other variables). Rather, there is a more thorough 
discussion of how the measurement of transphobia has been approached in the 
literature and how the decision was reached for this study to utilise and modify 
specific items from existing studies. 
The literature approaches transphobia from two angles: attitudes towards trans 
individuals (prejudice) (e.g., Nagoshi et al., 2008) and experiences or acts of 
transphobia (harassment and victimisation) (e.g., Clements-Nolle, Marx, & Katz, 
2006; McGuire, Anderson, Toomey, & Russell, 2010). As such, the 
measurement of transphobia is divided into these two areas. For example, the 
Genderism and Transphobia Scale (GTS; Hill & Willoughby, 2005) focuses on 
attitudes towards gender non-conformity rather than being a victim of 
transphobia. However, this study was solely interested on the psychological 
impact of having actively experienced transphobia. To date, there has been 
little consistency in the way experiences of transphobia have been measured. 
Some researchers have modified existing scales of homophobia (Nemoto et al., 
2011; Sugano et al., 2006) or sexism and racism (Lombardi, 2009). Although, 
these adapted scales have received little empirical testing. Others have 
constructed original, individual items to assess transphobia. For example, one 
study used the item “how often do you hear other students make negative 
comments or use slurs based on gender identity or expression (not being 
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‘masculine’ enough or not being ‘feminine’ enough or being transgender)?” 
(answers: 1 = never, 2 = rarely, 3 = sometimes, 4 = often) (McGuire et al., 
2010). Another study asked first if the respondent had ever been a victim of 
violence or harassment because of their status as transgender (Lombardi, 
Wilchins, Priesing, & Malouf, 2002). If this had occurred, respondents were then 
asked to recall their experiences, describing the two worst incidents. As the 
nature of this study was quantitative, a simple, numerically rated scale or 
question was necessary, rather than the descriptive response desired by other 
research (e.g., Clements-Nolle et al., 2006; Lombardi et al., 2002). 
 
Despite inconsistencies in the measurement of transphobia in the literature, a 
common approach was to investigate how frequently incidents occurred. This 
was the approach adopted in this study. Two items were selected and adapted 
from previous studies measuring frequency of experiences of transphobic 
victimisation (Clements-Nolle et al., 2006; Nuttbrock et al., 2010). The items 
asked “have you ever been verbally/physically abused or harassed due to your 
gender identity or presentation?” The wording of these items was replicated 
from Clements-Nolle et al. (2006) but rather than using a yes/no response as 
the authors chose, participants were asked how often they had experienced 
trans-specific victimisation: never (scoring 0), once (1), a few times (2), and 
several times (3). More frequent experiences of transphobic victimisation were 
indicated by higher scores. It was important to include the caveat “based on 
gender identity or presentation” so that the items specifically captured 
experiences of transphobia rather than general bullying or victimisation. This 
format was very similar to that employed by Nuttbrock et al. (2010). 
 
2.6.5 Body image 
 
Body Uneasiness Test (BUT; Cuzzolaro, Vetrone, Marano, & Garfinkel, 2006) 
 
There are two parts to the BUT: the first, BUT*A, focuses on weight 
phobia, body image concerns, avoidance, compulsive self-monitoring, and 
depersonalization whereas the second, BUT*B, measures worries about 
specific parts of the body (e.g., abdomen, buttocks) and bodily functions (e.g., 
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sweating, blushing). An example item from BUT*A is “I avoid mirrors”. Higher 
scores relate to greater body uneasiness. This 71-item instrument is applied as 
a screening tool for abnormal body image attitudes and eating disorders 
(Cuzzolaro et al., 2006). Psychometric testing on females from the general 
population and females with eating disorders revealed satisfactory internal 
consistency and high test-retest reliability (Cuzzolaro et al., 2006). The BUT 
also demonstrated concurrent validity with others measures, including the 
Three-Factor Eating Questionnaire and Binge Eating Scale (Marano et al., 
2007). The BUT has previously been utilised in trans studies (Bandini et al., 
2013; Fisher et al., 2013). 
 
Hamburg Body Drawing Scale (HBDS; Appelt & Strauss, 1988) 
 
Applying a schematic body drawing as a template, this 35-item scale 
measures satisfaction relating to different areas of the body, a subset of which 
refer to primary and secondary sexual characteristics (Appelt & Strauss, 1988). 
The final item gives a global indication of body satisfaction. A five-point likert 
scale is used where 1 = very satisfied, 2 = satisfied, 3 = average, 4 = 
dissatisfied, and 5 = very dissatisfied. Therefore higher scores are indicative of 
greater body dissatisfaction. Subscales include body shape, androgen-
responsive features, genitalia, head, upper body, body hair, and extremities. 
The HBDS achieved good internal consistency in a study of trans and 
cisgender young adults, ranging from .62 to .91 across the subscales (Becker, 
et al., 2015). The measure was designed specifically for use with trans 
participants and has been utilised as such (Kreukels et al., 2012), though 
testing in cisgender populations has not yet been conducted. 
 
Rationale for choice of measure 
 
For body image, two measures were considered in depth, before 
deciding upon the HBDS for this study. Many of the more common measures of 
body image, not detailed here, and to an extent the BUT, are designed 
specifically to capture attitudes and behaviours associated with eating 
disorders, for example the Eating Disorders Inventory (Garner, 2004) and Body 
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Related Behaviours Scale (Meyer, McPartlan, Rawlinson, Bunting, & Waller, 
2011). Though some include scores on body dissatisfaction, it was decided that 
these measures veered away from the interests of this study. In contrast, the 
HBDS focuses solely on body dissatisfaction and importantly, includes items on 
sexual characteristics. This inclusion was considered vital when assessing body 
image among trans individuals as gendered aspects of the body are often 
cause for distress. For these reasons, the HBDS was considered more suitable 
than other measures of body image despite comparatively less published data 
on its psychometric properties. The scale was translated into English by one of 
the researchers and as some items are sex-specific, it was deemed appropriate 
to add a ‘not applicable’ option to responses. 
 
2.6.6 Perceived social support 
 
Social Support Questionnaire (SSQ; Sarason, Levine, Basham, & Sarason, 
1983) 
 
The SSQ measures perceptions of and satisfaction with social support 
(Sarason et al., 1983). There are 27 items which require a two-part response. 
First, respondents list all the ‘people in their environment’ that fit a particular 
description, such as “whom can you talk with frankly, without having to watch 
what you say?”. Second, respondents rate how satisfied they are with the 
overall support they receive on a six-point Likert scale from ‘very satisfied’ to 
‘very dissatisfied’. The number of individuals listed by the respondent yields a N 
score per item. The overall score of perceived availability of support is the 
mean of the N scores. The overall satisfaction score is also calculated by the 
mean of all satisfaction ratings (S scores) across the questionnaire. Higher 
scores equal greater social support. Both internal consistency and retest 
reliability is high, however the psychometric data available is based only on 
student samples (Sarason et al., 1983). The SSQ has been used health-related 
research (e.g., Malcolm & Janisse, 1991; Swindells et al., 1999), though not 
with trans participants, and a 6-item short version is available (Sarason, 
Sarason, Shearin, & Pierce, 1987). 
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Medical Outcomes Study: Social Support Survey (MOS-SSS; Sherbourne & 
Stewart, 1991) 
 
The MOS-SSS gathers data on four components of perceived social 
support: emotional/informational support, tangible support, positive interaction, 
and affectionate support (Sherbourne & Stewart, 1991). Respondents are 
asked “how often are the following kinds of support available to you if you need 
it?” and an example item is “someone to help you if you were confined to bed”. 
Responses relating to availability of support are rated on a 5-point Likert scale 
from ‘none of the time’ to ‘all of the time’. A total score of the 19 items and four 
subscale scores can be calculated. Higher scores indicate greater social 
support. The MOS-SSS was originally developed for use with patients with 
chronic health conditions but has since been used in culturally diverse 
populations (e.g., Campos et al., 2008; Yu, Lee, & Woo, 2004), though not 
trans populations. Evidence demonstrates high internal consistency for the total 
and subscale scores (Campos et al., 2008; Gjesfjeld, Greeno, Kim, & 
Anderson, 2010). 
 
Multidimensional Scale of Perceived Social Support (MSPSS; Zimet, Dahlem, 
Zimet, & Farley, 1988) 
 
This 12 item scale measures perceived social support from three 
sources – family, friends and significant other (Zimet et al., 1988). Each item is 
rated on a likert scale of 1 to 7 (where 1 = very strongly disagree, 2 = strongly 
disagree, 3 = mildly disagree, 4 = neutral, 5 = mildly agree, 6 = strongly agree, 
and 7 = very strongly agree). Example items are “I get the emotional help and 
support I need from my family” and “I can count on my friends when things go 
wrong”. A total mean score can be calculated to denote global social support 
and higher scores represent higher levels of social support. The MSPSS has 
been used in numerous studies with diverse samples and has consistently 
demonstrated good psychometric properties (e.g., Bruwer, Emsley, Kidd, 
Lochner, & Seedat, 2008; Cecil, Stanley, Carrion, & Swann, 1995; Clara, Cox, 
Enns, Murray, & Torgrudc, 2003; Dahlem, Zimet, & Walker, 1991; Zimet, 
Powell, Farley, Werkman, & Berkoff, 1990). It has also been used with trans 
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populations (e.g., Colton Meier, Sharp, Michonski, Babcock, & Fitzgerald, 
2013). 
 
Rationale for choice of measure 
 
Three measures of social support were evaluated, with the MSPSS 
deemed as most suitable. The first measure considered, the SSQ, gathers data 
on the availability of support and the respondent’s satisfaction with that support 
(Sarason et al., 1983). Similarly, the MOS-SSS assesses social support in 
terms of availability (Sherbourne & Stewart, 1991), however it does not 
differentiate who provides the support. The MOS-SSS and SSQ are also similar 
in that they both obtain a total number of supportive contacts and investigate 
support in specific circumstances, for example “who can you really count on to 
help you feel more relaxed when you are under pressure or tense?” (SSQ) or 
“how often is support available in the form of someone to take you to the doctor 
if you needed it?” (MOS-SSS). Though the SSQ and MOS-SSS were suitable 
measures, one of the appealing aspects of the MSPSS was that it could provide 
a direct comparison between different sources of support. This was a distinct 
advantage as, in terms of the trans literature, there is ample evidence regarding 
support (or lack of) from individuals’ families, whereas the evidence on support 
from friends and partners is relatively scarce. Thus, the MSPSS had an 
additional draw over the other measures (as well as having good psychometric 
properties and prior use with trans participants) and was selected for this study. 
 
2.6.7 Interpersonal functioning 
 
Inventory of Interpersonal Problems (IIP-32; Barkham, Hardy, & Startup, 1996) 
 
The IIP-32 is used to identify interpersonal difficulties (Barkham et al., 
1996). Items describe common interpersonal problems, such as “it is hard for 
me to open up and tell my feelings to another person” and “I am too envious 
and jealous of other people”. These items are rated in terms of how distressing 
that particular problem is to the respondent, using a five-point likert scale 
where: 0 = not at all, 1 = a little bit, 2 = moderately, 3 = quite a bit, and 4 = 
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extremely. The measure consists of eight subscales: hard to be assertive, hard 
to be sociable, hard to be supportive, hard to be involved, too dependent, too 
caring, too aggressive, and too open. A total mean score provides an overall 
measure of interpersonal functioning and higher scores indicate greater severity 
of interpersonal problems. The IIP-32 is a shortened version of the original IIP 
which retains its psychometric properties as well as being more suitable for 
routine clinical assessment than other versions of the IIP (Barkham et al., 
1996). A confirmatory factor analysis demonstrated high reliability with alpha 
coefficients of .70 to .88 (Barkham et al., 1996). The IIP-32 has been used 
successfully in both non-clinical (e.g., Berry, Wearden, Barrowclough, & 
Liversidge, 2006) and clinical samples (Conway, Audin, Barkham, Mellor-Clark, 
& Russell, 2003; Paley et al., 2008). Interpersonal problems is not an area that 
has been investigated among trans individuals, therefore the IIP has not yet 
been utilised in this group. 
 
Rationale for choice of measure 
 
Only one measure of interpersonal functioning was appraised in depth, 
the IIP, however of all its variations, the IIP-32 was chosen as the most 
appropriate for this study. The reason for solely investigating this particular 
measure further was that the IIP (Horowitz, Rosenberg, Baer, Ureño, & 
Villaseñor, 1988) appears to be the leading assessment tool for interpersonal 
functioning, with very few contenders. For example, the Relationship Structures 
Questionnaire (Fraley, Niedenthal, Marks, Brumbaugh, & Vicary, 2006) places 
more emphasis on attachment while the Interpersonal Reactivity Index (Davis, 
1980) is limited to empathy towards others. Given their clear lack of suitability, 
these two measures are not detailed here. The IIP is unique in that it presents 
interpersonal problems that many people experience and assesses the level of 
distress the respondent associates with each particular problem. It was initially 
constructed from clinical observations and in response to clinical needs, for 
example the IIP can be used to identify areas for intervention and to measure 
change between starting and concluding psychotherapy. Despite its clinical 
background, the IIP is suitable for the general population (Berry et al., 2006). 
While the IIP was a clear choice for measuring interpersonal functioning, it 
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comes in multiple forms which meant the task was to select the version most 
suited for the purposes of the study. The major difference among its formations 
is structure: whether it is the straightforward questionnaire version (Horowitz et 
al., 1988) or the circumplex model (Horowitz, Alden, Wiggins, & Pincus, 2000). 
The subscales from the IIP and the dimensional axes of the IIP-Circumplex 
though not identical, are very similar. Responses to the circumplex version, 
however, can be plotted graphically so a visual representation of an individual’s 
difficulties can be seen. While this may be useful in therapeutic work, it was not 
necessary to and did not add to the study; the study aimed to look at the trans 
group as a whole rather than examining individuals. Therefore, the circumplex 
was decided against. A further consideration was length: available versions of 
the IIP vary from 127 items (Horowitz et al., 1988) to 32 items (Barkham et al., 
1996). The IIP-32 was deemed preferable given that it is psychometrically 
robust yet would not over-burden respondents. Given that interpersonal 
functioning has not yet been quantitatively assessed in the trans literature, the 
choice of instrument was not guided by the methodology of other trans-specific 
studies. This lead to the final choice of the IIP-32 for the measurement of 
interpersonal problems. 
 
2.6.8 Self-esteem 
 
Coopersmith Self-Esteem Inventory (CSEI; Coopersmith, 1967) 
 
The 50-item CSEI assesses attitudes towards oneself in academic, 
social, family and personal areas of experience (Coopersmith, 1967). Though 
the CSEI was originally designed for children, it has been developed for use 
with adults and demonstrated high retest reliability (Ryden, 1978). Respondents 
answer statements, such as “things usually don’t bother me” or “I find it very 
hard to talk in front of a group”, either with ‘not like me’ or ‘like me’. Higher 
scores represent higher levels of self-esteem. A short version of half the items 
is available, for which internal consistency and retest reliability was reportedly 
good among a sample of students (Bedeian, Teague, & Zmud, 1977). However, 
reports of the inventory’s validity have been criticised for lacking empirical data 
(Sewell, 1985). It has also not been employed within trans research. 
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Rosenberg Self Esteem Scale (RSE; Rosenberg, 1965) 
 
This ten-item global measure of self-esteem includes items such as “I 
feel that I’m a person of worth, at least on an equal plane with others” and “all in 
all, I am inclined to feel that I am a failure” (Rosenberg, 1965). Items are 
assessed on a four-point scale where 3 = strongly agree, 2 = agree, 1 = 
disagree, and 0 = strongly disagree. Five items are positively worded and five 
items are negatively worded. The items are summed to produce a global score, 
whereby scores between 15 and 25 are considered within the normal range, 
and scores below 15 signify low self-esteem. Therefore, higher scores indicate 
higher self-esteem. In the wider literature, the RSE is the most commonly used 
self-report measure of global self-esteem (e.g., Blascovich & Tomaka, 1991; 
Gray-Little, Williams, & Hancock, 1997) and has been used in clinical and non-
clinical groups (e.g., Roth, Decker, Herzberg, & Brähler, 2008; Silverstone & 
Salsali, 2003). Likewise, the RSE is by far the most frequently employed 
measure of self-esteem among the trans literature (e.g., Skrapec & MacKenzie, 
1981a; Vocks, Stahn, Loenser, & Legenbauer, 2009). It has also received 
rigorous psychometric analysis and validation above all other self-esteem 
measures (Robins, Hendin, & Trzesniewski, 2001). 
 
Rationale for choice of measure 
 
Two measures were evaluated for self-esteem, however as with 
interpersonal functioning, there was a standout choice for this study: the RSE 
(Rosenberg, 1965). The CSEI (Coopersmith, 1967) is somewhat similar but is 
less widely used and consists of a much greater number of items which were 
deemed unnecessary and overly cumbersome for this study. Therefore, the 
RSE took preference in this study.  
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2.6.9 NSSI 
 
Deliberate Self-Harm Inventory (DSHI; Gratz, 2001) 
 
The DSHI comprises 17 items that measure the type, frequency, 
severity, and duration of NSSI (Gratz, 2001). Both lifetime history and most 
recent time of engaging in NSSI are recorded. An example item is “have you 
ever intentionally (i.e., on purpose) cut your wrists, arms or other areas of your 
body without intending to kill yourself?”. Scores can be calculated in terms of 
frequency or as a dichotomous variable, whereby a score of 1 is given to 
respondents who answer yes to any of the 17 items and a score of 0 to 
respondents who answer no in all cases. The DSHI has been applied in both 
non-clinical and clinical populations, including university students (Brown, 
Williams, & Collins, 2007; Gratz, Conrad, & Roemer, 2002) and psychiatric 
inpatients (Fliege et al., 2006), but not yet trans participants. While internal 
consistency appears to be high, test-retest reliability and construct, discriminant 
and convergent are only adequate (Fliege et al., 2006; Gratz, 2001). 
 
Self-Injury Questionnaire – Treatment Related (SIQ-TR; Claes & 
Vandereycken, 2007) 
 
The SIQ-TR assesses NSSI in the form of cutting, bruising, biting, 
burning, and/or scratching (Claes & Vandereycken, 2007). Respondents are 
asked whether they have deliberately injured themselves in the past year using 
each of these methods and if they report that they have done so in the past 
week or month, more detailed questions follow. In addition to assessing the 
type, duration and frequency of NSSI, the SIQ-TR also gathers data relating to 
localisation of injury, experience of pain, functions, and affective antecedents 
and consequences. The SIQ-TR has recently been used in clinical populations, 
including female patients with eating disorders (Claes, Klonsky, Muehlenkamp, 
Kuppens, & Vandereycken, 2010), psychiatric patients (Claes et al., 2010), and 
treatment-seeking trans individuals (Claes et al., 2015). The authors report 
good psychometric properties in the original paper (Claes & Vandereycken, 
2007). 
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Rationale for choice of measure 
 
To measure self-injury, two questionnaires were selected for more 
thorough evaluation before determining the SIQ-TR as the most appropriate for 
this study. A recent review of the most commonly administered measures of 
self-injury concluded that, since the psychometric quality was satisfactory 
across the six instruments, researchers’ choice of measure should be guided by 
which one most represents their operational definition of self-injury (Latimer, 
Meade, & Tennant, 2013). As the intention of the study was to investigate NSSI 
that was deliberate, without suicidal intent, and involved direct injury to bodily 
tissue (Favazza & Conterio, 1989), some measures were immediately 
excluded. The Self-Harm Inventory (Sansone, Wiederman, & Sansone, 1998) 
for example, which contained questions relating to incidents of overdosing, 
driving recklessly, and abusing alcohol on purpose, was discounted for this 
reason. The Deliberate Self-Harm Inventory (Gratz, 2001) was considered as it 
is a concise measure which employs the same definition of NSSI adopted by 
the study. However, there are notable weaknesses. One limitation is that some 
of the methods of NSSI listed are very specific, such as carving words into or 
dripping acid onto one’s skin, and scarcely reported by respondents (Gratz, 
2001). Though this did not reportedly affect the validity of the inventory. Another 
is that several of the items are open-ended, for example “how old were you 
when you first (self-harmed)?” which is problematic in regards to scoring. A 
more standardised measure was needed. 
 
One of the newer measures, which also is congruent with the chosen notion of 
NSSI, is the Self-Injury Questionnaire Treatment Related (Claes & 
Vandereycken, 2007). Partly due to its development within a clinical population, 
the SIQ-TR balances depth with pragmatism. It focuses on the five of most 
common types of NSSI (and provides the opportunity for the respondent to 
name a further type if required) and where relevant, some of the responses are 
grouped which enable an easier comparison between participants. For 
example, frequency responses are 1 to 5 days, 6 to 10 days, 11 to 15 days, or 
more than 15. The SIQ-TR collects very detailed information on NSSI as it was 
designed for clinical use. It was important to implement a measure in this study 
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that corresponded with our conceptualisation of NSSI. For example, NSSI 
differs from self-harm (McAllister, 2003) in that excessive drinking, substance 
abuse, eating disordered behaviours and harmful sexual behaviours can be 
perceived as self-harm (Di Stefano, 2008; Laye-Gindhu & Schonert-Reichl, 
2005) whereas NSSI is more specifically the intentional injuring of body tissue, 
without underlying suicidal motivation. Therefore, the SIQ-TR was chosen to 
administer to participants.  
2.7 Data analysis 
 
Several tests revealed that the data did not meet the assumptions of 
normal distribution. For example, SCL data were positively skewed in both the 
clinical and control groups and non-normally distributed, as indicated by 
significant (p<.002) Kolmogorov-Smirnov tests and Shapiro-Wilk tests. 
Likewise, SF data were mostly non-normally distributed, however these data 
demonstrated a negative skew in both groups. Therefore, non-parametric tests 
were applied where possible. Where non-parametric equivalents were not 
available (e.g., multiple regression, ANCOVA), it was advised that these results 
are viewed caution.  
 
The endpoint of the research was to test a model of predictors of psychological 
wellbeing. With this in mind, the total sample size was calculated using 
guidelines set out by Cohen (1992) for conducting multiple regression analysis. 
Initially, it was expected that an alpha level of .05 would be applied (this 
changed for reasons below). Additionally, at the outset, seven predictors 
(independent variables) were proposed (Figure 1.1, Chapter 1). Based on these 
initial assumptions, the sample size required to achieve a medium effect size 
was 102 participants. 
 
On reflection (after the data collection), it was decided that a more conservative 
alpha level of .01 was appropriate to apply throughout the thesis to determine 
significance. This is advised when performing a large number of statistical tests 
to reduce the risk of type I errors (false positive results). 
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2.7.1 Statistical analysis by study 
 
The statistical tests (and which hypotheses they relate to) applied within 
each study are as follows: 
 
In Study 1, one-tailed Mann-Whitney U tests were performed to compare 
MSPSS scores between the clinical and control groups (hypothesis one). To 
identify gender differences in MSPSS scores across subgroups (trans women, 
trans men, control women and control men, test hypothesis two) one tailed 
Kruskal-Wallis tests were used. In order to control for SCL depression scores, 
significant results were followed up by post-hoc one-way analyses of 
covariance (ANCOVA). Further one tailed Mann-Whitney U tests were 
performed to compare SCL, SF and PWI scores between the clinical and 
control groups (hypothesis three). Lastly, multiple regression analyses using 
enter method were conducted to test whether MSPSS subscales significantly 
predicted SCL, SF and PWI scores (hypothesis four).  
 
In Study 2, a series of one-tailed Mann-Whitney U tests were used to test the 
hypotheses. This first enabled the comparison of IIP scores between the clinical 
and control groups (hypothesis one). A series of one-tailed Kruskal-Wallis tests 
were subsequently performed to examine gender differences on IIP scores 
(hypothesis two). Pairwise comparisons were conducted to follow up significant 
results and identify where these differences were present. A further one-tailed 
Mann-Whitney U test was carried out to test whether the clinical and control 
group differed significantly on depression scores. This justified subsequent 
analyses of covariance (ANCOVA) on all significant results, entering SCL 
depression as the covariate. This enabled testing of whether differences on IIP 
scores remained significant after controlling for depression (hypothesis three). 
There is no non-parametric equivalent to ANCOVA, therefore it was advised for 
these results to be interpreted with caution.  
 
In Study 3, Pearson Chi Square tests were conducted using two categories of 
NSSI: current NSSI and no current NSSI (which combined SIQ-TR responses 
‘never’ and ‘more than a month ago’). The first Pearson Chi Square compared 
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prevalence rates of NSSI between the clinical and control group (hypothesis 
one). The second compared prevalence rates between trans women and trans 
men (hypothesis two). Following this, three gender-matched groups were 
formed: a clinical group who currently engage in NSSI (trans NSSI), a clinical 
group with no history of NSSI (trans no NSSI) and a non-clinical group with no 
history of NSSI (non-trans no NSSI). A series of Kruskal Wallis analyses were 
conducted to test differences between these three groups on SCL, HBDS, RSE, 
and MSPSS scores (hypothesis three). A further Kruskal Wallis analysis 
examined (unmatched) group differences in age, testing whether the trans 
NSSI group was significantly younger than the trans no NSSI group and non-
trans no NSSI group (hypothesis four). Significant results from the Kruskall 
Wallis tests were explored further using one-tailed Mann-Whitney U tests 
(hypotheses three and four). 
 
In Study 4, a series of one-tailed Mann Whitney U tests were performed to 
compare the clinical and control groups’ scores on SCL, SF, RSE, HBDS and 
IIP measures (hypothesis one). Next, a series of one-tailed Spearman’s Rho 
correlations were run as preliminary tests for subsequent regression analyses. 
These tested which of the predictor variables were significantly correlated to the 
outcome variables. Predictor (independent) variables were age, global RSE, 
global HBDS, IIP subscales, and transphobic (TV) victimisation scores. 
Outcome (dependent) variables were SCL GSI and SF MHCS scores. Predictor 
variables that demonstrated significant correlations to the outcome variables 
were entered into multiple linear (enter method) regressions (hypotheses two 
and three). 
 
For the mediation analysis (hypothesis four), testing global RSE and global 
MSPSS as mediators, there were four necessary conditions: the predictor 
variable significantly predicts the outcome variable; the predictor variable 
significantly predicts the mediator variable; the mediator variable significantly 
predicts the outcome variable; and the relationship between predictor variable 
and outcome variable is smaller when the mediator is present in the model than 
when it is excluded (Baron & Kenny, 1986). Following the Baron and Kenny 
method, mediation analysis was only performed when all these conditions were 
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met. Mediation is then indicated by the size of indirect effect of the predictor 
variable on the outcome variable and its confidence interval. Where the 
confidence intervals for the indirect effect do not contain zero, mediation has 
occurred. The size of the effect is calculated using kappa-squared: .01 indicates 
a small effect, .09 a medium effect, and .25 a large effect (Preacher & Kelley, 
2011). This study did not use the Sobel test as it has low statistical power and 
is only appropriate for much larger sample sizes and normally distributed data. 
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Chapter 3: Social support and psychological wellbeing among trans 
individuals: A comparison of patients with matched controls 
 
 
This chapter has been published in Journal of Sexual Medicine (impact factor 
3.150) as: 
 
Davey, A., Bouman, W. P., Arcelus, J. & Meyer, C. (2014). Social 
support and psychological well-being in Gender Dysphoria: A comparison of 
patients with matched controls. Journal of Sexual Medicine, 11, 12: 2976–2985. 
doi: 10.1111/jsm.12681 
 
The content of Chapter 3 is largely the same as the published paper but the 
formatting, presentation and terminology has been altered so that it remains 
consistent with the rest of the thesis. 
 
 
3.1 Introduction to Chapter 3 
 
Social support has long been recognised in the literature concerning the 
general population as key to psychological wellbeing (e.g., Dumont & Provost, 
1999; Hinson Langford et al., 1997; Shumaker & Brownell, 1984; Winefield, 
Winefield, & Tiggemann, 1992). Given that social support has such a crucial 
impact on wellbeing, it was a clear starting point for this thesis. In relation to 
other wellbeing factors in the proposed model outlined in the introduction 
chapter, social support had, comparatively, received greater attention in the 
trans literature. Due to the stigma attached to the trans identity (e.g., Boza & 
Perry, 2014; Nemoto et al., 2011), trans individuals are a group likely to be less 
socially connected. Existing relationships may be tested when individuals 
disclose their trans identity (e.g., Koken et al., 2009) and undergo transition, 
and forming new relationships may be viewed with apprehension. Despite a 
considerable amount of literature on social support, a number of methodological 
shortcomings limit the existing knowledge. One example is that there is a lack 
of research into support outside the family. Additionally, as social attitudes and 
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public understanding towards the trans community is continually evolving, fresh 
exploration of levels of social support is needed. This chapter sought to 
replicate previous findings whilst addressing some of the methodological 
limitations of previous research.  
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3.2 Abstract 
 
Objectives 
There is a paucity of research in the area of social support and psychological 
wellbeing among trans individuals. Therefore, the present study aimed to 
investigate levels of social support among trans individuals compared to a 
matched control group. It also aimed to examine the relationship between social 
support and psychological wellbeing. 
Method 
Participants were 103 individuals diagnosed with Transsexualism (according to 
ICD-10 criteria) attending a national gender identity clinic (GIC), and an age- 
and gender- matched non-clinical control group, recruited via social networking 
websites. All participants completed measures of social support 
(Multidimensional Scale of Perceived Social Support, MSPSS), 
psychopathology (Symptom Checklist 90 Revised, SCL), quality of life (Short 
Form 36 version 2, SF), and life satisfaction (Personal Wellbeing Index, PWI). 
Results 
Trans women reported significantly lower MSPSS total and MSPSS family 
scores compared to control women, although these differences in levels of 
social support were no longer significant when SCL depression was controlled 
for. No significant differences were found between trans men and any other 
group. MSPSS scores did not significantly predict SCL subscales but did 
predict both SF subscales and PWI total scores.  
Conclusions 
Trans women perceived themselves to be lacking social support. Given that 
social support is beneficial to quality of life and life satisfaction among trans 
individuals, this is of great concern. Though these findings have been derived 
from correlational results, extended research may highlight the value of 
clinicians helping trans women to seek out and maintain social support. 
Additionally, efforts could be made to educate and challenge attitudes of 
cisgender (non-trans) people towards those who are trans.  
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3.3 Introduction 
 
 
Psychological wellbeing is a multi-faceted construct which encompasses 
affective aspects of personal experience (Warr, 1978). Trans individuals 
experience compromised psychological wellbeing, both in terms of their 
psychological health and life satisfaction. Specifically, a considerable number 
experience mental health difficulties (e.g., Couch et al., 2007; Hepp et al., 
2005), with more than half reporting clinically depressive symptoms (Nuttbrock 
et al., 2013a). For instance, one clinical study reports that 80% of trans women 
and 55% of trans men have a history of mental illness (Hepp et al., 2005b). 
Similarly, prevalence rates of attempted suicide in this population, at 32%, are 
worryingly high (e.g., Clements-Nolle et al., 2006). This may be explained by 
the fact that trans individuals are frequently exposed to gender-based prejudice 
and discrimination (e.g., Clements-Nolle et al., 2006; Grant et al., 2011; 
Lombardi et al., 2002) which has been associated with an increased risk of 
depression (Nemoto et al., 2011; Nuttbrock et al., 2013a) and diminished life 
satisfaction (Toomey, Ryan, Diaz, Card, & Russell, 2010). Given these elevated 
risks, it is important to elucidate factors that might potentially increase 
psychological wellbeing in this group. 
 
There are several factors known to affect psychological wellbeing in the general 
population, including levels of self-esteem, problem solving coping strategies, 
and social support (e.g. Grant et al., 2011; Nemoto et al., 2011). Social support 
is defined as the provision of resources from others which are perceived to be 
beneficial to the recipient (Shumaker & Brownell, 1984). Being socially 
connected and supported has been found to have a positive effect on self-
esteem, mood, perceived control, and coping behaviours in the general 
population (e.g., Nemoto et al., 2011; Shumaker & Brownell, 1984; Toomey et 
al., 2010). Conversely, a lack of social support is associated with an increased 
vulnerability to mental health problems, such as depression, suicidality and 
eating psychopathology (e.g., Dumont & Provost, 1999; Hinson Langford et al., 
1997; Nemoto et al., 2011; Shumaker & Brownell, 1984; Winefield et al., 1992). 
Recent research has highlighted some of the benefits of social support 
specifically among trans individuals. For example, social support has been 
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linked with lower levels of both depression and anxiety (Colton Meier, Pardo, 
Labuski, & Babcock, 2013; Nemoto et al., 2011) and fewer suicidal behaviours 
(Moody & Smith, 2013). In addition, social support has been positively 
associated with self-esteem (Erich et al., 2008) and quality of life (Colton Meier 
et al., 2013) among trans individuals and is considered a predictor of 
psychological functioning following sex reassignment surgery (SRS) (Ross & 
Need, 1989). 
 
While social support may be beneficial in many ways (e.g., Winefield et al., 
1992), it is often limited among trans individuals. For example, compared to 
their siblings, specifically their sisters, trans individuals perceived less social 
support from their families (Factor & Rothblum, 2007). In fact, outright rejection 
from families is not uncommon, particularly when individuals first disclose their 
gender identity (Koken et al., 2009). In addition to a lack of familial support, 
support from friends may also be limited. For instance, Tully (1993) describes a 
tendency among treatment-seeking individuals to avoid making new friends 
until SRS has been completed. Consequently, post treatment, they may face a 
challenging new life with few existing support resources readily accessible. One 
plausible theoretical model explaining limited support networks in this 
population is that the stigma surrounding a trans identity may impair an 
individual’s ability to form and maintain relationships (Golub, Walker, Longmire-
Avital, Bimbi, & Parsons, 2010). An alternative explanation is that reduced 
social support may be linked to the high levels of depression observed in this 
population (e.g., Nemoto et al., 2011; Nuttbrock et al., 2013a), given that 
depression is typically associated with social withdrawal (Barrett & Barber, 
2007). However, not all research suggests a lack of social support. For 
example, Erich et al. (2008) reports that the majority (78%) of trans individuals 
rate support from family members positively.  
 
While the term gender dysphoria denotes a dissonance between a person’s 
gender and their phenotype, trans individuals’ experiences of dysphoria can 
vary considerably and as such, heterogeneous samples are often apparent in 
the literature. Additional inadequacies are that previous studies have primarily 
recruited self-identified, rather than clinical, trans individuals and typically lack 
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control groups. Trans women, as a group, tend to be researched independently 
(e.g., Golub et al., 2010; Nemoto et al., 2011), with far fewer attempts to study 
trans men. In studies where both trans women and trans men are invited to 
participate, gender differences are rarely distinguished. The only study to 
separate trans women and trans men reported similar levels of social support 
from family and friends across the two groups (Factor & Rothblum, 2007). 
Therefore it remains unclear as to whether levels of social support differ 
specifically between clinically diagnosed, treatment-seeking trans women and 
trans men, and the general population. 
 
3.3.1 Aims 
 
The global aim of this research was to examine a potential theoretical 
model whereby being trans is linked with low levels of perceived social support, 
and where such a lack of support is linked with decreased psychological 
wellbeing. There were four objectives and associated hypotheses. 
 
The first objective was to examine whether trans individuals perceive different 
levels of social support compared to an age- and gender-matched control 
sample. In this instance, the focus was on individuals’ perceptions of, rather 
than actual, social support, though the two are often conflated in the literature. 
In keeping with the non-clinical findings of Factor and Rothblum (2007), 
hypothesis one predicted that trans individuals feel significantly less socially 
supported compared to matched controls.  
 
The second objective was to identify differences in perceived social support 
across gender groups: trans women, trans men, control women, and control 
men. Given that trans women are met with more intense social disapproval than 
trans men (Devor, 2004), hypothesis two predicted that trans women perceive 
significantly less social support than trans men.  
 
The third objective was to investigate whether trans individuals significantly 
differ from controls on psychological wellbeing variables. Hypothesis three 
predicted that trans individuals would report significantly higher 
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psychopathology and significantly lower quality of life and life satisfaction than 
controls.   
 
The fourth objective was to investigate whether perceived social support 
predicts psychological wellbeing among trans individuals. In accordance with 
findings regarding the general population, hypothesis four predicted that greater 
social support significantly predicts better psychological wellbeing in the trans 
group.  
 
Given the relationship between depression and social support (e.g., Shumaker 
& Brownell, 1984), when testing differences in levels of social support in 
hypotheses one and two, levels of depression were controlled for. 
 
3.4 Methods 
 
3.4.1 Participants 
 
There were two groups of participants: a clinical sample of trans 
individuals and a matched control sample.  
 
3.4.1.1 Clinical sample  
 
The clinical sample comprised patients attending a national GIC, in the 
Midlands of England. Participants were eligible to take part if they had a 
diagnosis of Transsexualism in line with the International Classification of 
Diseases 10 (WHO, 1992), and were aged 18 years or over. All participants 
were engaged in the treatment pathway and at one of three phases: 
assessment, Real Life Experience, or post-surgery. Assessment comprises 
psychological and psychiatric evaluation spanning several months. The Real 
Life Experience is typically a two-year period where individuals enter full social 
and occupational adaption to their chosen gender role, commence hormone 
therapy, and make documentary changes to articles, such as their driving 
license. Post-surgery applies to individuals who have undergone the Real Life 
Experience (RLE) and at least one gender reassignment surgical procedure. 
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Approximately 275 questionnaire packs were offered, of which 103 were 
returned fully completed. Sixty three participants identified themselves as 
women and 40 identified themselves as men. The mean age was 36.4 years 
(SD 15.22) and ranged from 18 to 72 years.  
 
3.4.1.2 Control sample 
 
An opportunity sample of non-clinical participants was recruited via a 
University campus, local businesses/organisations and social networking 
websites. The non-clinical sample was comprised of adults who identified 
themselves as not having gender dysphoria or being trans. The female:male 
ratio was also 63:40 as a result of matching the two groups on gender identity 
(not birth sex). The mean age was 37.48 (SD 15.29) and ranged from 18 to 73 
years which not significantly different from the clinical sample (U=5044.5, 
p=.312). Further demographic information is presented in Table 3.1. 
 
3.4.2 Procedure 
 
Ethical approval was granted from an NHS research ethics committee 
and University Institutional Ethics Board. Informed consent was obtained from 
all participants. 
 
For the clinical sample, clinicians identified and subsequently distributed 
questionnaire packs to eligible patients in person after their nearest 
appointment. Each questionnaire pack contained an information sheet, consent 
form, socio-demographic questionnaire and several self-report measures (in the 
order presented below). Participants completed the questionnaire pack at home 
and posted it back to the clinic using a pre-paid envelope. Data were collected 
over the course of eleven months. A hundred and nine participants returned 
questionnaires, producing a response rate of 39.6%, however six were 
subsequently discounted due to substantial missing data. Non-clinical 
participants were emailed or messaged via social networking websites a web-
link to an online survey identical to the questionnaire pack completed by clinical 
participants and encouraged to forward the web-link onto others. A total of 160 
non-clinical participants completed the online survey from which 103 were 
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selected on the basis of age and gender identity to enable matching with the 
clinical sample. Each clinical participant was paired with a control participant of 
the same gender identity and as closely as possible by age. A subsequent 
analysis was performed to ensure the mean ages of the two groups were not 
significantly different. 
 
3.4.3 Main outcome measures 
 
3.4.3.1 Multidimensional Scale of Perceived Social Support (MSPSS) 
 
The MSPSS (Zimet et al., 1988) measures perceived social support. It 
comprises three subscales: family support, friend support, and support from a 
significant other. All 12 items are rated on a scale from 1 to 7. A total mean 
score and mean subscale scores are calculated, with higher scores indicating 
greater perceived support. The MSPSS has been used with diverse samples 
and has consistently demonstrated good psychometric properties (Cecil et al., 
1995; Clara et al., 2003; Dahlem et al., 1991). It has also been used in 
transgender populations (Colton Meier, Pardo, et al., 2013). For these data, the 
Cronbach’s alpha was .93.  
 
3.4.3.2 Symptom Checklist 90 Revised (SCL-90-R) 
 
Psychopathology was measured using the SCL-90-R (Derogatis, 1977). The 
SCL-90-R contains 90 items divided into nine primary symptom dimensions 
(somatisation, obsessive-compulsive, interpersonal sensitivity, depression, 
anxiety, hostility, phobic anxiety, paranoid ideation, and psychoneuroticism). 
Scores, on a five-point Likert scale, indicate how much a particular problem has 
distressed the respondent during the previous seven days with higher scores 
indicating greater distress. The total mean score, Global Severity Index (GSI), 
indicates overall psychological distress. The instrument demonstrates good 
construct validity and reliability across a multitude of samples and populations 
(Derogatis & Unger, 2010). It has also been used widely across the trans  
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Table 3.1. Demographic characteristics of the clinical and control samples 
 
 Clinical 
sample 
Control 
sample 
Trans 
women 
Trans 
men 
Control 
women 
Control 
men 
 n=103 n=103 n=63 n=40 n=63 n=40 
Mean age (years) 36.35 37.48 56.9 28.05 40.37 32.93 
Ethnic origin         
   White 92 (89.3%) 98 (95.1%) 62 (98.4%) 30 (75%) 58 (92.1%) 40 (100%) 
   Indian 0 (0%) 1 (1%) - - 1 (1.6%) - 
   Black other 1 (1%) 0 (0%) - 1 (2.5%) - - 
   Pakistani 1 (1%) 0 (0%) - 1 (2.5%) - - 
   Chinese 1 (1%) 0 (0%) 1 (1.6%) - - - 
   Other 8 (7.8%) 4 (3.9%) - 8 (20%) 4 (6.3%) - 
Employment status       
   Employed full-time 42 (40.8%) 37 (35.9%) 26 (41.3%) 16 (40%) 21 (33.3%) 16 (40%) 
   Employed part-time 4 (3.9%) 19 (18.4%) 2 (3.2%) 2 (5%) 18 (28.6%) 1 (2.5%) 
   Student 15 (14.6%) 35 (34%) 5 (7.9%) 10 (25%) 17 (27%) 18 (45%) 
   Volunteer work 10 (9.7%) 4 (3.9%) 3 (4.8%) 7 (17.5) 2 (3.2%) 2 (5%) 
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   Housewife/husband - - - - 2 (3.2%) - 
   Disabled 3 (2.9%) 2 (1.9%) 1 (1.6%) 2 (5%) - - 
   Unemployed 13 (12.6%) 1 (1%) 10 (15.9%) 3 (7.5%) 1 (1.6%) - 
   Other 16 (15.5%) 5 (4.9%) 16 (25.4%) - 2 (3.2%) 3 (7.5%) 
Civil status       
   Single, never married 71 (68.9%) 52 (50.5%) 36 (57.1%) 35 (87.5%) 25 (39.7%) 27 (67.5%) 
   Married 8 (7.8%) 35 (34%) 6 (9.5%) 2 (5%) 27 (42.9%) 8 (20%) 
   Civil partnership 1 (1%) 3 (2.9%) - 1 (2.5%) 1 (1.6%) 2 (5%) 
   Separated 3 (2.9%) 3 (2.9%) 1 (1.6%) 2 (5%) 2 (3.2%) 1 (2.5%) 
   Divorced 15 (14.6%) 4 (3.9%) 15 (23.8%) - 4 (6.3%) - 
   Widowed 2 (1.9%) 3 (2.9%) 2 (3.2%) - 3 (4.8%) - 
   Other 1 (1%) 1 (1%) 1 (1.6%) - 1 (1.6%) - 
Living situation       
   With family of origin 29 (28.2%) 13 (12.6%) 13 (20.6%) 16 (40%) 7 (11.1%) 6 (15%) 
   Alone 34 (33%) 21 (20.4%) 27 (42.9%) 7 (17.5%) 12 (19%) 9 (22.5%) 
   Shares with non-partner(s) 15 (14.6%) 10 (9.7%) 7 (11.1%) 8 (20%) 2 (3.2%) 8 (20%) 
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   With partner only 15 (14.6%) 25 (24.3%) 8 (12.7%) 7 (17.5%) 15 (23.8%) 10 (25%) 
   With partner and child/ren 3 (2.9%) 24 (23.3%) 3 (4.8%) - 19 (30.2%) 5 (12.5%) 
   With child/ren only 2 (1.9%) 4 (3.9%) 2 (3.2%) - 4 (6.3%) - 
   Other 5 (4.9%) 5 (4.9%) 3 (4.8%) 2 (5%) 3 (4.8%) 2 (5%) 
Treatment stage       
   Assessment 7 (6.8%) - 4 (6.3%) 3 (7.5%) - - 
   Real Life Experience 78 (75.7%) - 47 (74.6%) 31 (77.5%) - - 
   Post-surgery 17 (16.5%) - 11 (17.5%) 6 (15%) - - 
Hormone status       
   No use 19 (18.5%) - 11 (17.5%) - - - 
   Current use 81 (78.6%) - 50 (79.4%) - - - 
   Previous use 1 (1%) - 1 (1.6%) - - - 
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literature (De Cuypere et al., 2006; Fischer et al., 2010; Haraldsen & Dahl, 
2000; Simon et al., 2011; Smith et al., 2005a). In this study, the Cronbach’s 
alpha was .97. 
 
3.4.3.3 Short Form Health Survey 36 version 2 (SF36) 
 
The SF36 (Ware & Sherbourne, 1992) measures functional quality of life, 
with higher scores indicating greater perceived quality of life. Calculating the 
mean of four subscales (vitality, social functioning, role limitations due to 
emotional problems, and mental health) produces a mental health component 
summary score. This scoring format, set out by the measure’s authors, has 
been used previously in transgender research (Gorin-Lazard et al., 2012). 
Subscales relating to physical health were considered not relevant to this study. 
Internal reliability and discriminant validity are reportedly high (McHorney et al., 
1994). The Cronbach’s alpha here was .93.  
 
3.4.3.4 Personal Wellbeing Index (PWI) 
 
The PWI (Cummins et al., 2003) measures life satisfaction across eight 
domain items, including standard of living, achievements in life, personal 
relationships, personal safety, community connectedness, future security, and 
spirituality/religion. A mean total score is calculated, with higher scores 
indicating greater life satisfaction. Although not yet been validated in clinical 
samples, the PWI is psychometrically sound in non-clinical samples, 
demonstrating good reliability, validity and sensitivity across diverse cultural 
populations (Lau et al., 2005). Here the Cronbach’s alpha was .88. 
 
3.4.4 Data analysis 
 
The data did not meet the assumptions of normal distribution (for 
instance, the Kolmogorov-Smirnov test on total MSPSS was significant, 
D(206)=.107, p<.000); therefore non-parametric tests were employed. To test 
hypothesis one, one-tailed Mann-Whitney U tests were performed to compare 
the clinical and control groups’ MSPSS scores. To test hypothesis two, one 
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tailed Kruskal-Wallis tests were conducted to examine differences between 
trans women, trans men, control women and control men. Where there were 
significant results, post-hoc one-way analyses of covariance (ANCOVA) were 
performed to control for participants’ scores on the SCL depression subscale. 
To test hypothesis three, one tailed Mann-Whitney U tests were used to 
compare the clinical and control groups’ SCL, SF and PWI scores. Data were 
bootstrapped in these analyses. For hypothesis four, multiple regression 
analyses using enter method were performed to test whether MSPSS 
subscales were significant predictors of SCL GSI and SCL subscales, SF 
mental health component summary score and SF subscales, and PWI total. An 
alpha level of .01 was used to determine significance.  
 
3.5 Results 
 
3.5.1 Perceived social support among the clinical and control group 
 
The clinical group reported significantly lower scores on MSPSS total 
and all MSPSS subscales compared to the control group (see Table 3.2). The 
effect sizes were as follows: .47 MSPSS total, .51 MSPSS family, .34 MSPSS 
friends, and .26 MSPSS significant other. However, when analysed by gender, 
trans men did not score significantly differently to trans women or either control 
group on MSPSS total or any MSPSS subscales. In contrast, trans women 
scored significantly lower on MSPSS total (Z=16.84 p=.001) and MSPSS family 
(Z=14.76 p=.002) compared to control women but not control men. When 
controlling for SCL depression, differences between the clinical and control 
group on MSPSS total remained significant, whereas differences on all three 
MSPSS subscales became non-significant (see Table 3.2). Furthermore, 
differences between trans women and control women on MSPSS total and 
MSPSS family also became non-significant (respectively F=1.99 p=.117 and 
F=2.26 p.082). 
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Table 3.2. Comparison of the clinical and control sample on each measure 
 
Measure Clinical 
sample 
Control 
sample 
Mann-Whitney U ANCOVA 
Mean (SD) Mean (SD) U, P F,P 
MSPSS       
Total score 5.03 (1.27) 5.64 (1.34) 3650 <.000** 6.86 .01* 
Family support 4.59 (1.95) 5.50 (1.62) 3733.5 <.000** 6.07 .015 
Friend support 5.23 (1.39) 5.68 (1.30) 4120 .0025* 1.59 .209 
Sig. other support 5.28 (1.78) 5.72 (1.65) 4379 .013* .383 .537 
SCL-90-R       
Global severity index .66 (.55) .28 (.32) 2755 <.000**   
Somatisation .53 (.53) .30 (.40) 3784 <.000**   
Obsessive-
compulsive 
.95 (.83) .50 (.58) 3440 <.000**   
Interpersonal 
sensitivity 
.83 (.76) .34 (.45) 3129 <.000**   
Depression .92 (.75) .36 (.49) 2554 <.000**   
Anxiety .45 (.53) .18 (.36) 3428.5 <.000**   
Hostility .46 (.50) .24 (.30) 3909 .0005**   
Phobic anxiety .45 (.66) .09 (.26) 2867.5 <.000**   
Paranoid ideation .65 (.66) .24 (.36) 3261 <.000**   
Psychoneuroticism .45 (.54) .12 (.28) 2794 <.000**   
SF36v2         
Mental health 
component summary 
69.31 
(16.81) 
76.73 
(13.01) 
3855.5 .005*   
Vitality 54.38 
(21.08) 
59.63 
(17.71) 
4447.5 .022   
Social functioning 77.46 
(26.02) 
89.98 
(17.30) 
3745 <.000**   
Role limitations due to 
emotional problems 
81.22 
(22.97) 
89.91 
(17.96) 
4093 .001**   
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Mental health 70.85 
(17.27) 
77.21 
(14.99) 
4092.5 .002*   
PWI       
Total score 63.23 
(16.49) 
71.77 
(17.30) 
3352.5 <.000**     
n=103, *p<.01, **p<.001, higher scores indicate greater social support (MSPSS), greater 
psychological distress (SCL-90-R), higher quality of life (SF36v2), and higher life 
satisfaction (PWI)  
 
3.5.2 Comparison of psychological wellbeing between the clinical and control 
group 
 
In comparison with the control group, the clinical group scored 
significantly higher on SCL GSI and SCL subscales (see Table 3.2). The clinical 
group also scored significantly lower on all SF subscales, with the exception of 
SF vitality, and PWI total, than the control group. 
 
3.5.3 Perceived social support as a predictor of psychological wellbeing 
 
In relation to psychopathology in the clinical sample, MSPSS subscales 
were only found to significantly predict SCL somatisation (F=4.7, p=.004), 
although there was a near significant result for SCL depression (F=3.63, 
p=.016). Regarding quality of life, MSPSS subscales significantly predicted SF 
mental health component summary as well as SF vitality and SF mental health 
(see Table 3.3). In terms of life satisfaction, MSPSS subscales significantly 
predicted 22% of the variance in PWI total.  
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Table 3.3. Social support as a predictor of psychological wellbeing variables 
 
Measure Clinical % 
Variance 
explained 
Sig. 
individual 
predictors 
Control % 
Variance 
explained 
Sig. 
individual 
predictors 
F, P F, P 
SCL-90-R         
Global severity index 2.735 .048 8% - 0.93 .429 3% - 
Somatisation 4.696 .004** 13% Family* 0.153 .928 1% - 
Obsessive-compulsive 1.616 .19 5% - 1.198 .315 4% - 
Interpersonal sensitivity 2.139 .1 6% - 1.129 .341 3% - 
Depression 3.632 .016 10% - 0.433 .73 1% - 
Anxiety 1.367 .257 4% - 0.57 .636 2% - 
Hostility 0.915 .437 3% - 0.287 .835 1% - 
Phobic anxiety 1.282 .285 4% - 1.829 .147 5% - 
Paranoid ideation 2.039 .113 6% - 4.841 .003*   
Psychoneuroticism 2.599 .056 7% - 2.475 .066 7% - 
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SF36v2 
        
Mental health 
component summary 
4.48 .005* 12% - 2.52 .062 7% - 
Vitality 4.35 .006* 12% Friends* 0.82 .486 2% - 
Social functioning 0.89 .447 3% - 0.45 .72 1% - 
Role limitations due to 
emotional problems 
2.61 .055 7% - 3.98 .01* 11% Friends* 
Mental health 5.74 .001* 15% - 2.583 .058 7% - 
PWI         
Total score 9.11 <.000** 22% Family* 6.85 <.000** 18% - 
n=103, *p<.01, **p<.001 
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3.6 Discussion 
 
The overarching aims of this paper were to determine differences in 
perceived social support between trans individuals and cisgender individuals, 
and to assess whether perceived social support predicted psychological 
wellbeing. Hypothesis one was supported: trans individuals reported 
significantly less perceived social support than the control group. The second 
finding that trans women reported lower perceived social support overall and 
from their families than control women offers partial support for hypothesis two. 
However trans men did not significantly differ to either trans women or controls. 
Trans individuals displayed significantly higher psychopathology and lower 
quality of life and life satisfaction compared to controls, as predicted in 
hypothesis three. Finally, perceived social support was not a significant 
predictor of psychopathology, however, it did predict quality of life and life 
satisfaction, lending some support to hypothesis four. 
 
Typical gender differences in seeking and utilising social support might explain 
why trans women experience less social support compared to control women 
but not control men. Men are less likely to seek social support compared to 
women (Ashton & Fuehrer, 1993), a trend attributed to male socialisation and 
the perception that seeking social support is a feminine behaviour (Blazina, 
2001). Having been socialised as male from childhood, trans women may have 
less developed support networks or may be more restricted in seeking support 
than control women who have continuously been socialised as female. 
Additionally, general attitudes to femininity in men are much less tolerant than 
attitudes to masculinity in women (Devor, 2004). Whilst this has not been 
considered in relation to families, it is plausible that these differences in 
acceptance may extend to family settings. 
 
In comparison to friends and partners (sometimes referred to as families of 
choice), relationship transitions may be more complicated among families of 
origin. Families of origin may have known the person longer in their sex 
assigned at birth and thus may find adjustment, and consequently being 
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supportive, more difficult. Parents especially can sometimes feel responsible for 
their child’s gender dysphoria (Lantz, 1999) and this may hinder a fully 
supportive relationship. In contrast, it would be expected that families of choice 
are selected on the basis of support and love that is not necessarily assured 
within families of origin and, therefore, would demonstrate greater acceptance. 
This explanation appears to be supported by the finding that family support, as 
opposed to support from friends and significant others, is lower among trans 
women. 
 
When participants’ levels of depression were taken into consideration, many of 
the differences between the clinical and control group became non-significant. 
This finding is not overly surprising, given the well documented relationship 
between depression and social support in the wider literature (e.g., Ashton & 
Fuehrer, 1993; Lau et al., 2005). For instance, depression is characterised by 
social withdrawal and isolation (Barrett & Barber, 2007)22. In line with previous 
research (e.g., Nuttbrock et al., 2013a), trans individuals reported higher levels 
of depression than controls. Therefore management of depression in this 
population may benefit from an approach aimed at increasing social support 
and healthy interpersonal relationships. Future research investigating 
interpersonal functioning in this population may be valuable. 
 
While perceived social support was a poor predictor of psychopathology, it did 
significantly predict quality of life and life satisfaction, supporting similar findings 
by Erich et al. (2008). There are two potential ways social support might benefit 
psychological wellbeing in trans individuals. It may have a direct effect on 
wellbeing by its intrinsic value, for example Moss (1973) describes social 
support as the subjective feeling of being accepted, loved and belonging. It may 
also, in line with Cohen’s stress-buffering hypothesis (Cohen & Wills, 1985), act 
indirectly as a buffer against negative experiences, such as discrimination and 
victimisation. This has been highlighted in a non-transgender sample where the 
association between stigma and psychological functioning was mediated by 
social support (Larios, David, Gallo, Henrich, & Talavera, 2009). 
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3.6.1 Limitations & directions for further research 
 
In this study, there are methodological limitations that must be 
acknowledged. Due to sampling of patients attending a UK GIC, the results 
cannot necessarily be applied to individuals outside the UK, those not seeking 
treatment or those who do not fulfil diagnostic criteria. Regarding statistics, 
though the data were not normally distributed, there is no non-parametric 
equivalent of regression, therefore it is advised the results are interpreted with 
caution. Also, differences were observed in the distribution of clinical 
participants across certain socio-demographic variables, compared to non-
clinical participants. While only age and gender were controlled, it should be 
acknowledged that socio-demographics, such as employment and civil status, 
are associated with wellbeing in the general literature and might be influenced 
by living as trans and its associated stigma. In terms of measures, a drawback 
of the MSPSS is that it measures sources but not types of social support. Social 
support can take various forms, for instance emotional, instrumental, 
informational and appraisal support (House, 1981). It is possible that trans 
individuals may need different types of support through their gender journey. A 
further limitation is that support from others who identify as trans was not 
measured, though other research suggests that support from transgender 
communities is highly valued (Budge et al., 2013). The unique experiences 
shared by trans communities may create a distinct source of support, as they 
can provide instrumental support regarding self-disclosure, ‘passing’, and ways 
to manage employers and government bureaucracies (Schrock et al., 2004). It 
is possible that this source of support may have been captured by friend 
support within the MSPSS, however it would be useful to explicitly measure 
support from transgender others in future. 
 
Recommended directions for further research include investigation into the 
impact of stage of treatment, actual received support, and mediating factors. 
Unfortunately, due to the homogeneity within the clinical sample, it was not 
possible to test whether stage of treatment was associated with perceived 
social support or whether social support predicted psychological wellbeing more 
or less strongly across the treatment trajectory. In other research, one of the 
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areas where improvements following SRS were most notable was interpersonal 
relationships (Abramowitz, 1986). Therefore it would be valuable for future 
research to examine the potential effects of stage of treatment and social 
transition. While this study examined subjective social support, a next step 
could be to objectively evaluate the support actually available, potentially by 
quantifying social ties or network size. It is currently not known whether trans 
individuals have interpersonal difficulties seeking social support or whether 
others are less supportive towards them. One final suggestion for further 
research is to explore potential mediators of the relationship between perceived 
social support and psychological wellbeing, such as interpersonal functioning. 
 
3.6.2 Conclusion 
 
These findings signify the importance of assisting trans individuals, 
particularly trans women, to develop and utilise various sources of social 
support, given the impact on quality of life and life satisfaction. To improve 
family support, greater involvement of family members in the treatment process 
is encouraged, in keeping with recent clinical guidelines (Ahmad et al., 2013; 
Wylie et al., 2014).  Family support is often lacking within GIC services and it 
has been highlighted that trans individuals would like support and help for their 
families in coping with a relative experiencing gender dysphoria (Davies et al., 
2013). Clinicians, together with other health professionals, are in a unique 
position to advocate for patients and liaise with their families, perhaps breaking 
down barriers of misunderstanding and fostering good communication. In 
addition, efforts could be made more broadly to educate and challenge attitudes 
of cisgender people towards those who are trans, thereby encouraging 
empathy and supportive responses.  
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Chapter 4: Interpersonal functioning among treatment seeking trans 
individuals  
 
 
This chapter has been accepted by Journal of Clinical Psychology (impact 
factor 2.111), with the authors listed as follows: Davey, A., Bouman, W. P., 
Arcelus, J. & Meyer, C.  
 
 
4.1 Introduction to Chapter 4 
 
The focus of the previous chapter was perceived social support. 
However, relationships are reciprocal and in order to be able to elicit and utilise 
support from others, it is important to have the necessary interpersonal skills. 
Therefore, investigating how trans individuals relate to others in terms of 
interpersonal problems was identified as a critical area. Surprising, this subject 
has scarcely been explored among the trans population until now. Given the 
link between interpersonal problems and psychological wellbeing (particularly 
the development and maintenance of mental health problems) identified in 
cisgender populations (Arcelus et al., 2013; Barrett & Barber, 2007; Eberhart & 
Hammen, 2006; Ravitz et al., 2007), this was an added justification to explore 
interpersonal functioning among trans individuals. 
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4.2 Abstract 
 
Objectives 
Trans people have been found to have high levels of depression relative to the 
general population. In view of the association between interpersonal problems 
and depression, and the importance of interpersonal skills to navigate the 
transition of trans people, this study aimed to investigate levels of interpersonal 
problems among treatment-seeking trans men and women, and the role of 
depression in this association.  
Method 
104 patients from a UK Gender Identity Clinic (GIC) and 104 age- and gender- 
matched controls completed self-report measures of interpersonal problems 
and general psychopathology, including depression.  
Results 
Trans people reported significantly higher scores on global interpersonal 
problems, and in the sociable, supportive, and involved subscales, and lower 
scores on the too open subscale. Depression accounted for significant 
differences on IIP global and the subscale open but not on IIP sociable, 
supportive and involved.  
Conclusions 
Trans individuals present with interpersonal problems, which could potentially 
increase their vulnerability to mental health problems. Therefore, addressing 
interpersonal problems may help to prevent the development of depressive 
symptomatology and facilitate transition to their experienced gender.  
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4.3 Introduction 
 
Interpersonal problems comprise a broad range of difficulties related to 
social interaction and engagement, whether in close relationships or broader 
interpersonal situations (Hartmann, Zeeck, & Barrett, 2010). Interpersonal 
functioning has a well-documented role in psychological health. Specifically, 
secure and fulfilling interpersonal relationships are considered essential to a 
person’s happiness and wellbeing (e.g., Berscheid & Peplau, 1983). 
Conversely, poor interpersonal functioning is often associated with a range of 
mental health problems, including depression (e.g., Barrett & Barber, 2007), 
anxiety (e.g., McEvoy, Burgess, Page, Nathan, & Fursland, 2013), eating 
disorders (e.g., Arcelus, Haslam, Farrow, & Meyer, 2013; Arcelus et al., 2009), 
and personality disorders (e.g., Pincus & Wiggins, 1990). 
 
Interpersonal problems, such as difficulties with social inhibition, dependency, 
assertiveness, self-sacrifice, and intimacy, have been proved to predict both the 
onset and the maintenance of depression (Barrett & Barber, 2007; Eberhart & 
Hammen, 2006; Ravitz et al., 2007). One group where depressive symptoms 
have been found to be particularly prevalent is among trans individuals 
(individuals diagnosed with Transsexualism) (Clements-Nolle, Marx, Guzman, 
& Katz, 2001; Colton Meier, et al., 2013; Nuttbrock et al., 2013a).  
 
Transsexualism is a formal diagnosis of the International Classification of 
Disease (ICD-10; (WHO, 1992). It describes individuals who present with 
discomfort or distress caused by the discrepancy between a person’s gender 
identity (their psychological sense of themselves as men or women) and the 
sex they were assigned at birth (with the accompanying primary/secondary 
sexual characteristics and/or expected social gender role).  Sometimes, the 
distress is sufficiently intense that individuals undergo transition from Male-to-
Female (people known as trans women) or from Female-to-Male (people known 
as trans men) (Ahmad et al., 2013; Wylie et al., 2014). The ICD-10 diagnosis 
for transsexualism is under review.  It is proposed that the ICD-11 recognises 
individuals who don’t identify themselves as either male or female and are 
therefore not part of the gender binary (Drescher et al., 2012).  This has been 
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acknowledged in the DSM-5, where the diagnosis of Gender Dysphoria has 
been introduced which incorporates all individuals on the gender spectrum 
(APA, 2013). Cisgender people (as a complement to trans people) are 
individuals who have a match between the gender they were assigned at birth, 
their bodies, and their personal identity.  
 
Transitioning to a different gender involves the negotiations of considerable 
social and interpersonal challenges (e.g., Budge, 2013). These challenges 
include disclosing one’s gender identity to others (Gagne, Tewksbury, & 
McGaughey, 1997; Wylie et al., 2014), facing rejection (Koken et al., 2009), 
coping with discrimination and stigma (Clements-Nolle et al., 2006), and 
managing social gender role transition (Budge, 2013; Rowniak & Chesla, 2013). 
Therefore, trans individuals who have interpersonal problems are likely to 
encounter greater difficulties in these areas. Interpersonal problems could make 
a person more vulnerable to develop stress and depressive symptoms as a 
result. Given the strong evidence in the general literature demonstrating a 
strong association between interpersonal problems and the development and 
maintenance of depressive symptoms (Barrett & Barber, 2007; Eberhart & 
Hammen, 2006; Ravitz et al., 2007) it can be hypothesised that this association 
is likely to be stronger among trans people. However, to our knowledge no 
studies have directly measured interpersonal problems in this population.  
Assessing interpersonal functioning may be clinically valuable in the prevention 
of mental health problems in trans individuals by identifying at risk population 
(Sheets, Duncan, Bjornsson, Craighead, & Craighead, 2014). 
 
In view of the high levels of affective disorders in trans people (Claes et al., 
2015; Clements-Nolle et al., 2006; Couch et al., 2007; Dhejne et al., 2011; 
Hepp et al., 2005; Heylens et al., 2014; Liu & Mustanski, 2012; Skrapec & 
MacKenzie, 1981) and the association between interpersonal problems and 
depression in the general literature (Barrett & Barber, 2007) the aims of this 
study are: 
  
1) To investigate the rates of interpersonal problems among trans 
individuals attending a GIC. It is hypothesised that interpersonal problems 
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are greater among trans individuals than cisgender individuals possibly 
due to the higher levels of depression among this population maintained 
by the amount of interpersonal challenges that they need to undertake, 
including the intense stigma (Clements-Nolle et al., 2006) and threat of 
rejection (Koken et al., 2009).  
 
2) To compare interpersonal problems between trans women and trans 
men. While previous research suggests that cisgender men and women 
differ across specific interpersonal domains such as assertiveness and 
aggression (Gurtman & Lee, 2009), it is currently unknown whether trans 
women and trans men differ in the same domains. It is hypothesised that 
these gender patterns will be replicated in accordance with birth sex 
(rather than gender identity), so that trans men score higher on the 
subscale ‘hard to be assertive’ and lower on ‘too aggressive’ compared to 
trans women. This is based on the assumption that typical childhood 
socialisation may prompt trans women to adapt to and exhibit male norms, 
and trans men to adapt to and exhibit female norms (Mallon, 2000). 
 
3) To assess whether any differences in interpersonal problems remain 
after controlling for levels of depression. If levels of interpersonal problems 
are elevated, it is important to test whether interpersonal problems are 
independently associated with the experience of being trans or associated 
with higher levels of depression. It is hypothesised that subsequent to 
controlling for depression, any differences between the clinical and control 
groups on interpersonal problems will remain significant. 
 
4.4 Method 
 
4.4.1 Participants 
 
4.4.1.1 Clinical sample  
 
The clinical sample was drawn from the pool of patients attending a 
national GIC in the United Kingdom. This is one of the largest clinics of its kind 
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in Europe and receives more than 600 referrals a year from all over the United 
Kingdom. Participants were eligible to take part if they had a clinician-provided 
diagnosis of Transsexualism according to ICD-10 criteria (F64.0, WHO, 1992) 
and were aged 18 years or over. The ICD-10 diagnostic criteria stipulate that 
the person desires to live and be accepted as a member of the opposite sex, 
and wishes to make his or her body as congruent as possible with the preferred 
sex through surgery and cross-sex hormone treatment. Additionally, the trans 
identity must be present for a minimum of two years and must not be a 
symptom of another mental disorder or a chromosomal abnormality (WHO, 
1992). First, patients attend three consecutive assessments over a six-month 
period before a diagnosis is reached. Once diagnosed, patients progress to the 
GIC’s treatment pathway, which includes cross-sex hormone treatment and 
SRS. 
 
4.4.1.2 Control sample 
 
Participants were selected (in chronological order based on gender) from 
a pool of 300 people recruited via an online survey hosted by Loughborough 
University. A snowballing sampling technique was employed whereby links 
were posted to social media networks or emailed to contacts; and respondents 
were asked to share these links with their networks. The control sample was 
comprised of adults who identified themselves as not being transgender or 
having gender dysphoria. Control participants were matched according to age 
and gender with the clinical group. 
 
4.4.2 Procedure 
 
4.4.2.1 Trans individuals 
 
275 individuals with a diagnosis of Transsexualism as per the ICD-10 
(WHO, 1992) were invited to participate in the study by completing a 
questionnaire pack. The questionnaire pack consisted of an information sheet, 
consent form, socio-demographic questionnaire, self-report measures, and pre-
paid return envelope. Data collection spanned just under a year. One hundred 
and ten participants returned questionnaires, producing a response rate of 
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40%; however six were subsequently discounted due to substantial missing 
data. 
 
4.4.2.2 Control group 
 
As the research team did not have face to face contact with the control 
group, they were sent a web-link to an online survey via email or social 
networking websites and asked to pass on the web-link to others who might be 
interested in taking part. The online survey replicated the clinical questionnaire 
pack barring socio-demographic questions specific to having gender dysphoria. 
Of the 161 control participants who completed the online survey, 104 were 
selected on the basis of age and gender identity to enable matching with the 
clinical sample. Ethical approval was obtained from Loughborough University 
Institutional Ethics Board and the NHS Local Research Ethics Committee. All 
participants gave their informed consent. 
 
4.4.3 Measures 
 
4.4.3.1 Socio-demographic questionnaire 
 
The demographic questionnaire contained questions categorising 
participants’ gender identity, ethnic origin, employment status, civil status, and 
living situation. Additional questions regarding treatment stage and cross-sex 
hormone use were included for clinical participants. 
 
4.4.3.2 Inventory of Interpersonal Problems (IIP-32; Barkham et al., 1996) 
 
The IIP-32 measures interpersonal difficulties. It consists of 32 items to 
be rated on a 5-point Likert scale ranging from 0 (‘not at all’) to 4 (‘extremely’) 
(Barkham et al., 1996). There are eight subscales of interpersonal problems: 
hard to be assertive, hard to be sociable, hard to be supportive, hard to be 
Involved, too dependent, too caring, too aggressive, and too open. A total mean 
score provides a global measure of interpersonal distress. Higher subscale 
scores indicate greater interpersonal difficulties. The IIP-32 is a shortened 
version of the original IIP, yet the psychometric properties are retained; a 
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confirmatory factor analysis demonstrated high reliability with alpha coefficients 
of .70 to .88 (Barkham et al., 1996). The IIP-32 has been used successfully in 
both non-clinical (e.g., Berry et al., 2006) and clinical samples (e.g., Arcelus et 
al., 2009; Paley et al., 2008). The Cronbach’s alpha ranged from .63 to .87 in 
the clinical group and from .72 to .88 in the control group across IIP subscales. 
 
4.4.3.3 Symptom Checklist 90 Revised (SCL-90-R; Derogatis, 1977) 
 
The SCL-90-R measures general psychopathology across nine primary 
symptoms dimensions, including depression (Derogatis, 1977). This study 
utilized only the subscale SCL depression to control for depression in the 
analysis. The 13 items, which are used to indicate severity of depression over 
the previous seven days, are rated on a five-point Likert scale. Good construct 
validity and reliability has been established for the SCL-90-R (Derogatis & 
Unger, 2010) and it has been used frequently across the literature on 
individuals with gender dysphoria (e.g., De Cuypere et al., 2006; Fischer et al., 
2010; I. R. Haraldsen & Dahl, 2000; Simon et al., 2011; Smith et al., 2005). The 
Cronbach’s alpha for the SCL depression subscale in the current sample was 
.89 and .90 for the clinical and control group respectively. 
 
4.4.4 Data Analysis 
 
As the data tended to be positively skewed (IIP global and the majority of 
the IIP subscales) and Kolmogorov-Smirnov tests proved significant, non-
parametric tests were applied where possible. To test all three hypotheses, a 
series of one-tailed Mann-Whitney U tests were performed. In order to further 
examine differences by gender for hypothesis two, a series of one-tailed 
Kruskal-Wallis tests were also conducted. Significant results were followed up 
with pairwise comparisons. Specifically, for hypothesis three, initially a one-
tailed Mann-Whitney U test was carried out to test whether the clinical and 
control group differed significantly on depression scores. This justified 
subsequent analyses of covariance (ANCOVA) on all significant results. SCL-
90-R subscale depression was entered as the covariate. Given the lack of a 
non-parametric equivalent to the ANCOVA, the results of this final analysis 
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should be treated with caution. To reduce the risk of type I errors, significance 
was determined using an alpha level of 0.01 throughout. Using the guidelines 
set out by Cohen (1992) for calculating sample sizes, in order to run a test of 
difference with a between subjects design that achieves a medium effect size, 
with an alpha of .01, a minimum of 190 participants are required to meet a 
power of 0.80. 
  
4.5 Results 
 
4.5.1 Characteristics of the sample 
 
The clinical population consisted of 64 trans women and 40 trans men, 
with a mean age of 36.52 years (SD =15.25). The control population also had a 
64:40 female: male ratio and a mean age of 37.63 (SD = 15.30). Age was not 
statistically different between the groups (z= 5250, p=.358). In both groups, an 
overwhelming proportion identified their ethnic origin as white and many were 
employed full-time. There were lower numbers of people in part-time work and 
education but a higher number in voluntary work among the clinical group. 
There were also differences in the levels of unemployment between both 
groups. Other notable comparisons were that more clinical participants were 
divorced and less were married than control participants. In relation to their civil 
status, clinical participants tended to live with their family of origin, non-
partners, and alone more frequently than control participants (Table 4.1). The 
clinical group’s mean scores were higher on all subscales, with the exception of 
IIP dependent and IIP open. The clinical and control group’s respective IIP 
global mean scores were lower than those reported in Barkham et al. (1996), 
which were 0.98 among a general population group and 1.51 among a patient 
population. 
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Table 4.1. Socio-demographic characteristics of the clinical and control sample  
 
  
Clinical sample Control sample 
104 (%) 104 (%) 
Gender identity   
   Female 64 (61.5%) 64 (61.5%) 
   Male 40 (38.5%) 40 (38.5%) 
Ethnic origin   
   White 93 (89.4%) 99 (95.2%) 
   Indian 0 (0%) 1 (1%) 
   Black other 1 (1%) 0 (0%) 
   Pakistani 1 (1%) 0 (0%) 
   Chinese 1 (1%) 0 (0%) 
   Other 8 (7.7%) 4 (3.8%) 
Employment status   
   Employed full-time 42 (40.4%) 38 (36.5%) 
   Employed part-time 4 (3.8%) 19 (18.3%) 
   Student 15 (14.4%) 35 (33.7%) 
   Volunteer work 10 (9.6%) 4 (3.8%) 
Housewife/husband 1 (1%) 2 (1.9%) 
   Disabled 3 (2.9%) 0 (0%) 
   Unemployed 13 (12.5%) 1 (1%) 
   Other 16 (15.4%) 5 (4.8%) 
Civil status   
   Single, never married 71 (68.3%) 52 (50%) 
   Married 8 (7.7%) 36 (34.6%) 
   Civil partnership 1 (1%) 3 (2.9%) 
   Separated 3 (2.9%) 3 (2.9%) 
   Divorced 16 (15.4%) 4 (3.8%) 
   Widowed 2 (1.9%) 3 (2.9%) 
   Other 2 (1.9%) 1 (1%) 
Living situation   
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   With family of origin 29 (27.9%) 14 (13.5%) 
   Alone 34 (32.7%) 21 (20.2%) 
   Shares with non-partner(s) 15 (14.4%) 10 (9.6%) 
   With partner only 16 (15.4%) 25 (24%) 
   With partner and child/ren 3 (2.9%) 24 (23.1%) 
   With child/ren only 2 (1.9%) 4 (3.8%) 
   Other 5 (4.8%) 5 (4.8%) 
Treatment stage   
   Assessment 7 (6.7%) - 
   Real Life Experience 78 (75%) - 
   Post-surgery 18 (17.3%) - 
Hormone status   
   No use  19 (18.3%) - 
   Current use 82 (78.8%) - 
   Previous use 1 (1%) - 
 
n=208 
4.5.2 Global interpersonal problems in trans individuals and controls 
 
The clinical group reported significantly higher scores on IIP global than 
the control group (Table 4.2), with an effect size (d) of 0.54. When analyzed by 
gender, trans women and trans men did not differ significantly from each other 
on IIP global, however trans men (but not trans women) reported significantly 
higher scores compared to both control men and women (Table 4.3). 
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Table 4.2. Results of the Interpersonal Problems Inventory and Symptom Checklist in the clinical group versus the control group 
with and without controlling for depression  
 
Measure Clinical Control Mann-Whitney U ANCOVA 
n=104 n=104  Depression 
mean (SD) mean (SD) Z               P F             P 
IIP       
Global score 1.11 (0.60) 0.79 (.48) 3651 <.001** 2.94 .088 
Hard to be assertive 1.38 (0.99) 1.15 (0.87) 4701 .051 - - 
Hard to be sociable 1.37 (1.01) 0.63 (0.69) 2991.5 <.001** 17.5 <.001** 
Hard to be supportive 0.80 (0.98) 0.37 (0.50) 4008.5 .001** 6.72 .01* 
Hard to be involved 1.24 (1.10) 0.62 (0.77) 35.16.5 <.001** 6.36 .012* 
Too dependent 0.93 (0.83) 0.96 (0.78) 5185.5 .303 - - 
Too caring 1.26 (0.81) 1.06 (0.75) 4653 .04 - - 
Too aggressive 0.69 (0.70) 0.66 (0.74) 5202.5 .316 - - 
Too open 1.46 (0.78) 1.82 (0.72) 4029.5 .001** 4.83 .029 
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SCL 
      
Depression 0.92 (0.75) 0.37 (0.50) 2663.0 <.001**   
n=208, *p<.01, **p<.001 
 
Table 4.3. Results of the Interpersonal Problems Inventory between the clinical group versus the control divided by gender with 
and without controlling for depression 
 
IIP Clinical Control Kruskal 
Wallis 
Sig. pairwise 
comparisons 
ANCOVA 
Depression 
Trans 
females 
Trans 
males 
Females Males Z 
P 
 F P 
n=64 n=40 n=64 n=40   
mean 
(SD) 
mean 
(SD) 
mean 
(SD) 
mean 
(SD) 
    
Global score 1.03  
(0.58) 
1.25 
(0.61) 
0.82 
(0.45) 
0.73 
(0.52) 
20.29  
<.001** 
Trans men > cismen 6.958 .01* 
Trans men > ciswomen 6.923 .01* 
Hard to be 
assertive 
1.30 
(0.89) 
1.50 
(1.13) 
1.27 
(0.86) 
0.96 
(0.85) 
6.156 
.052 
- - - 
Hard to be 
sociable 
1.21 
(0.95) 
1.62 
(1.07) 
0.65 
(0.64) 
0.59 
(0.78) 
35.34 
<.001** 
Trans women > ciswomen 5.569 0.02 
Trans women > cismen 2.512 0.116 
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Trans men > cismen 14.93 <.001** 
Trans men > ciswomen 22.53 <.001** 
Hard to be 
supportive 
0.82 
(1.00) 
0.76 
(0.98) 
0.40 
(0.55) 
0.34 
(0.41) 
11.03 
.006* 
- 2.287 0.08 
Hard to be 
involved 
1.19 
(1.09) 
1.33 
(1.11) 
0.54 
(0.73) 
0.73 
(0.84) 
21.44  
<.001** 
Trans women > ciswomen 5.194 0.024 
Trans men > ciswomen 9.472 .003* 
Too dependent 0.80 
(0.72) 
1.15 
(0.96) 
0.98 
(0.78) 
0.94 
(0.79) 
3.60  
.155 
- - - 
Too caring 1.16 
(0.77) 
1.41 
(0.86) 
1.17 
(0.73) 
0.89 
(0.75) 
9.13 
.014* 
Trans men > cismen 3.842 0.054 
Too aggressive 0.56 
(0.60) 
0.89 
(0.78) 
0.67 
(0.65) 
0.65 
(0.88) 
7.377 
.031 
- - - 
Too open 1.61 
(0.68) 
1.21 
(0.87) 
1.94 
(0.68) 
1.64 
(0.76) 
19.36  
<.001** 
Ciswomen > Trans men 14.98 <.001** 
n=208, *p<.01, **p<.001 
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4.5.3 Specific interpersonal problems in trans individuals vs controls 
 
There were no significant differences between the clinical and control 
group on IIP assertive, IIP dependent, IIP aggressive or IIP caring; however the 
clinical group did display significantly higher scores on IIP sociable (d=0.25), IIP 
supportive (d=0.55), IIP involved (d=0.65), and IIP open (d=0.48). In terms of 
gender, there were no differences between trans women and trans men on any 
IIP subscales. However, both trans women and trans men had significantly 
higher scores on IIP sociable than ‘ciswomen’ (cisgender women) and ‘cismen’ 
(cisgender men). Similarly, both trans women and trans men displayed 
significantly higher scores on IIP involved than ciswomen. In contrast, 
ciswomen reported significantly higher scores on IIP open than trans men.  
 
4.5.4 Interpersonal problems among trans individuals vs controls after 
controlling for depression 
 
Preliminary analyses found that the clinical group scored significantly 
higher on SCL depression than the control group (see Table 4.2), with an effect 
size of 0.86. When SCL depression scores were controlled, differences 
between the clinical and control group on IIP global and IIP open became non-
significant. However, the clinical group continued to display significantly higher 
scores on IIP sociable, IIP supportive, and IIP involved compared to controls. 
With regards to gender, differences between trans women and cismen and 
ciswomen on IIP sociable, as well as the difference between trans women and 
ciswomen on IIP involved ceased to be significant once SCL depression was 
accounted for. Similarly, the difference between trans men and cismen on IIP 
caring became non-significant. However, the difference between trans men and 
controls on IIP sociable remained significant. All the other significant differences 
remained after the effect of SCL-90 depression had been removed.  
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4.6 Discussion 
 
This study showed that trans individuals attending a GIC reported more 
interpersonal problems than a non-clinical control group. They reported greater 
difficulties being sociable, supportive of and involved with others as well as 
greater difficulties being assertive, and caring. This suggests that trusting 
people may be more difficult among trans individuals than controls. The 
prevalence of problems with social engagement may be for several reasons. 
Trans individuals may be living or have lived with an outward appearance that 
contradicts how they feel internally. This incongruence may make social 
interaction difficult, yielding self-consciousness and anxiety in relation to being 
judged by others. Verbal and physical abuse towards trans individuals are well 
documented (Nemoto et al., 2011; Whittle, Turner, & Al-Alami, 2007) and these 
hostile social interactions may consequently inhibit individuals in future social 
situations. If true, this might be a learned behaviour, yet it is also possible that 
trans individuals might anticipate negative responses. This anticipation is likely 
to result in individuals shying away from social interaction as an avoidant 
coping strategy. In contrast to expectations, trans individuals did not have 
greater difficulties with assertiveness than cisgender individuals. However, this 
could be due to the nature of the sample. Those engaged in the treatment 
pathway may have had to use a degree of assertiveness to be referred to a 
GIC, to seek treatment and to disclose their trans identity.  
 
When split according to gender, both trans women and trans men found it 
difficult to be sociable and become involved with others compared to controls. 
However, only trans men differed significantly to controls in being overly caring 
and less open. It was expected from the literature on cisgender men and 
women (Gurtman & Lee, 2009) that trans women and trans men would be 
similar in terms of overall interpersonal problems but display differences in 
assertiveness and aggression. This was partly the case: trans women and trans 
men did not differ from each other in terms of global or specific interpersonal 
problems, however neither did ciswomen and cismen.  
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In line with previous research (e.g., Clements-Nolle et al., 2001), levels of 
depression were significantly higher among trans individuals than controls. 
Accounting for depression in this study contributed further to our understanding, 
although cause and effect cannot be inferred due to the cross-sectional nature 
of the data. Specifically, the differences between the two groups on overall 
interpersonal problems and difficulties with opening up to others, became non-
significant when controlling for depression. Yet, differences in sociability, 
supportiveness and involvement remained, which suggest that difficulties 
socialising and being involved with others is not linked to depression but 
possibly related to the difficulties that trans individuals may experience during 
their social gender role transition, which makes them more aware of others and 
less trusting. These difficulties may contribute to trans individuals’ vulnerability 
to mental health problems due to the difficulties in developing social support 
(Davey et al., 2014). Among trans women, once the effect of depression was 
eliminated, interpersonal problems were similar to cisgender individuals. 
However, among trans men difficulties in interpersonal functioning appeared to 
be higher, despite controlling for depression. Addressing these specific 
interpersonal problems might be valuable clinically, both to improve social 
support (which is often lacking among individuals with gender dysphoria; Factor 
& Rothblum, 2007), reduce vulnerability to depression (Bernecker, Constantino, 
Pazzaglia, Ravitz, & McBride, 2014) and facilitate the transitional process trans 
people undertake in order to make their body as congruous as possible with 
their gender identity (Coleman et al., 2012; Davies et al., 2013; Wylie et al., 
2014). 
 
The association between interpersonal problems and depression in this 
population also indicates the importance of clinically addressing these 
difficulties through treatment aiming at improving interpersonal problems, for 
instance with Interpersonal Psychotherapy (Klerman, Weissman, Rounsaville, & 
Chevron, 1984). Interpersonal Psychotherapy (IPT) has been found to alleviate 
depression by improving interpersonal problems (Ravitz et al., 2007). As IPT 
has been successfully applied in various populations (e.g., Arcelus, Whight, & 
Haslam, 2011; Hara, Stuart, Gorman, & Wenzel, 2000; Mufson, Weissman, 
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Moreau, & Garfinkel, 2013),  IPT could be adapted for use within the trans 
population (Budge, 2013). 
 
This is the first study to have measured interpersonal problems among 
treatment-seeking trans individuals and presents a wealth of opportunity for 
future investigation. The strength of this study is the high number of trans 
people who agreed to participate. However, it must be acknowledged that not 
every trans individual seeks cross-sex hormone treatment and/or sex 
reassignment surgery and that this is not necessarily the proper end of a trans 
person’s journey (Ahmad et al., 2013; Bouman & Richards, 2013; Coleman et 
al., 2012; Davies et al., 2013). The study focusses on people attending a large 
national clinic in order to be able to have a population with a clear diagnosis 
which will make the study replicable and more reliable. The results of this study 
may not be generalisable to all trans individuals as the study only selects 
people who are attending a GIC and are going through the process of 
transition. It is likely that those going through the transition will require higher 
interpersonal skills to deal with the interpersonal challenges that transitioning 
requires. Lack of these skills throughout the transitional process may make the 
individual more vulnerable to the development of depressive symptoms. Once 
full transition has been achieved (including gender reassignment surgery) the 
individual may be more settled and the interpersonal skills needed may not be 
as challenging. A replication of the study with trans people who have fully 
transitioned to their experienced gender (including those who have undergone 
gender reassignment surgery) would help shed light on this. 
 
While there are limitations due to the cross-sectional nature of the data, future 
research could test whether the extent of one’s transition influences 
interpersonal functioning as well as the role of interpersonal difficulties in 
treatment outcome and satisfaction, and the potential role of IPT in trans 
individuals. From the current data, it is not possible to determine whether 
interpersonal problems predate or are a consequence of the challenges of 
transitioning. Longitudinal data would provide the ideal avenue to explore this. 
Another limitation of this study was that depression was self-reported. Although 
the SCL-90 depression subscale demonstrates excellent internal reliability, in 
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future a diagnosis of depression could be used to differentiate the clinical group 
into those with and those without depression. 
 
A further note on the generalisability of these findings is that when living as a 
trans person in the UK, there are particularities with regards to medical 
treatment and legislation. For example, some aspects of gender reassignment 
treatment (e.g. cross-sex hormone treatment and genital reconstructive 
surgeries) are available through the National Health Service for all free at the 
point of access, while the Gender Recognition Act provides legal recognition of 
a trans individual’s chosen/acquired gender. In addition, the Sex Discrimination 
(Gender Reassignment) Regulations Act 1999, and its amendment in 2008, 
deemed it unlawful to discriminate on the basis of gender reassignment within 
employment and vocational training, and within the provision of goods, facilities 
and services. Consequently, the experience of living as trans in the UK may be 
different to living as trans in other countries. A cross-cultural validation of the 
findings would be expedient, as differences in legislation and health service 
provision are likely to impact the experience of being trans. 
 
In conclusion, this study found that trans individuals experience greater 
interpersonal problems than cisgender people. They report particular difficulties 
with socialising, being supportive and being involved with others. Problems in 
this interpersonal domain may negatively affect treatment outcome, both in 
terms of being able to engage with clinicians and significant others, as well as 
with treatment compliance. Moreover, it may render individuals vulnerable to 
develop depressive symptomatology by affecting the individuals’ ability to form 
meaningful relationships with others. As social support is critical to 
psychological wellbeing (Colton Meier et al., 2013; Nemoto et al., 2011), quality 
of life (Davey et al., 2014), and suicide prevention (Liu & Mustanski, 2012; 
Moody & Smith, 2013) in this population, interventions aiming at reducing 
interpersonal problems among trans populations attending gender clinics may 
be useful.   
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Chapter 5: Self-injury among trans individuals and matched controls: 
Prevalence and associated factors 
 
 
This chapter has been published in Health and Social Care in the Community 
(impact factor 1.151) as:  
 
Davey, A., Arcelus, J., Meyer, C. & Bouman, W. P. (2015). Self-injury 
among trans individuals and matched controls: Prevalence and associated 
factors. Health and Social Care in the Community, doi: 10.1111/hsc.12239. 
Published online 30 Apr 2015. 
 
The content of Chapter 5 is largely the same as in the published paper but the 
formatting and presentation has been altered so that it remains consistent with 
the rest of the thesis. 
 
 
5.1 Introduction to Chapter 5 
 
So far, this thesis has aimed to gain a deeper understanding of some of 
the social and interpersonal factors that might influence trans wellbeing. As part 
of that exploration, psychopathology and quality of life have been applied as the 
main parameters of psychological wellbeing. This chapter explores a further 
aspect of psychological wellbeing: non-suicidal self-injury (NSSI). NSSI is a 
behaviour that can be viewed as a marker of psychological distress (e.g., Laye-
Gindhu & Schonert-Reichl, 2005) and therefore increasing what is known of 
NSSI in the trans population will add to the overall knowledge of psychological 
wellbeing. While NSSI is often a hidden behaviour, in part due to its taboo 
nature (McAllister, 2003), it is critical to draw attention to this behaviour, 
particularly in a clinical setting where an individual’s safety is paramount. It 
might be assumed that once trans individuals access treatment and progress 
through their transition, the need for maladaptive coping mechanisms, such as 
NSSI, is reduced. However, evidence is needed to confirm or refute this 
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hypothesis and health professionals working in the trans field must be aware if 
there is a continued risk to both individuals’ physical and psychological 
wellbeing. 
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5.2 Abstract  
 
Objectives 
Evidence shows that trans individuals have a high prevalence of mental health 
problems and suicide, however, there are no studies investigating the rates of 
self-harm behaviour in trans individuals going through the transitional process. 
This study aimed to determine the prevalence rate of current non-suicidal self-
injury (NSSI) among trans individuals, in comparison to a control sample of 
non-trans adults. It also aimed to compare those with current NSSI and those 
with no history of NSSI in terms of psychological wellbeing, self-esteem, body 
dissatisfaction, social support, and demographic factors. 
Method 
Participants were 97 adults, diagnosed with Transsexualism (F64.0, ICD-10), 
attending a national gender clinic in the United Kingdom, and a matched control 
group. Clinical participants were all engaged on the treatment pathway. 
Participants completed the following self-report measures: Self-Injury 
Questionnaire – Treatment Related (SIQ-TR), Symptom Checklist 90 Revised 
(SCL-90-R), Rosenberg Self-Esteem Scale (RSE), Hamburg Body Drawing 
Scale (HBDS), and Multidimensional Scale of Perceived Social Support 
(MSPSS). 
Results 
Trans participants had a significantly higher prevalence of current NSSI 
behaviour than the non-trans group, with 19% currently engaging in NSSI. 
Trans men, but not trans women, had a significantly higher prevalence of 
current NSSI than both control men and women. Compared to both trans and 
non-trans participants with no history of NSSI, trans participants with current 
NSSI had significantly higher scores on SCL; significantly lower scores on RSE, 
HBDS and MSPSS; and were younger in age.  
Conclusions 
In conclusion, trans men specifically are more at risk of NSSI than trans women 
and the general population, even when on the treatment pathway. Those who 
currently self-injure have greater psychopathology, lower body satisfaction, 
lower self-esteem, lower social support, and tend to be younger, than those 
who do not engage in NSSI.  
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5.3 Introduction 
 
Transsexualism is the formal ICD-10 diagnosis categorising the 
discomfort or distress caused by the discrepancy between a person’s gender 
identity (their psychological sense of themselves as men or women) and the 
sex they were assigned at birth.  Sometimes, the distress is sufficiently intense 
that individuals undergo transition from one point on a notional gender 
continuum to another – most commonly from Male-to-Female (people known as 
trans women) or Female-to-Male (people known as trans men) (WHO, 1992).  
In some cases this typically involves changes to social gender role and 
presentation, and may necessitate their taking cross-sex hormones and/or 
having sex reassignment surgery (Ahmad et al., 2013; Wylie et al., 2014). The 
ICD-10 diagnosis is currently under review and it is expected that the revised 
ICD-11, which is scheduled for publication in 2016, will include a new diagnostic 
term (“Gender Incongruence” instead of “Transsexualism”) in order to include 
individuals who identify themselves outside the gender binary (Drescher et al., 
2012). The DSM-5 uses the term Gender Dysphoria as a diagnosis, which 
includes people who identify on a gender continuum (thus allowing inclusion of 
a multitude of gender variations beyond the two traditional discrete categories 
of men or women) (APA, 2013). 
 
Depression has been highlighted as a particular problem among trans 
individuals (Budge, Adelson, & Howard, 2013; Heylens et al., 2014), with some 
studies reporting clinically depressive symptoms among more than half in this 
group (Clements-Nolle et al., 2001; Nuttbrock et al., 2013a). Given that 
depression is a known antecedent of non-suicidal self-injury behaviour (NSSI; 
Skegg, 2005), which has been described as deliberate, physical harm to body 
tissue without suicidal intent (Klonsky, 2007), it can be hypothesised that trans 
individuals will present with a high prevalence of NSSI. Anecdotal evidence 
from clinicians suggests precisely this (Gapka & Raj, 2003), however, figures of 
current NSSI and comparisons to control groups are lacking. Until recently the 
only quantitative study looking at clinical data relating to trans adults focuses 
specifically on self-injury to genitals and breasts, whereby 2-9% of patients 
reported this type of self-injury (Dixen et al., 1984). A recent study has identified 
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high levels of NSSI among individuals who attend a gender identity clinic (GIC) 
at the time of the assessment process (Claes et al., 2015). Among children and 
adolescents with symptoms of gender dysphoria, evidence suggests that self-
injury is more common, with 21% presenting to services with a history of self-
mutilation (Spack et al., 2012a). A study has also investigated the connection 
between LGBT and self-destructiveness using a qualitative methodology 
(Scourfield, Roen, & McDermott, 2008). 
 
Although NSSI among trans individuals at the time of assessment has been 
investigated (Claes et al., 2015), focusing on self-injury among trans individuals 
who have initiated treatment is of particular value. There is strong evidence of 
improved psychological and social functioning following gender transition 
(Cohen, de Ruiter, Ringelberg, & Cohen-Kettenis, 1997; Johansson et al., 
2010; Murad et al., 2010). Many individuals experience a great deal of relief 
during transition, for example cross-sex hormone treatment can alleviate a 
degree of anxiety and depression (e.g., Coleman et al., 2012; Gómez-Gil et al., 
2012). Additionally, initial treatment can lead to both improvements in self-
confidence and a sense of stability, and a decrease in harmful behaviour and 
substance misuse (Cole et al., 1997). This is perhaps due to increasing 
recognition in individuals’ expressed gender and the reassurance that their 
treatment goals will be achieved. It is expected that those progressing through 
and completing treatment experience less distress and therefore should have a 
reduced need for maladaptive coping mechanisms, such as NSSI. Therefore, 
the first aim of this study is to investigate the prevalence of current NSSI among 
adults diagnosed with Transsexualism according to the ICD-10 (WHO, 1992) 
and presently on the treatment pathway, compared to an age- and gender- 
matched non-trans control group. Given that NSSI has been associated with 
depression (Skegg, 2005) and that depression is elevated in this population 
(Budge, 2013), it was hypothesised that current NSSI would be significantly 
more prevalent among trans individuals than controls. In line with existing 
evidence (Skagerberg, Parkinson, & Carmichael, 2013), it was also 
hypothesised that trans men would report a significantly higher prevalence of 
current NSSI than trans women. While in the general population, women are 
reportedly three to four times more likely to self-injure than men (Mental Health 
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Foundation, 1997), in the trans literature, NSSI appears to be more common in 
trans men than trans women (Skagerberg et al., 2013). This suggests that 
gender patterns of NSSI may align with individuals’ birth sex rather than their 
experienced gender. 
 
If the rate of NSSI is high among trans adults, despite being on the treatment 
pathway, comparing those who self-injure with those who do not can shed light 
on what factors are associated with NSSI in this population. Considering the 
limited literature available, there appear to be several potential associated 
factors that are relevant to this population, including poor psychological 
wellbeing, high body dissatisfaction, and low social support (Davey et al., 2014; 
Factor & Rothblum, 2007; Hepp et al., 2005; Skagerberg et al., 2013). In the 
general population, NSSI is consistently linked to low levels of psychological 
wellbeing, including poor self-esteem, high levels of emotional distress, 
depression, and anxiety (Laye-Gindhu & Schonert-Reichl, 2005). As lower 
psychological wellbeing has been observed in trans individuals (Couch et al., 
2007; Harcourt, van Beek, Heslop, McMahon, & Donovan, 2001; Hepp et al., 
2005; Nuttbrock et al., 2013a; Skrapec & MacKenzie, 1981), psychopathology 
and poor self-esteem may contribute to NSSI behaviour in this population. In 
terms of body image, it has been suggested that NSSI among trans individuals 
may stem from the distress experienced from having a birth sex that contradicts 
one’s internal sense of gender (Mizock & Lewis, 2008). Given that physical 
appearance is a focal point of this distress, body dissatisfaction is also likely to 
be strongly linked to self-injury. Regarding other populations, social support is 
cited as a protective factor against NSSI in non-trans groups (Brausch & 
Gutierrez, 2010), however social support is reportedly lower among trans 
individuals (Davey et al., 2014; Factor & Rothblum, 2007). Consequently, social 
support may be significantly associated with NSSI in this group.  
 
A significant demographic factor associated with NSSI, observed in the general 
population, is age (Meltzer et al., 2002; Mental Health Foundation, 1997). For 
example, adolescents and young adults are known to be particularly at risk of 
NSSI (Meltzer et al., 2002), with the behaviour usually first occurring between 
14 and 24 years old (Favazza & Conterio, 1989; Herpertz, 1995). Therefore, 
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NSSI is likely to be associated with younger age. In view of the above, the 
second aim of the study is to compare trans adults who currently self-injure to 
trans and non-trans control groups with no history of NSSI. It was hypothesised 
that, compared to both trans and non-trans individuals with no history of NSSI, 
trans adults who currently engage in NSSI would have significantly higher 
levels of psychopathology, lower body satisfaction, lower self-esteem, and 
lower social support. It was further hypothesised that the trans group with 
current NSSI would be younger in age than both control (non-NSSI) groups. 
 
5.4 Methods 
 
5.4.1 Participants 
 
5.4.1.1 Clinical sample  
 
Trans participants were recruited from a national GIC in the United 
Kingdom (UK). This is one of the biggest clinics of its kind in Europe and 
receives more 500 referrals a year from the whole country. Eligibility was 
dependent on age (18+ years) and being accepted on the treatment pathway 
for gender reassignment following an independent assessment of two clinicians 
with expertise in the field. All trans participants had a diagnosis of 
Transsexualism (ICD-10; WHO, 1992) and were undertaking sex hormone 
treatment previous to sex reassignment surgery. The diagnostic criteria applied 
are that the person desires to live and be accepted as a member of the 
opposite sex, and wishes to make his or her body as congruent as possible with 
the preferred sex through cross-sex hormone treatment and surgery (WHO, 
1992). The trans identity must be present for a minimum of two years and must 
not be a symptom of another mental disorder or a chromosomal abnormality 
(WHO, 1992). Patients on the treatment pathway receive on going supportive 
assessment and treatment, which typically involves a permanent social gender 
role change during which cross-sex hormone treatment is initiated and 
monitored and sex reassignment surgery (SRS) takes place (Real Life 
Experience; RLE) (Davies et al., 2013; Wylie et al., 2014). Follow-up care is 
provided for those who have completed their gender role transition and/or 
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undergone SRS. It should be noted that not all patients necessarily desire or 
need SRS to feel they have completed transition. 
 
5.4.1.2 Control sample 
 
Control participants were recruited, via opportunity and snowballing 
techniques, from a University, local organisations, and social networking 
websites. All control participants identified themselves as not being trans and 
not having gender dysphoria. This group was age- and gender- matched with 
the trans group. 
 
5.4.2 Procedure 
 
This study received ethical approval from Loughborough University 
Institutional Ethics Board and the National Health Service (NHS) Local 
Research Ethics Committee. Written informed consent was given by all 
participants. 
 
In terms of trans participants, all suitable candidates, who met the inclusion 
criteria, were offered a questionnaire pack when they attended the clinic. Each 
questionnaire pack contained an information sheet, consent form, socio-
demographic questionnaire, and several self-report measures (see below). 
Participants were asked to complete the questionnaire pack at home and post it 
back to the clinic, using a pre-paid return envelope. A response rate of 40% 
was achieved. Potential participants for the control sample were recruited 
through email and social networking websites, accessing an online version of 
the survey via a web-link. Control participants were encouraged to circulate the 
web-link to others who might be interested in participating. The control sample 
was purposefully over-recruited to enabling adequate matching to the clinical 
sample. In total, 161 control participants completed the online survey. For each 
clinical participant, the nearest control participant in age and of the same 
gender identity was selected and carried forward into the analysis, resulting in a 
sample size of 97. Total data collection spanned 12 months. 
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5.4.3 Main outcome measures 
 
5.4.3.1 Socio-demographic questionnaire 
 
A set of demographic questions, regarding characteristics such as 
gender identity, ethnic origin, employment status, civil status, and living 
situation, were administered. Trans participants were also asked to provide 
their treatment stage and cross-sex hormone status. Treatment stage was 
categorised as RLE, or post-surgery. Post-surgery applied to those who had 
undergone at least one SRS procedure. Hormone status was categorised into 
current use, previous use, or none at all. 
 
5.4.3.2 Self-Injury Questionnaire Treatment Related (SIQ-TR; (Claes & 
Vandereycken, 2007)  
 
The SIQ-TR measures types, duration and frequency of NSSI among 
clinical populations. For the purposes of this study, participants were grouped 
according to their response to the first item: “how long ago did you 
[cut/bruise/bite/burn/scratch/other method of self-injury] yourself?” Those who 
had never self-injured were classed as no history of NSSI, those who had self-
injured more than a year or several months ago were classed as history of 
NSSI, and those who had self-injured in the last month or week were classed 
as current NSSI. The SIQ-TR also provides information relating to body 
location, experience of pain, affective antecedents and consequences, and 
functions of NSSI, this information was not used in this study as it main aim is 
to identify levels of NSSI in the clinical population. Designed specifically for use 
in clinical populations, the reliability and validity of the measure has been 
demonstrated in clinical groups (Claes & Vandereycken, 2007). Self-injury is 
conceptually different from self-harm (McAllister, 2003), for example excessive 
drinking, substance abuse, eating disordered behaviours and harmful sexual 
behaviours can be perceived as self-harm (Di Stefano, 2008; Laye-Gindhu & 
Schonert-Reichl, 2005). The SIQ-TR employs the previously stated definition of 
NSSI, with emphasis on self-injury being an intentional injuring of body tissue, 
in the absence of suicidal motivation.    
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5.4.3.3 Symptom Checklist 90 Revised (SCL-90-R; Derogatis, 1977) 
 
General psychopathology was assessed with the SCL-90-R. Mean 
scores from nine primary symptoms dimensions, depression, anxiety, 
obsessive-compulsive, phobic anxiety, somatisation, interpersonal sensitivity, 
paranoid ideation, hostility and psychoneuroticism, are calculated to produce a 
mean global score (Derogatis, 1977). A higher global score indicates greater 
psychopathology. The SCL-90-R is known for good construct validity and 
reliability (Derogatis & Unger, 2010) and is used widely across the literature on 
gender dysphoria (De Cuypere et al., 2006; Fischer et al., 2010; Haraldsen & 
Dahl, 2000; Simon et al., 2011; Smith et al., 2005a). The Cronbach’s alphas for 
the SCL-90-R among the clinical and control group were each .97. 
 
5.4.3.4 Rosenberg Self Esteem Scale (RSE; Rosenberg, 1965)  
 
The RSE is the most commonly used self-report measure of global self-
esteem (Blascovich & Tomaka, 1991; Gray-Little et al., 1997). Lower scores 
indicate lower self-esteem. The RSE has received extensive empirical 
validation (Robins et al., 2001) and has been used previously with individuals 
with gender dysphoria (Skrapec & MacKenzie, 1981; Vocks et al., 2009). The 
Cronbach’s alphas for the RSE respectively were .92 and .56 for the clinical 
and control group. 
 
5.4.3.5 Hamburg Body Drawing Scale (HBDS; Appelt & Strauss, 1988) 
 
The HBDS employs a schematic drawing to measure satisfaction across 
all parts of the body, a subset of which refer to primary and secondary sexual 
characteristics. This is a pictorial measure that asks participants to indicate how 
(dis)satisfied they are with specific parts of their body. Thirty-three different 
body characteristics (e.g., voice, skin, arms, chest, outer labia, penis) are 
identified on a body drawing and participants are asked to rate each (if 
applicable) on a 5-point Likert scale ranging from 1 (‘very satisfied’) to 5 (‘very 
dissatisfied’). In addition, respondents are asked to give a rating for their overall 
whole body (dis)satisfaction and “other”, if applicable. A global mean score was 
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calculated from all items, except ‘other’ (where respondents can optionally state 
a part of the body not yet specified) and ‘overall’ body satisfaction. The HBDS 
was specifically developed for use within trans populations (Appelt & Strauss, 
1988). The Cronbach’s alpha for the HBDS among the clinical group was .70 
whereas in the control group it was .91. 
 
5.4.3.6 Multidimensional Scale of Perceived Social Support (MSPSS; (Zimet et 
al., 1988)  
 
The MSPSS (Zimet et al., 1988) assesses perceived social support 
across three sources: family, friends, and significant other. All 12 items are 
rated on a scale from 1 to 7. A total mean score is calculated, with lower scores 
indicating lower support. The MSPSS has well documented psychometric 
properties (Cecil et al., 1995; Clara et al., 2003; Dahlem et al., 1991) and has 
been used in trans populations (Colton Meier et al., 2013). In this study, the 
Cronbach’s alpha for the MSPSS among the clinical group was .90 and among 
the control group was .96. 
 
5.4.4 Data analysis 
 
Non-parametric tests were selected, due to the data being non-normally 
distributed, and an alpha level of .01 was applied throughout to reduce the risk 
of type I errors. To test hypothesis one, that prevalence of current NSSI is 
higher in the clinical trans group than the control non-trans group, and 
hypothesis two, that prevalence of current NSSI is higher among trans men 
compared to trans women, Pearson Chi Square tests were performed using two 
categories of NSSI: current NSSI and no current NSSI (which combined 
responses of never having self-injured and NSSI more than a month ago). To 
enable the testing of hypotheses three, three gender-matched groups were 
created to form a clinical group who currently engage in NSSI (trans NSSI), and 
two control groups - a clinical group with no history of NSSI (trans no NSSI) and 
a non-clinical group with no history of NSSI (non-trans no NSSI). Age between 
the three matched groups was not significantly different (H=3.883, p=.143). To 
test hypothesis three, that the trans NSSI group has higher psychopathology, 
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higher body dissatisfaction, lower self-esteem, and lower social support than 
the two control groups with no history of NSSI, a series of Kruskal Wallis 
analyses was then performed. Significant results were subsequently explored 
through one way Mann Whitney U tests. To test hypothesis four, that the trans 
NSSI group is younger in age than the two control groups, the unmatched 
(total) groups of trans NSSI, trans no NSSI, and non-trans no NSSI were 
entered into the analysis. Unmatched (total) group sizes were as follows: trans 
NSSI n=18, trans no NSSI n=48, and non-trans no NSSI n=76. Hypothesis four 
was tested by conducting a Kruskal Wallis analysis. Significant results were 
again followed up by one-tailed Mann-Whitney U tests.  
 
5.5 Results 
 
5.5.1 Characteristics of the clinical and control sample 
 
The clinical sample comprised 97 patients; 60 trans women and 37 trans 
men, with a mean age of 36.18 years (SD=14.85, range=18-72). Due to 
matching, the control sample also had a 60:37 women: men ratio and a mean 
age of 37.16 years (SD=14.90, range=19-72). There was no significant 
difference in age between the clinical and control groups (U=4501.5, p=.69). 
The majority of both the clinical and control group identified their ethnic origin 
as white (89% and 96% respectively). In relation to employment status, while 
similar proportions of each group were employed full-time, disabled or 
housewives/husbands, there were notable differences across the remaining 
categories between the groups. Compared to the control group, more clinical 
participants were volunteers (9% vs. 3%), unemployed (12 vs. 1%) or in a form 
of employment not otherwise stated (other, 16% vs. 5%), and fewer clinical 
participants were students (16% vs. 34%) or employed part-time (3% vs. 19%).  
There were also notable differences in some of the categories of civil status and 
living situation. A higher number of clinical participants were single/never 
married (68% vs. 52%) or divorced (16% vs. 4%) than control participants, and 
consequently a lower number were currently married (7% vs. 34%). Regarding 
living situation, clinical participants were more likely to live with their family of 
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origin (28% vs 14%) or alone (34% vs. 19%) and less likely to live with a 
partner (13% vs. 24%) or a partner and child/ren (3 vs. 23%), than control 
participants. Full demographic information is presented in Table 5.1. 
 
Table 5.1. Demographic characteristics of the clinical and control sample 
 
 Clinical sample 
n (%) 
Control sample 
n (%) 
Gender identity 
   Female 
   Male 
 
60 (61.9%) 
37 (38.1%) 
 
60 (61.9%) 
37 (38.1%) 
Ethnic origin 
   White 
   Indian 
   Black other 
   Pakistani 
   Chinese 
   Other 
 
86 (88.7%) 
0 (0.0%) 
1 (1.0%) 
1 (1.0%) 
1 (1.0%) 
8 (8.2%) 
 
93 (95.9%) 
1 (1.0%) 
0 (0.0%) 
0 (0.0%) 
0 (0.0%) 
3 (3.1%) 
Employment status 
   Employed full-time 
   Employed part-time 
   Student 
   Volunteer work 
Housewife/husband 
   Disabled 
   Unemployed 
   Other 
 
39 (40.2%) 
3 (3.1%) 
15 (15.5%) 
9 (9.3%) 
1 (1.0%) 
3 (3.1%) 
12 (12.4%) 
15 (15.5%) 
 
35 (36.1%) 
18 (18.6%) 
33 (34.0%) 
3 (3.1%) 
2 (2.1%) 
0 (0.0%) 
1 (1.0%) 
5 (5.2%) 
Civil status 
   Single, never married 
   Married 
   Civil partnership 
   Separated 
   Divorced 
   Widowed 
   Other 
 
67 (68.3%) 
7 (7.2%) 
1 (1.0%) 
3 (3.1%) 
15 (15.5%) 
1 (1.0%) 
1 (1.0%) 
 
50 (51.5%) 
33 (34.0%) 
3 (3.1%) 
2 (2.1%) 
4 (4.1%) 
2 (2.1%) 
1 (1.0%) 
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Living situation 
   With family of origin 
   Alone 
   Shares with non-partner(s) 
   With partner only 
   With partner and child/ren 
   With child/ren only 
   Other 
 
27 (27.8%) 
33 (34.0 %) 
15 (15.5%) 
13 (13.4%) 
3 (3.1%) 
2 (2.1%) 
4 (4.1%) 
 
14 (14.4%) 
18 (18.6%) 
10 (10.3%) 
23 (23.7%) 
22 (22.7%) 
4 (4.1%) 
5 (5.2%) 
Treatment stage 
   RLE 
   Post-surgery 
Cross-sex hormone status 
   No use  
   Current use 
   Previous use 
 
78 (80.4%) 
18 (18.6%) 
 
15 (15.5%) 
79 (81.4%) 
1 (1.0%) 
 
- 
- 
 
- 
- 
- 
 
 
5.5.2 Characteristics of trans individuals who currently self-injure 
 
Eighteen (19%) of the clinical participants reported current NSSI. The 
mean age of these participants was 28.28 years (SD=11.29; range=18-59). The 
gender ratio was 13:5 trans men: trans women. In terms of transition, 15 were 
in the RLE phase and two were in the post-surgery phase (1 missing data), and 
67% of the group were currently receiving cross-sex hormone treatment. Of the 
two categorised as post-surgery, one participant had undergone full SRS and 
the other had undergone chest reconstructive surgery. Regarding type of NSSI, 
39% self-injured by cutting, 33% in a way not listed by the SIQ-TR, 28% by 
scratching, 11% by bruising, and 6% by biting. Three participants reported 
engaging in more than one form of NSSI. The most commonly injured body 
areas were arms, hands, fingers or nails (43%), while much fewer participants 
reported injuring torso, belly, buttocks (14%), head, neck (10%), or legs, feet, 
toes (5%). No participants self-injured their breasts or genitals. Of those who 
injured themselves, the majority (71%) reported engaging in NSSI between one 
and five days in the last month. 
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5.5.3 Prevalence of NSSI among the clinical vs. control group 
 
Table 5.2 presents the prevalence rates of NSSI among each group. The 
clinical group had a significantly higher prevalence of current NSSI than the 
non-clinical group (X2=10.05, p=.002). Among the clinical group, 19% of 
participants were currently engaging in NSSI, compared to 4% of the control 
group. Approximately half of the clinical group had no history of NSSI compared 
to more than three quarters of the non-clinical group.  
 
Table 5.2. Prevalence of NSSI among the clinical and control groups  
 
NSSI 
category 
Clinical Control 
TW TM Both CW CM Both 
n=60 n=37 n=97 n=60 n=37 n=97 
n(%) n(%) n(%) n(%) n(%) n(%) 
No history 35(58.3) 13(35.1) 48(49.5) 42(70.0) 34(91.9) 76(78.4) 
History 20(33.3) 11(29.7) 31(32.0) 14(23.3) 3(8.1) 17(17.5) 
Current 5(8.3) 13(35.1) 18(18.6) 4(6.7) 0(0.0) 4(4.1) 
 
Trans women (TW), trans men (TM), control women (CF), control men (CM) 
 
5.5.4 Prevalence of current NSSI among trans men and trans women 
 
Prevalence rates of current NSSI were significantly higher among trans 
men than trans women (X2=10.88, p=.001). Among trans men, 35% were 
currently engaging in NSSI compared to only 8% of trans women. 
 
5.5.5 Differences between the trans NSSI group, trans no NSSI group, and 
non-trans no NSSI group 
 
Table 5.3 presents group differences on the measures SCL, RSE, 
HBDS, and MSPSS. Initial Kruskal Wallis analyses found significant differences 
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between the trans NSSI group and the two control groups (trans no NSSI and 
non-trans no NSSI) on all scores. Further investigation found that the trans 
NSSI group had significantly higher scores on SCL, compared to both the trans 
no NSSI group and the non-trans no NSSI group. The trans NSSI group also 
had significantly lower scores on RSE, HBDS, and MSPSS, compared to both 
control groups. In terms of the two control groups, the trans no NSSI were not 
significantly different to the non-trans no NSSI on RSE, HBDS, or MSPSS 
scores. However, the trans no NSSI group scored significantly higher on SCL 
than the non-trans no NSSI group. Effect sizes for differences between the 
trans NSSI and trans no NSSI groups on SCL, RSE, HBDS, and MSPSS 
scores all exceeded 0.86. Effect sizes for differences between the trans NSSI 
and non-trans no NSSI groups were all greater than 1.15, whereas effect sizes 
for differences between the trans no NSSI and non-trans no NSSI groups 
ranged between 0.25 and 0.83.  
 
In relation to age, there were significant differences in age across the three 
unmatched NSSI groups (respectively age H=13.25, p=.001). The trans NSSI 
group was significantly younger in age than both the trans no NSSI group 
(U=176, p<.001) and non-trans no NSSI group (U=401, p=.004).  
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Table 5.3. Group differences between those who self-injure and those with no history of self-injury  
 
Measure Trans 
NSSI 
Trans 
no NSSI 
Non-trans 
no NSSI 
Kruskal-Wallis Sig. Mann Whitney U 
 n=18 n=18 n=18    
 mean (SD) mean (SD) mean (SD) H p  
SCL 1.14 (0.57) 0.54 (0.43) 0.27 (0.22) 23.70 <.001** T NSSI>T no NSSI 
      T NSSI>Non-T no NSSI 
      T no NSSI>Non-T no NSSI 
RSE 15.11 (5.86) 20.72 (6.22) 23.83 (4.79) 15.86 <.001** T NSSI<T no NSSI 
      T NSSI<Non-T no NSSI 
HBDS 3.07 (0.28) 3.42 (0.47) 3.68 (0.51) 13.25 .001* T NSSI<T no NSSI 
T NSSI<Non-T no NSSI 
MSPSS 4.44 (0.86) 5.38 (1.30) 5.70 (1.31) 10.35 .006* T NSSI<T no NSSI 
T NSSI<Non-T no NSSI 
 
Symptom Checklist 90 Revised (SCL), Rosenberg Self-Esteem Scale (RSE), Hamburg Body Drawing Scale (HBDS), Multidimensional 
Sources of Perceived Social Support (MSPSS), total n=60, *p<.01, **p<.001 
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5.6 Discussion 
 
The principal aims of this study were to determine the prevalence rate of 
current NSSI among adults with a diagnosis of Transsexualism according to the 
ICD-10 (WHO, 1992) who are engaged on the treatment pathway, either 
undergoing transition or having completed transition, and to compare those who 
self-injure to those who do not. As predicted, the prevalence rate of current 
NSSI was significantly higher among trans individuals compared to matched 
non-trans controls. A fifth of trans individuals currently engaged in NSSI in one 
form or another, in comparison to only 5% of the control group. This rate is 
notably higher than that reported in a national UK interview survey of general 
population adults, wherein 3% of women and 2% of men had a history of NSSI 
(Meltzer et al., 2002). Furthermore, bearing in mind that the present study used 
a broader definition of NSSI as well as collecting data from an adult sample, the 
prevalence of a history of NSSI was also higher than in youth with gender 
dysphoria (Spack et al., 2012a).  
 
In terms of gender, in keeping with existing research (Skagerberg et al., 2013), 
a significantly higher prevalence of trans men engaged in current NSSI 
compared to trans women. This finding suggests trans men are most at risk of 
NSSI. If NSSI is perceived as maladaptive strategy for regulating negative 
affect and self-punishment (Klonsky, 2007; Laye-Gindhu & Schonert-Reichl, 
2005), though trans men identify as men, they tend to display typically feminine 
coping behaviours. 
 
In accordance with expectations, trans individuals who engage in NSSI have 
greater psychopathology, lower self-esteem, lower body satisfaction, lower 
social support, and are younger in age compared to both trans and non-trans 
individuals with no history of NSSI. This supports previous research in other 
populations (Hawton, Zahl, & Weatherall, 2003; Laye-Gindhu & Schonert-
Reichl, 2005; Meltzer et al., 2002; Nock, 2009; Ross & Heath, 2002; Skegg, 
2005). The results of the study are clinically important as it highlights the need 
for clinicians working in this field to assess NSSI behaviour in individuals who 
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are undergoing treatment. The role of the clinician aiming at helping individuals 
to develop coping strategies, which increase individuals’ psychological 
wellbeing, positive body image, self-esteem may be important. Clinicians may 
also need to work with the individual at increasing their support networks as this 
may be valuable for those who currently self-injure.  The finding that trans 
individuals who do not engage in NSSI show lower levels of psychopathology 
than control groups without NSSI may suggest that GIC services in general, 
and cross-sex hormone treatment for trans people in particular may be of 
benefit for this population although only a longitudinal study will be able to 
demonstrate this claim (Bouman & Richards, 2013; Davies et al., 2013; Gijs & 
Brewaeys, 2007; Murad et al., 2010).  
 
5.6.1 Limitations & recommendations for future research 
 
This study is a vital step in exploring NSSI among a clinical sample of 
trans individuals. However, there are notable limitations. In comparison to 
responses on other measures, there was a high rate of missing data on the 
SIQ-TR following on from the question regarding prevalence, notably among 
those who reported more than one form of NSSI. This may be because NSSI is 
largely considered a social taboo (McAllister, 2003) and participants may have 
been unwilling to be forthcoming in the details of their NSSI behaviour. While 
NSSI was categorised as current if it had been performed within the previous 
month, there is a possibility that individuals had ceased NSSI behaviour within 
that period. In this study, the description ‘post-surgery’ was not synonymous 
with having completed full SRS but having undergone at least one procedure. 
The distress that compels NSSI may persist until transition has been completed 
or even beyond, as some stressors, such as stigma and discrimination, may be 
experienced, in spite of achieving physical congruence. 
 
The study did not assess for psychiatric comorbidity, which is another limitation 
of the study. The assessment of comorbidity, such as depression, may have 
allowed the authors to control for this variable. Although this would have been 
interesting, it will not have made a difference to the results and conclusions of 
the study, as it aimed to explore NSSI levels in the trans population.  
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Among the current NSSI group, six individuals were not receiving cross-sex 
hormone treatment at the time of study. This could be because they were at the 
start of their social gender role transition, were found to have physical 
contraindications, or they decided against going through the transitional 
process at this moment in time, as not all trans individuals feel cross-sex 
hormone treatment and/or surgery is required to express one’s gender identity 
(Bockting, 2008; Coleman et al., 2012) . Due to a lack of statistical power, it 
was not possible to test whether cross-sex hormone status influenced NSSI 
behaviour. It would be expected that those receiving hormone treatment would 
be less likely to self-injure than those not receiving hormones, as distress 
should be lower according to the how far the body is aligned with experienced 
gender. Ideally, a prospective study assessing NSSI throughout the stages of 
transition would shed light on the impact of transition on NSSI, as it has been 
suggested that avoidant coping strategies (which may encompass NSSI) 
decrease through transition (Budge, 2013). 
 
The generalisability of the study is affected by the low response rates of the 
clinical group.  It is important to highlight also that the present findings only 
represent adults with a diagnosis of Transsexualism, who are engaged on the 
treatment pathway. It is possible that prevalence of NSSI is higher among those 
who are not in contact with GIC services. Those too ashamed or fearful to seek 
treatment may be more likely to engage in NSSI as a means of coping with their 
emotional distress. Furthermore, considering that the majority of trans 
participants in the present study were on the treatment pathway where harmful 
behaviour/severe NSSI might threaten their eligibility for future surgical 
treatment, the frequency or severity of NSSI may be deliberately reduced. 
Alternatively, there may exist an issue of relying on self-report data. It is 
possible that trans participants may under-report NSSI for fear of damaging 
their treatment prospects, despite researchers assuring the anonymity of their 
data. The introduction of a control sample, although it is a strength, introduced 
a volunteer bias into the study, and it is likely that the control population will be 
healthier than the general population. 
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Due to the cross-sectional nature of the data and the small proportion of 
participants who reported current NSSI, only an exploratory analysis of potential 
factors could be presented. Additionally, it was unfortunately not possible to 
analyse correlations between frequency of NSSI and associated factors, owing 
to missing frequency data and too little variation. It is therefore recommended 
that, in order to verify these findings and further test whether these factors 
predict NSSI, a replication of this study be executed with a prospective design 
with a much larger sample and assessing and controlling for psychiatric 
comorbidity. Being able to clarify predictive factors will enable healthcare 
professionals and clinicians to take preventative measures with those at risk. 
This is a critical issue as NSSI is known to increase a person’s risk of suicide 
(Hawton et al., 2003).   
 
5.6.2 Conclusion 
 
Treatment-seeking trans men have a higher risk of current NSSI than 
trans women and non-trans adults. NSSI behaviour among trans adults is 
linked to greater psychopathology, lower self-esteem, lower body satisfaction, 
lower social support, and younger age. Investigation into the predictive value of 
these factors would further knowledge of who is most at risk of NSSI among 
trans individuals. Health and social care professionals who work in this 
particular field should be vigilant for NSSI behaviour and be aware that those 
who are receiving treatment may still be vulnerable. 
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Chapter 6: Predictors of psychological wellbeing among treatment 
seeking trans individuals 
 
 
This chapter has been submitted to Journal of Sex Research (impact factor 
2.730), with the authors listed as follows: Davey, A., Bouman, W. P., Meyer, C., 
Witcomb, G. & Arcelus, J. 
 
6.1 Introduction to Chapter 6 
 
The final empirical chapter of this thesis is intended to draw in what has 
been learnt through the preceding chapters and test the initial model of 
predictors formulated in the introduction. Three of the factors within the initial 
model have been explored in their own right: social support, interpersonal 
problems, and non-suicidal self-injury (NSSI). Based on the previous findings, 
in this chapter, only interpersonal problems is carried forward as a potential 
predictor of psychological wellbeing from these three, though social support is 
investigated as a mediator. NSSI was removed from the model as it was 
considered more appropriate as an indicator of psychological wellbeing, in the 
same way as psychopathology and quality of life, rather than a potential 
predictor. In the introduction’s literature review, self-esteem, body 
dissatisfaction, and experiences of transphobia were seen to have substantial 
evidence to suggest they were pertinent issues among the trans population. 
Therefore these factors did not require prior testing to this chapter. 
 
 
 
 
 
 
 
  
138 
6.2 Abstract 
 
 
Objectives 
Research has found associations between being trans and a range of negative 
outcomes (e.g., high rates of self-harm and depression) associated to 
psychological wellbeing. However, research has yet to identify specific 
predictors of poor psychological wellbeing and quality of life in this population. 
This study aimed to explore the predictive value of five variables known to be 
associated with poor psychological wellbeing: age, self-esteem, victimisation, 
interpersonal problems, and body dissatisfaction. 
Method 
Two hundred and eight participants (104 trans and 104 cisgender controls) 
completed measures of these predictor variables, along with general 
psychopathology and functional quality of life. 
Results 
The results indicate that in the trans group, greater psychopathology and 
greater depression was predicted by younger age (psychopathology only), 
lower self-esteem, greater body dissatisfaction, and greater interpersonal 
problems. In the cisgender group, only lower self-esteem and greater 
interpersonal problems were significant predictors of these variables. For 
quality of life, lower self-esteem and greater interpersonal problems were 
significant predictors of low quality of life in both groups, as was younger age in 
the cisgender group only. 
Conclusions 
Overall, self-esteem and interpersonal problems appear to be crucial factors 
that influence wellbeing among the trans population and those providing 
treatment to trans people should incorporate support in these areas. 
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6.3 Introduction 
 
Transsexualism is the formal diagnosis as per the International 
Classification of Diseases (10th edition; WHO, 1992), given to individuals who 
desire to live and be accepted as a member of the opposite sex to the one 
assigned at birth, usually accompanied by the wish to make their body as 
congruent as possible with the preferred sex through cross-sex hormone 
treatment and surgery (ICD-10; WHO, 1992). Experienced genders are not 
necessarily binary (i.e., male or female) and the new edition of the ICD (ICD-11) 
expected to be published in 2017, is likely to include diagnoses for individuals 
who do fit the binary notion of gender (Drescher et al., 2012), and do not 
necessarily wish to transition from one to another (i.e., male to female or female 
to male). This is in line with the DSM-5 diagnosis of Gender Dysphoria (APA, 
2013). A recent meta-analysis found the prevalence for transsexualism to be 
4.6 in 100,000 individuals; 6.8 for trans females (birth assigned males who 
identify as female) and 2.6 for trans males (birth assigned females who identify 
as male), with time analysis finding an increase in reported prevalence over the 
last 50 years (Arcelus et al., in press).  
 
A number of different terms have been used to describe individuals who do not 
identify with their birth assigned binary gender, with varying levels of agreement 
from clinicians and the trans community. In this paper, the terms “trans 
individuals/people”, “trans females” and “trans males” will be used. In contrast 
the term cisgender is used to refer to those people who are content to remain 
the gender they were assigned at birth – i.e. they are non-trans people. 
 
Trans individuals have been found to have lower levels of psychological 
wellbeing compared to the general population (e.g., Davey, Bouman, Arcelus & 
Meyer, 2014; Heylens et al., 2014). Psychological wellbeing is a multi-
dimensional concept comprising of affective aspects of personal experience 
(Warr, 1978). It includes, but is not limited to, an absence of psychopathology 
(Jahoda, 1958) and a satisfactory quality of life (WHO, 1997). More specifically, 
trans individuals are known to have a high prevalence of mental health 
problems, including affective and anxiety disorders as well as non-suicidal self-
140 
injuries (NSSI) and even suicide  (e.g., Claes et al., 2015; Clements-Nolle, 
Marx, & Katz, 2006; Couch et al., 2007; Davey et al., in press; Hepp et al., 
2005; Heylens et al., 2014; Nuttbrock et al., 2010, 2013; Skrapec & MacKenzie, 
1981). Such psychopathology has been reported to affect up to 40% of trans 
individuals (Heylens et al., 2014). In addition, trans individuals have been found 
to report low quality of life compared to the general cisgender population (e.g., 
Newfield et al., 2006). This is most prevalent among trans men (Newfield et al., 
2006), though less is known about quality of life among trans women.  
 
While poor psychological wellbeing in this population is relatively well 
documented (e.g., Couch et al., 2007; Hepp et al., 2005; Heylens et al., 2014; 
Nuttbrock et al., 2010, 2013), factors that might predict this wellbeing are 
inadequately understood. Previous studies reviewing risk factors of poor 
psychological wellbeing among trans people, have lacked statistical power and 
have mainly focused on depression (Hoffman, 2014; Rotondi, 2012). Therefore 
the aim of this study was to investigate the predictors of psychological wellbeing 
in treatment seeking individuals with a diagnosis of transsexualism (WHO, 
1992). The study investigates five specific variables that have been found to be 
strongly associated to psychopathology and quality of life in both the trans and 
cisgender population. These variables are: age (e.g., Heylens et al., 2014), self-
esteem (e.g., Strain & Shuff, 2010), transphobic victimisation (e.g., Collier, Van 
Beusekom, Bos, & Sandfort, 2013; Goldblum et al., 2012), interpersonal 
problems (e.g., Barrett & Barber, 2007) and body dissatisfaction (e.g., Paxton, 
Neumark-Sztainer, Hannan, & Eisenberg, 2006). 
 
Firstly, in trans individuals, younger age has been associated with greater 
mental health problems (Heylens et al., 2014) and lower mental health-related 
quality of life (Newfield et al., 2006). Secondly, low self-esteem has been linked 
to higher levels of depression and anxiety in trans women (Strain & Shuff, 
2010) and, in the general cisgender population, low self-esteem is a known risk 
factor for poor psychological wellbeing (while high self-esteem acts as a 
protective factor; e.g., Mann, Hosman, Schaalma, & de Vries, 2004). Thirdly, 
discrimination, harassment and abuse on the basis of being trans (transphobia) 
has been linked to increased risk of suicide (e.g., Goldblum et al., 2012; 
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Grossman, D’Augelli, & Frank, 2011), depression (e.g., Lombardi, 2009; 
Nemoto, Bödeker, & Iwamoto, 2011) and substance use (e.g., Reisner, 
Greytak, Parsons, & Ybarra, 2015). The fourth variable is that of interpersonal 
functioning, where poor interpersonal functioning has been linked to a range of 
mental health problems in the general cisgender population, such as 
depression (e.g., Barrett & Barber, 2007; Eberhart & Hammen, 2006; Ravitz, 
Maunder, & McBride, 2007), anxiety (e.g., McEvoy, Burgess, Page, Nathan & 
Fursland, 2013), and eating disorders (e.g., Arcelus et al., 2009; Arcelus, 
Haslam, Farrow, & Meyer, 2013) as well as in the trans population (Davey et 
al., accepted).  Finally, the detrimental effects of body dissatisfaction in 
cisgender groups are observed in increasing risk for depression (e.g., Paxton et 
al., 2006), low self-esteem (e.g., Davison & McCabe, 2006), and eating 
psychopathology (e.g., Stice & Shaw, 2002). Body dissatisfaction has also been 
found to be higher in trans people compared to a control group (e.g., Witcomb 
et al., in press) and some evidence suggests it is manifested in restrictive 
eating behaviours (e.g., Ålgars, Santilla, & Sandnabba, 2010).  
 
All of the above risk factors can be formulated within a testable, preliminary 
model of predictors of psychological wellbeing among trans individuals (Figure 
6.1). Consequently, the overarching aim of this study was to test this model, 
underpinned by four objectives and associated hypotheses. Firstly, to replicate 
previous findings demonstrating greater psychopathology (Hepp et al., 2005a), 
increased interpersonal problems (Davey et al., 2014), higher body 
dissatisfaction (Witcomb et al., in press), lower quality of life (Newfield et al., 
2006), and lower self-esteem (Skrapec & MacKenzie, 1981), among trans 
individuals, compared to cisgender controls. Secondly, to identify which factors 
significantly predict psychopathology (including general psychopathology and 
depression) in this population compared to cisgender controls. It was 
hypothesised that greater psychopathology and greater levels of depression 
among trans individuals would be significantly predicted by lower self-esteem, 
greater interpersonal problems, higher body dissatisfaction, more frequent 
experiences of transphobic victimisation, and younger age. Thirdly, to identify 
which factors significantly predict quality of life, compared to cisgender controls. 
It was hypothesised that lower quality of life among trans individuals would be 
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also significantly predicted by lower self-esteem, greater interpersonal 
problems, higher body dissatisfaction, more frequent experiences of 
transphobic victimisation, and younger age. Fourthly, to test whether either self-
esteem or social support mediated any significant effects of predictors on 
psychopathology, depression or quality of life. It was hypothesised that self-
esteem and social support would mediate the effects of predictors on 
psychological wellbeing variables. A previous report of this study’s data found 
that social support predicted quality of life but not global psychopathology or 
depression (Davey et al., 2014), hence, to avoid duplication, social support was 
only entered into the mediation analysis rather than included as a predictor. 
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Figure 6.1. Proposed model of predictors and mediators of poor psychological wellbeing among trans individuals 
 
Hypothesis 4 
Mediator variables: 
Self-esteem 
Social support Hypothesis 4 
Predictor variables: 
↓ Age 
↑ Age of ‘coming out’ 
↑ Age of first referral 
↓ Self-esteem 
↑ Body dissatisfaction 
↑ Interpersonal problems 
Outcome variables: 
↑ Psychopathology 
↓ Quality of life 
Hypotheses 2 & 3 
Hypothesis 1 
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6.4 Method 
 
6.4.1 Participants 
 
6.4.1.1 Clinical sample  
 
The clinical sample consisted of 104 patients (64 trans females and 40 
trans males) who had received a diagnosis of Transsexualism (WHO, 1992) 
and were on the treatment pathway. Trans participants were selected from all 
consecutive, eligible patients assessed at the Nottingham National Centre for 
Gender Dysphoria. This is one of the largest clinics of its kind in Europe and 
receives more than 500 referrals per year from the United Kingdom. 
Participants were considered eligible if they were over the age of 18, fulfilled a 
diagnosis of Transsexualism as per the ICD-10 (WHO, 1992) as determined by 
two independent gender specialists working at the Centre, and had been 
accepted for the treatment programme. In order for trans people to be accepted 
into the programme they will need to have made a full social gender role 
transition, have demonstrated evidence of social and/or occupational function, 
as well as have amended most of their legal documentation, including name 
changing. If there are no physical contraindications, patients will usually receive 
cross-sex hormone treatment. Following a minimum of 6 months of living in 
their newly acquired gender role and being part of the treatment programme 
patients are generally considered for chest reconstructive surgery (for trans 
males). Trans people wishing genital reconstructive surgery are usually part of 
the treatment programme for a minimum of one year. Once sex reassignment 
surgery (SRS) has been completed, follow-up care can be organised at the 
Centre. Although not all trans people attending the service may desire or deem 
cross-sex hormone treatment necessary (Bockting, Coleman, & De Cuypere, 
2011), most present to the service requesting this in order to reduce their 
gender and body dysphoria; however, not all trans people will request or would 
like to undergo SRS (Wylie et al., 2014). 
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6.4.1.2 Control sample 
 
The control sample comprised 104 cisgender participants, recruited from 
a university campus, local organisations, and social networking websites, 
through opportunity and snowballing techniques where participants are 
encouraged to invite others to take part. Control participants were those who 
identified themselves as not being trans or having gender dysphoria, and were 
matched by age and with the experienced gender of the clinical sample. 
 
6.4.2 Procedure 
 
Trans participants were identified by their clinician and invited to 
complete a questionnaire pack which included the following: information sheet, 
consent form, socio-demographic questionnaire, self-report measures, and 
return envelope. Those who were interested in participating were asked to 
complete the questionnaire pack at home and return it to the Centre using the 
pre-paid envelope provided. Data collection continued for approximately a year 
and yielded a response rate of 40%. Control participants were sent a web-link 
to an online survey via email or social networking websites and were asked to 
pass on the web-link to others who might be interested in taking part. The 
online survey replicated the clinical questionnaire pack barring trans-specific 
questions, for example stage of transition and experiences of transphobia. Of 
161 controls who participated, 104 were matched with the clinical sample. 
 
Ethical approval was provided by Loughborough University Institutional Ethics 
Board and a NHS Local Research Ethics Committee. Informed consent was 
obtained from all participants. 
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6.4.3 Measures 
 
6.4.3.1 Symptom Checklist 90 Revised (SCL-90-R; Derogatis, 1977) 
 
The SCL-90-R (SCL) assesses general psychopathology and provides a 
global score, referred to as the Global Severity Index (GSI, Derogatis, 1977). 
This is calculated from scores across nine primary symptoms dimensions: 
depression, anxiety, obsessive-compulsive, phobic anxiety, somatisation, 
interpersonal sensitivity, paranoid ideation, hostility, and psychoneuroticism. 
This study utilised the GSI score as well as the 13 item depression subscale. 
Higher scores indicate greater psychopathology. The SCL has good construct 
validity and reliability (Derogatis & Unger, 2010) and is applied widely in trans 
research (De Cuypere et al., 2006; Fischer et al., 2010; Haraldsen & Dahl, 
2000; Simon et al., 2011; Smith et al., 2005a). For this sample, the Cronbach’s 
alphas across SCL subscales were >.72 in the clinical group and >.66 in the 
control group. 
 
6.4.3.2 Short Form Health Survey 36 version 2 (SF36; Ware & Sherbourne, 
1992) 
 
The SF36v2 (SF; Ware & Sherbourne, 1992) measures functional quality 
of life. Four subscales, which relate to quality of life in psychological wellbeing 
(vitality, social functioning, role limitations due to emotional problems, and 
mental health) produce a mean score, denoted as the Mental Health 
Component Summary score (MHCS). Higher scores indicate higher quality of 
life. The MHCS, devised by the original authors, has been used in existing trans 
research (e.g., Gorin-Lazard et al., 2012). The equivalent physical health 
component summary score was not relevant to the objectives of this study. The 
SF has excellent high internal reliability and discriminant validity (McHorney, 
War, Lu, & Donal Sherbourne, 1994). Within this sample, the Cronbach’s 
alphas for SF subscales were >.76 in the clinical group and >.79 in the control 
group. 
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6.4.3.3 Rosenberg Self Esteem Scale (RSE; Rosenberg, 1965) 
 
The RSE evaluates global self-esteem (e.g., Blascovich & Tomaka, 
1991; Gray-Little, Williams, & Hancock, 1997). Ten items produce a global 
score, which is considered in the normal range when between 15 and 25. A 
global score lower than 15 indicates low self-esteem. The RSE has been 
empirically validated (Robins et al., 2001) and administered previously to trans 
individuals (Skrapec & MacKenzie, 1981b; Vocks et al., 2009). The Cronbach’s 
alphas were .91 and .92 for the clinical and control group, respectively. 
 
6.4.3.4 Inventory of Interpersonal Problems (IIP-32; Barkham et al., 1996) 
 
The IIP-32 (IIP) assesses common interpersonal problems, across 
eight subscales: hard to be assertive, hard to be sociable, hard to supportive, 
hard to be involved, too dependent, too caring, too aggressive, and too open. A 
global score provides an indication of overall interpersonal problems, where 
higher scores indicate greater interpersonal problems. The IIP has 
demonstrated high reliability (Barkham et al., 1996) and has been applied in 
both non-clinical (e.g., Berry, Wearden, Barrowclough, & Liversidge, 2006) and 
clinical samples (e.g., Arcelus et al., 2009; Paley et al., 2008). The Cronbach’s 
alphas among the clinical and control groups across IIP subscales were >.62 
and >.71 respectively. 
 
6.4.3.5 Hamburg Body Drawing Scale (HBDS; Appelt & Strauss, 1988) 
 
The HBDS is a pictorial measure of body dis/satisfaction. Respondents 
rate how satisfied they are with each specific part of the body as identified on 
the body drawing, including primary and secondary sexual characteristics. 
Lower scores signify higher body dissatisfaction. A global mean score is 
derived from all items, barring ‘other’ and ‘overall’ body satisfaction. The HBDS 
was purposely developed for use within trans populations (Appelt & Strauss, 
1988). 
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6.4.3.6 Experiences of transphobic victimisation 
 
Two items were adapted from previous studies measuring transphobic 
victimisation (Clements-Nolle, Marx, & Katz, 2006; Nuttbrock et al., 2010). The 
items asked “have you ever been verbally abused or harassed due to your 
gender identity or presentation?” and “have you ever been physically abused or 
harassed due to your gender identity or presentation?”. Participants responded 
with the frequency of how often they had experienced trans-specific verbal or 
physical victimisation. Scores were as follows: 0 never, 1 once, 2 a few times, 
and 3 several times. 
 
6.4.3.7 Multidimensional Scale of Perceived Social Support (MSPSS; Zimet et 
al., 1988) 
 
The MSPSS (Zimet et al., 1988) assesses perceived social support from 
three sources of support: family support, friend support, and support from a 
significant other. The total mean of 12 items provides a global score, where 
higher scores indicate greater perceived support. The MSPSS has 
demonstrated good psychometric properties across diverse populations (Cecil 
et al., 1995; Clara et al., 2003; Dahlem et al., 1991), including trans samples 
(Colton Meier, Pardo, et al., 2013). The Cronbach’s alpha across the three 
subscales varied between .94 and .96 among the clinical group, and .96 and 
.97 among the control group. 
 
6.4.4 Data analysis 
 
All SCL data were positively skewed in both groups and non-normally 
distributed, as demonstrated by significant (p<.002) Kolmogorov-Smirnov tests 
and Shapiro-Wilk tests across all subscales. Similarly, SF data were mostly 
non-normally distributed but negatively skewed in both groups. Therefore, non-
parametric tests were selected where appropriate and it is advised that 
regression analyses are interpreted with caution, as there are no non-
parametric equivalents available. In order to analyse the first hypothesis of this 
study (to test significant differences between the clinical and control groups 
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across each measure), a series of one-tailed Mann Whitney U tests were run. 
To test hypotheses two and three, a series of one-tailed Spearman’s Rho 
correlations were performed prior to regression analyses to test whether factors 
were significantly associated with psychological wellbeing variables. Both global 
and subscale scores were entered in correlational analyses. Subsequently, 
factors from significant correlations were put forward into multiple linear (enter 
method) regressions. Predictor (independent) variables were age, global RSE, 
global HBDS, IIP subscales, and transphobic (TV) victimisation scores. 
Regarding outcome (dependent) variables, general scores of psychopathology 
and quality of life were applied: SCL GSI and SF MHCS scores. According to 
Cohen (1992), in order to run a multiple regression analysis with five 
independent variables, between 91 and 126 participants are required to meet a 
power of 0.80 (for a medium effect size, with an alpha of .05 or .01). Owing to 
the large number of tests conducted, an alpha level of .01 was applied 
throughout to determine significance. In order to test global RSE and global 
MSPSS as mediators, there were four necessary conditions: the predictor 
variable significantly predicts the outcome variable; the predictor variable 
significantly predicts the mediator variable; the mediator variable significantly 
predicts the outcome variable; and the relationship between predictor variable 
and outcome variable is smaller when the mediator is included in the model 
than when it is absent. Only when all conditions were met was mediation 
analysis performed. The size of indirect effect of the predictor variable on the 
outcome variable and its confidence interval indicate whether mediation has 
occurred. If the confidence intervals for the indirect effect do not contain zero, it 
can be concluded that mediation has occurred. The size of the effect is 
calculated in the form of kappa-squared: .01 is considered a small effect, .09 a 
medium effect, and .25 a large effect (Preacher & Kelley, 2011). 
 
6.5 Results 
 
6.5.1 Characteristics of the sample 
 
The mean ages of the clinical and control groups were 36.52 years (SD 
15.25) and 37.63 years (SD 15.30), respectively. Age was not significantly 
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different between the two groups (U=5146, p=.626). The gender ratio of 64:40 
trans women to trans men was similar to previous research investigating clinical 
trans samples (e.g., Heylens et al., 2014). Further socio-demographic 
information is presented in Table 6.1, while the means and standard deviations 
of psychological wellbeing variables and predictive variables are presented in 
Table 6.2. 
 
Table 6.1. Demographic characteristics of the clinical and control sample  
 
 Clinical sample 
(n=104) 
n (%) 
Control sample 
(n=104) 
n (%) 
   
Gender identity 
   Female 
   Male 
 
64 (61.5%) 
40 (38.5%) 
 
64 (61.5%) 
40 (38.5%) 
Ethnic origin 
   White 
   Indian 
   Black other 
   Pakistani 
   Chinese 
   Other 
 
93 (89.4%) 
0 (0%) 
1 (1%) 
1 (1%) 
1 (1%) 
8 (7.7%) 
 
99 (95.2%) 
1 (1%) 
0 (0%) 
0 (0%) 
0 (0%) 
4 (3.8%) 
Employment status 
   Employed full-time 
   Employed part-time 
   Student 
   Volunteer work 
Housewife/husband 
   Disabled 
   Unemployed 
   Other 
 
42 (40.4%) 
4 (3.8%) 
15 (14.4%) 
10 (9.6%) 
1 (1%) 
3 (2.9%) 
13 (12.5%) 
16 (15.4%) 
 
38 (36.5%) 
19 (18.3%) 
35 (33.7%) 
4 (3.8%) 
2 (1.9%) 
0 (0%) 
1 (1%) 
5 (4.8%) 
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Civil status 
   Single, never married 
   Married 
   Civil partnership 
   Separated 
   Divorced 
   Widowed 
   Other 
 
71 (68.3%) 
8 (7.7%) 
1 (1%) 
3 (2.9%) 
16 (15.4%) 
2 (1.9%) 
2 (1.9%) 
 
52 (50%) 
36 (34.6%) 
3 (2.9%) 
3 (2.9%) 
4 (3.8%) 
3 (2.9%) 
1 (1%) 
Living situation 
   With family of origin 
   Alone 
   Shares with non-partner(s) 
   With partner only 
   With partner and child/ren 
   With child/ren only 
   Other 
 
29 (27.9%) 
34 (32.7%) 
15 (14.4%) 
16 (15.4%) 
3 (2.9%) 
2 (1.9%) 
5 (4.8%) 
 
14 (13.5%) 
21 (20.2%) 
10 (9.6%) 
25 (24%) 
24 (23.1%) 
4 (3.8%) 
5 (4.8%) 
Treatment stage 
   Assessment 
   Real Life Experience 
   Post-surgery 
 
7 (6.7%) 
78 (75%) 
18 (17.3%) 
 
- 
- 
- 
Hormone status 
   No use  
   Current use 
   Previous use 
 
19 (18.3%) 
82 (78.8%) 
1 (1%) 
 
- 
- 
- 
n=208  
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6.5.2 Differences between the clinical and control groups 
 
The clinical group had significantly higher scores on psychopathology, 
across SCL GSI and all SCL subscales, and specific interpersonal problems, 
IIP hard to be sociable, IIP hard to be supportive, and IIP hard to be involved, 
compared to the control group (Table 6.2). They also scored significantly lower 
on quality of life, both on the mental health composite score SF MHCS and the 
majority of SF subscales (except SF vitality, though this neared significance), 
global RSE self-esteem, global HBDS body satisfaction, and interpersonal 
problems subscale IIP too open, than controls. 
 
Table 6.2. Means and standard deviations (SD) of each measure among the 
clinical and control group, including results of the tests of comparison 
 
Measure Clinical Control 
Mann Whitney U 
test 
 mean(SD) mean(SD) U p 
SCL GSI 0.67(0.55) 0.29(0.33) 2828 <.001** 
SCL depression 0.92(0.75) 0.37(0.49) 2625 <.001** 
SF MHCS 70.9(17.9) 79.3(12.8) 3560 .001* 
RSE global 19.9(5.86)  22.6(5.9) 3701 <.001** 
HBDS global  2.97(0.51) 3.57(0.66) 2618.5 <.001** 
IIP global 1.11(0.60) 0.79(0.48) 3651 <.001** 
TV verbal 1.60(1.13) - - - 
TV physical 0.33(0.68) - - - 
 
Table abbreviations: Symptom Checklist 90 Revised (SCL), Global Severity Index 
(GSI), Short Form 36 Health Survey version 2 (SF), Rosenberg Self-Esteem Scale 
(RSE), Hamburg Body Drawing Scale (HBDS), Inventory of Interpersonal Problems 
(IIP), Experiences of transphobic victimisation (TV), p<.01*, p<.001** 
 
153 
6.5.3 Links between psychopathology and quality of life 
 
Among the clinical group, every SCL psychopathology subscale was 
significantly, negatively correlated to every SF quality of life subscale (r > -.26, 
p < .006 in all cases, Table 6.3). Among the control group, SCL subscales were 
all significantly, negatively correlated with SF MHCS, SF vitality and SF mental 
health (r > -.25, p < .006, Table 6.4). Most SCL subscales, including SCL 
obsessive compulsive, SCL interpersonal sensitivity, SCL depression, SCL 
anxiety, SCL phobic anxiety, and SCL psychoneuroticism were significantly, 
negatively correlated with SF role limitations due to emotional problems (r > -
.28, p < .003). However, SCL somatisation, SCL hostility, and SCL paranoid 
ideation were not significantly correlated with SF role limitations due to 
emotional problems. Only SCL depression and SCL phobic anxiety were 
correlated with SF social functioning (respectively r = -.26, p = .004, r = -.25, p = 
.005). 
 
Table 6.3 Correlations between psychopathology and quality of life measures 
among the clinical group 
 
  SCL          
  GSI som obs int dep anx hos pho par psy 
SF MHCS  -.68** -.56** -.60** -.55** -.66** -.65** -.42** -.59** -.51** -.52** 
 vit -.53** -.46** -.44** -.38** -.54** -.50** -.31* -.35** -.35** -.37** 
 soc -.54** -.55** -.45** -.46** -.49** -.51** -.34** -.58** -.43** -.43** 
 rol -.65** -.51** -.59** -.57** -.63** -.57** -.36** -.49** -.49** -.55** 
 men -.51** -.26* -.50** -.42** -.53** -.53** -.31** -.44** -.38** -.42** 
Additional abbreviations: Symptom Checklist 90 (SCl), Global Severity Index (GSI), 
somatisation (som), obsessive-compulsive (obs), interpersonal sensitivity (int), 
depression (dep), anxiety (anx), hostility (hos), phobic anxiety (pho), paranoid ideation 
(par), psychoneurotism (psy), Short Form Health Survey 36 version 2 (SF), Mental 
Health Composite Score (MHCS), vitality (vit), social functioning (soc), role limitations 
due to emotional problems (rol), and mental health (men). p<.01*, p<.001** 
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Table 6.4 Correlations between psychopathology and quality of life among the 
control group 
 
  SCL          
  GSI som obs int dep anx hos pho par psy 
SF MHCS -.45** -.34** -.31* -.32* -.54** -.41** -.36** -.39** -.28* -.38** 
 vit -.48** -.42** -.31* -.38** -.50** -.36** -.42** -.36** -.36** -.36** 
 soc -.17 -.20 -.09 -.02 -.26* -.19 -.14 -.25* -.03 -.14 
 rol -.31* -.19 -.28* -.28* -.40** -.33** -.22 -.33** -.16 -.30* 
 men -.43** -.28* -.26* -.41** -.48** -.48** -.25* -.37** -.34** -.39** 
p<.01*, p<.001** 
 
6.5.4 Predictors of psychopathology  
 
Among the clinical group, SCL GSI was not significantly correlated with 
either of the transphobic victimisation scores: TV verbal or TV physical. 
However, it was significantly, positively correlated with scores on IIP 
interpersonal problems (global score and all subscales, except IIP too open) 
and significantly, negatively correlated with age, global RSE self-esteem, and 
global HBDS body satisfaction (Table 6.5). Similarly, SCL depression was not 
significantly correlated with TV verbal or TV physical but was significantly, 
positively correlated with scores on RSE and IIP (global score and all 
subscales, except IIP too open) and negatively correlated with global HBDS 
and age. The full regression model for SCL GSI, containing the predictors age, 
global RSE, global HBDS, and all IIP subscales (except IIP too open) was 
statistically significant (R2=.536, F=10.262, p<.001, betas ranged from -.3.15 to 
.34, Figure 6.2). The model explained 54% of the variance in global 
psychopathology. Similarly, the full regression model for SCL depression, 
containing the predictors age, global RSE, global HBDS, and all IIP subscales 
(except IIP too open) was also significant (R2=.527, F=9.926, p<.001). The 
model explained 53% of the variance in depression. In both models, global RSE 
and IIP too dependent were significant individual predictors. 
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Table 6.5 Correlations between psychopathology and predictor variables 
among the clinical group 
 
  SCL          
  GSI som obs int dep anx hos pho par psy 
Age  -.34** -.19 -.31* -.30* -.25* -.30** -.34** -.27** -.32** -.42** 
RSE glo -.62** -.35** -.54** -.53** -.62** -.34** -.34** -.36** -.39** -.41** 
HBDS glo -.41** -.21 -.30* -.45** -.39** -.34** -.34** -.36** -.39** -.41** 
IIP glo .61** .38** .54** .60** .55** .52** .48** .52** .53** .46** 
 ass .34** .11 .33** .44** .36** .33** .19 .36** .34** .23* 
 soc .49** .32** .51** .45** .45** .49** .26* .49** .38** .35** 
 sup .28* .20 .20 .27* .27* .22* .25* .16 .24* .21 
 inv .39** .17 .34** .39** .39** .27* .26* .26* .29* .33** 
 dep .62** .38** .55** .60** .55** .56** .48** .53** .60** .52** 
 car .39** .31* .33** .31* .31* .34** .26* .48** .32** .39** 
 agg .38** .30* .37** .39** .30* .31* .60** .22* .35** .22* 
 ope -.19 -.10 -.20 -.24* -.16 -.09 -.24* -.09 -.18 -.10 
TV       ver       .20      .22       .18       .18      .08        .23        .13      .27*      .24*       .18 
TV       phy      .10      .07       .05       .05       .04       .03        .13      .05       .15        .11 
Additional table abbreviations: verbal (ver), physical (phy), global (glo), hard to be 
assertive (ass), hard to be sociable (soc), hard to be supportive (sup), hard to be 
involved (inv), too dependent (dep), too caring (car), too aggressive (agg), and too 
open (ope). p<.01*, p<.001** 
 
Among the control group, psychopathology scores SCL GSI and SCL 
depression were both significantly, positively correlated with global IIP 
interpersonal problems (but not individual IIP subscales) and significantly, 
negatively correlated with global RSE self-esteem (Table 6.6). SCL GSI, but not 
SCL depression was also significantly, positively correlated with age. The full 
regression model for SCL GSI, containing age, global RSE and global IIP was 
statistically significant (R2=.298, F=13.848, p<.001, betas ranged from -.286 to 
.339, Figure 6.3). The full regression model for SCL depression, containing 
global RSE and global IIP was also significant (R2=.287, F=19.964, p<.001, 
betas were -.328 and .287). In both models, global RSE and global IIP were 
significant individual predictors and the overall variance explained was 30% and 
29%, respectively. 
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Table 6.6 Correlations between psychopathology and predictor variables 
among the control group 
 
  SCL          
  GSI som obs int dep anx hos pho par psy 
Age  .17* .12 .16 .16* .08 .09 .05 -.11 .09 .12 
RSE glo -.37** -.20 -.39** -.36** -.39** -.35** -.30* -.37** -.26* -.31* 
HBDS glo -.18 -.12 -.19 -.20 -.10 -.11 -.12 -.16 -.20 -.31* 
IIP glo .42** .29* .30* .42** .39** .39** .21 .39** .28* .40** 
 ass -.10 -.25* -.07 .00 -.10 -.21 -.13 -.02 -.05 -.03 
 soc -.09 -.15* -.11 .00 .00 -.07 -.09 -.05 .07 .04 
 sup -.16 -.10 -.23* -.13 -.08 -.16 -.20 -.15 -.13 -.14 
 inv -.07 -.11 -.03 -.10 -.03 -.18 -.16 .08 .01 -.00 
 dep .02 -.10 .04 .08 .05 .01 .05 -.02 .05 .07 
 car .04 -.00 .04 .05 .05 -.10 -.02 -.01 .05 .05 
 agg .12 .13 .08 .14 .15 .08 .11 -.03 .12 .15 
 ope .17 .14 .12 .21 .09 .19 .29* -.03 .17 .15 
p<.01*, p<.001** 
 
6.5.5 Predictors of quality of life 
 
Among the clinical group, mental health related quality of life (SF MHCS) 
was not significantly correlated to global HBDS body satisfaction, interpersonal 
problems subscale IIP too open, or transphobic victimisation (neither TV verbal 
or TV physical, Table 6.7). However, it was significantly, positively correlated 
with age and global RSE self-esteem, and negatively correlated with 
interpersonal problems (global IIP and all remaining subscales). The full 
regression model, containing age, global RSE and all IIP subscales, barring IIP 
too open, was statistically significant (R2=.491, F=9.221, p<.001, betas ranged 
from -.176 to .432), explaining 49% of the variance in quality of life (Figure 6.2). 
Significant individual predictors were global RSE and IIP too dependent. Among 
the control group, SF MHCS was also not significantly correlated to global 
HBDS, but was significantly, positively correlated with age and global RSE, and 
significantly, negatively correlated with global IIP (Table 6.8). The full 
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regression model, containing age, global RSE, and global IIP was significant 
(R2=.383, F=19.219, p<.001, betas ranged between -.339 and .377), explaining 
38% of the variance in quality of life (Figure 6.3). Significant individual 
predictors were global RSE and IIP global. 
 
Table 6.7 Correlations between quality of life and predictor variables among the 
clinical group 
 
  SF     
  MHCS vit soc rol men 
Age  .22* .13 .17* .28** .22* 
RSE glo .52** .44** .30* .51** .60** 
HBDS glo .12 .11 .08 .21 .07 
IIP glo -.52** -.34** -.47** -.44** -.47** 
 ass -.27* -.13 -.27* -.20 -.37** 
 soc -.49** -.33** -.43** -.40** -.49** 
 sup -.26* -.14 -.23* -.18 -.28* 
 inv -.37** -.27* -.35** -.31* -.27* 
 dep -.47** -.32* -.36** -.42** -.47** 
 car -.38** -.23* -.40** -.41** -.21 
 agg -.23* -.16 -.13 -.20 -.27* 
 ope .17 .02 .20 .17 .17 
TV       ver       -.12 
TV       phy      -.03 
p<.01*, p<.001** 
 
6.5.6 Self-esteem as a mediator 
 
Where predictor variables significantly predicted the outcome variables 
(SCL GSI, SCL depression, and SF MHCS) mediation analyses were 
performed entering global RSE self-esteem as the mediator. In the clinical 
group, mediation analysis could not be performed with IIP hard to be supportive 
as the predictor variable with any of the outcome variables, as this variable did 
not significantly predict global RSE. IIP hard to be involved also did not 
significantly predict global RSE in the model where SF MHCS was the 
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outcome. Thus, in these cases, not all the necessary criteria for mediation were 
met. However, global RSE self-esteem was found to be a consistent mediator 
between the following predictor variables and both SCL GSI and SCL 
depression: age, global HBDS, and IIP subscales hard to be assertive, hard to 
be sociable, hard to be involved, too dependent, too caring, and too aggressive. 
In addition, the relationships between SF MHCS and predictor variables age, 
IIP hard to be assertive, IIP hard to be sociable, IIP too dependent, IIP too 
caring, and IIP too aggressive were mediated by global RSE. 
 
Table 6.8 Correlations between quality of life and predictor variables among the 
control group 
 
  SF     
  MHCS vit soc rol men 
Age  .38** .19* .41** .32** .18* 
RSE glo .30* .30* .20 .32* .41** 
HBDS glo .15 .29* .04 .14 .23* 
IIP glo -.35** -.33** -.18 -.32** -.40** 
 ass .14 .22* .10 .00 .03 
 soc -.06 -.01 -.10 -.09 -.01 
 sup .02 .07 -.04 .01 .02 
 inv .01 .09 -.09 -.06 .13 
 dep -.01 .08 -.04 -.15 .03 
 car -.03 -.03 -.09 -.06 .02 
 agg -.18 -.19 -.08 -.20 -.09 
 ope -.03 -.15 .09 -.01 .01 
p<.01*, p<.001** 
 
In the control group, as global RSE did not significantly predict SCL GSI or SF 
MHCS, mediation analysis could not be performed with these as outcome 
variables and age as the predictor variable. However, the relationship between 
global IIP and SCL GSI was mediated by global RSE (b = .107, BCa CI [.027, 
.268]) with a medium effect (k2 = .145, BCa CI [.045, .291]). Similarly, the 
relationship between global IIP and SCL depression was mediated by global 
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RSE (b = .178, BCa CI [.045, .430]) with a medium to large effect (k2 = .163, 
BCa CI [.054, .332]). 
 
Figure 6.2. Model outlining significant predictors of psychological wellbeing 
among trans individuals, including beta values and regression models 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: Beta values are given in the following order: (related to outcomes) SCL global, 
SCL depression, and SF MHCS. Body dissatisfaction was only a significant predictor of 
SCL global and SCL depression and is therefore represented by a dashed arrow.  
↓ Self-esteem 
β  -.32, -.45, .43 
 
↓ Age 
β  .11, .17, -.11 
↑ Interpersonal problems 
hard to be assertive 
β  -.09, -.01, .07 
hard to be sociable 
β  .12, ..07, -.17 
hard to supportive 
β  -.05, -.01, .01 
hard to be involved 
β  .14, .12, -.18 
too dependent 
β  .34, .31, -.17 
too caring 
β  .08, .01, -.16 
too aggressive 
β  -.02, -.03, .103 
 
↑ Body dissatisfaction 
β  -.18, -.12 
 
↑ Psychopathology 
Global psychopathology 
R2=.536, F=10.262, p<.001 
Depression 
R2=.527, F=9.926, p<.001 
↓ Quality of life 
R2=.491, F=9.221, p<.001 
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↓ Self-esteem 
β  -.29, -.33, .24 
 
↓ Age 
β  .03, - , .38 
↑ Interpersonal problems 
global 
β  .34, .29, -.34 
 
 
↑ Psychopathology 
Global psychopathology 
R2=.298, F=13.848, p<.001 
Depression 
R2=.287, F=19.964, p<.001↓ 
Quality of life 
R2=.383, F=19.219, p<.001 
Figure 6.3. Model outlining significant predictors of psychological wellbeing 
among cisgender individuals, including beta values and regression models 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: Beta values are given in the following order: (related to outcomes) SCL global, 
SCL depression, and SF MHCS. Age was only a significant predictor of SCL global 
and SF MHCS and is therefore represented by a dashed arrow. 
 
6.5.7 Social support as a mediator 
 
In previous research (Davey et al., 2014) MSPSS subscales were not 
found to significantly predict SCL GSI or SCL depression in either the clinical or 
control group. Among the clinical group however, MSPSS subscales did 
significantly predict SF MHCS. In this study, all IIP subscales (except IIP too 
open) significantly predicted SF MHCS. However, IIP subscales did not predict 
MSPSS global, therefore, in all cases, the criteria for testing MSPSS as a 
mediator were not met. 
6.6 Discussion 
 
The principal aim of this study was to test a preliminary model of 
predictors of psychological wellbeing among a sample of treatment-seeking 
individuals fulfilling a diagnosis of Transsexualism as per ICD-10 (WHO, 1992) 
compared to a matched cisgender control group. The two components of 
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psychological wellbeing that were explored were psychopathology (including 
depression) and quality of life (WHO, 1997). In doing so, the study replicated 
and extended previous research on factors associated with psychological 
wellbeing in this population. In line with existing research (Davey et al., 
accepted; Hepp et al., 2005; Newfield et al., 2006; Skrapec & MacKenzie, 1981; 
Witcomb et al., in press) trans individuals were found to have greater levels of 
psychopathology, body dissatisfaction, and interpersonal problems, and lower 
levels of self-esteem, compared to cisgender individuals. As hypothesised, 
among the trans group, greater psychopathology was predicted by younger 
age, lower levels of self-esteem, greater body dissatisfaction, and greater 
interpersonal problems (Figure 6.4). Similar results were found for predicting 
high levels of depression, though age was not significant. In comparison, 
among the cisgender group, only lower self-esteem and greater overall 
interpersonal problems were significant predictors of greater psychopathology 
and depression. In terms of lower quality of life, lower self-esteem and greater 
interpersonal problems were significant predictors among trans individuals. 
Against expectations, higher body dissatisfaction was not associated with lower 
quality of life. Among the cisgender group, younger age, lower self-esteem, and 
greater overall interpersonal difficulties were significant predictors of low quality 
of life. Interestingly, frequency of transphobic victimisation was not correlated 
with psychopathology, depression, or quality of life in the trans group, though 
verbal transphobic victimisation was correlated with four SCL subscales 
(somatisation, anxiety, phobic anxiety, and paranoid ideation). 
 
With age tends to come more developed coping strategies (Diehl, Coyle, & 
Labouvie-Vief, 1996) which may explain the role of age in psychological 
wellbeing. Younger trans adults may be more vulnerable to mental health 
difficulties as they have less experience in managing stress, whereas those 
who are older may have had time to develop and establish more effective 
coping mechanisms. The finding that self-esteem has a prominent contribution 
to psychological wellbeing among trans individuals reflects evidence in the 
literature on cisgender groups (e.g., Mann et al., 2004). Although individuals’ 
self-esteem may improve as the body undergoes treatment and distress is 
alleviated, it may be beneficial for clinicians to focus on bolstering self-esteem 
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in its own right. However, in other areas this has been found to be complicated 
and of mixed success (e.g., Forsyth, Lawrence, Burnette, & Baumeister, 2007).   
 
Interpersonal functioning appears to be of great importance to psychological 
wellbeing among trans individuals and this is an area which could be targeted 
within clinical services. For example, interpersonal psychotherapy may help to 
improve psychological wellbeing by assisting individuals to develop their 
interpersonal skills, manage potentially difficult relationship transitions, and 
build their confidence in interacting with others (Klerman et al., 1984).  
 
Body dissatisfaction has been linked to a number of indicators of poor 
psychological wellbeing (e.g., Davison & McCabe, 2006; Paxton et al., 2006; 
Stice & Shaw, 2002) and, as expected, predicted greater psychopathology in 
the trans group. Cross-sex hormone treatment and sex reassignment surgery 
are intended to better align the physical body with the person’s experienced 
gender, though this is achieved to varying degrees between individuals. 
Consequently, psychopathology should be reduced accordingly with the 
progression of treatment (e.g., Gómez-Gil et al., 2012). Previous research 
regarding trans individuals following sex reassignment surgery show that the 
adequacy of surgical results influences psychopathology (Ross & Need, 1989). 
It is surprising, in this population, that body dissatisfaction did not predict quality 
of life. Although it is recommended that a replication be conducted to verify 
findings, this particular result may be due to selecting a sample within a 
treatment programme, where cross-sex hormone interventions are underway 
and so bodily changes are already occurring and while dissatisfaction may still 
be high, the relief from knowing that the body is changing and will continue to 
change may negate any negative impact positively on quality of life. 
Alternatively, it may be because this study examined functional quality of life as 
opposed to life satisfaction or general happiness that body dissatisfaction was 
not a significant predictor. 
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Figure 6.4. Conceptual model outlining significant predictors of psychological 
wellbeing among trans individuals 
 
 
Though this study contributes valuable evidence to the literature on wellbeing 
among trans individuals, there are some limitations which must be considered. 
Whilst reasonably strong relationships were found, the data are cross-sectional 
and therefore requires a robust replication, applying a prospective design, to 
determine true predictive effects. This study examined levels of 
psychopathology which is not necessarily synonymous with clinically diagnosed 
mental health problems. With regards to sample characteristics, the trans group 
had a higher proportion of individuals who were not in paid employment, had 
never been married or were divorced, and were either living alone, with their 
families of origin or non-partners, compared to the cisgender group. It is 
possible that these socio-demographic differences may have influenced the 
differences, particularly in psychological wellbeing and interpersonal 
functioning. However, these differences in socio-demographic characteristics, 
such as divorce or living alone, may be inextricably associated with being trans, 
↓ Self-esteem 
↓ Age 
↑ Interpersonal problems 
hard to be assertive 
hard to be sociable 
hard to supportive 
hard to be involved 
too dependent 
  
↑ Body dissatisfaction 
↑ Psychopathology 
↓ Quality of life 
164 
since many trans people lose relationships, housing, and employment as a 
result of their transition (e.g., Factor & Rothblum, 2007; Whittle et al., 2007).  
 
Due to the specific nature of the clinical sample, these findings can only be 
generalised to individuals diagnosed with Transsexualism, who are on the 
treatment pathway. Different factors may be salient to the psychological 
wellbeing of those who are not receiving treatment or in contact with services, 
or of those who have fully completed their transition. The lack of association 
between transphobic victimisation and psychological wellbeing variables might 
be explained by a floor effect of having the majority of trans participants 
reporting few to no incidents, unlike in previous research (e.g., Nemoto et al., 
2011). Experiences of non-verbal/subtle acts of transphobic discrimination were 
not measured in this study but may have more of an impact on psychological 
wellbeing. In light of the present findings, further research into the potential 
benefit and efficacy of improving self-esteem and interpersonal functioning of 
trans individuals would be valuable.  
 
Overall, this study has found that the most salient predictors of low 
psychological wellbeing among trans individuals are self-esteem and 
interpersonal problems. Younger age and greater body dissatisfaction predict 
greater psychopathology, but not lower quality of life, whereas lower self-
esteem and greater interpersonal problems predict both. This evidence 
suggests that increased attention should be paid to ways to bolster self-esteem, 
decrease interpersonal problems, and address body dissatisfaction, particularly 
in younger trans people, with the aim of improving overall psychological 
wellbeing. 
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Chapter 7: Discussion 
 
 
7.1 Reviewing the general aims of this thesis 
 
At the beginning of this thesis, several general aims were outlined that 
would underpin the research as a whole. Most importantly, this body of 
research aimed to explore the relationships between several different factors 
and psychological wellbeing among treatment seeking trans individuals. Before 
testing the factors in a model for predicting psychological wellbeing, which was 
the endpoint of this research, more investigation was needed to understand 
whether some factors were indeed relevant to the trans population. Some of the 
chosen factors were novel in that little to no research had been published that 
applied to the trans population, for example interpersonal problems (Chapter 4). 
If trans individuals were no different to cisgender individuals in terms of 
interpersonal problems, there would not be a particular need to examine 
whether this factor is related to trans wellbeing. Other factors had previously 
been explored to an extent but required clarification, such as non-suicidal self-
injury (NSSI, Chapter 5), or an approach from a new angle, for example social 
support from friends and significant others (Chapter 3). This preliminary work 
enabled the testing of predictors in study four (Chapter 6) and the production of 
the final model (Figure 6.2) which represents the combination of these findings. 
 
Whilst pursuing this investigation, additional aims were to incorporate an 
appropriate matched control group and to identify gender differences between 
trans men and trans women. Importantly, it was observed in the existing 
literature that control groups were often absent (e.g., Gómez-Gil et al., 2012; 
Pitts et al., 2009; Rotondi, Bauer, & Scanlon, 2011), resulting in both a lack of 
rigour and a marker for comparison. To address this, a group of cisgender 
participants were recruited from the general population to provide a 
comparative group to the trans participants. It was also noted that trans men as 
a group tend to be overlooked in the literature (e.g., Bazargan & Galvan, 2012; 
Midence & Hargreaves, 1997; Strain & Shuff, 2010), perhaps due to a lower 
prevalence of Transsexualism among trans men (e.g., Arcelus et al., in press) 
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and lesser visibility in comparison to trans women. Where research has 
included both trans men and trans women, it is not uncommon for potential 
gender differences to remain unexplored (e.g., Erich et al., 2008; Lombardi et 
al., 2002). To rectify this shortcoming, both trans men and trans women were 
recruited, and where relevant to the analysis, variations relating to gender were 
assessed. Keeping in mind these broad aims, a summary of the findings 
generated by this research will be presented. 
 
7.2 Summary of studies and their findings 
 
7.2.1 Study 1 
 
In Study 1 (Chapter 3), it was identified that there was a lack of 
knowledge of perceived social support, and its relationship to psychological 
wellbeing in the trans population. Therefore, the study aimed to measure levels 
of perceived social support across different sources (family, friends and 
significant others) in a group of trans individuals and to compare these to levels 
of support among a cisgender group. It also aimed to examine gender 
differences in social support, and to investigate the link between social support 
and psychological wellbeing. It was found that as a group, trans individuals 
perceived lower levels of social support compared to cisgender individuals. 
Specifically, trans women perceived lower levels of social support, particularly 
from their families, compared to cisgender women. However, depression was 
observed to play a key role in this difference, as this finding became non-
significant once levels of depression were accounted for. In contrast, trans men 
reported similar levels of social support to their cisgender peers. In terms of 
psychological wellbeing, trans individuals displayed significantly higher scores 
of psychopathology and lower scores of quality of life and life satisfaction than 
cisgender individuals. While, social support was not a significant predictor of 
psychopathology, it did significantly predict quality of life and life satisfaction. 
Due to the impact on psychological wellbeing and inadequacy of perceived 
family support, working alongside trans individuals to develop different sources 
of support was emphasised as a particular need. Encouraging greater inclusion 
and involvement of families within the treatment process, as has previously 
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been recommended (e.g., Ahmad et al., 2013; Wylie et al., 2014), could be one 
way to address this. Moreover, it is an issue which trans people themselves find 
very important and see as an integral part of the treatment pathway with GICs 
(Davies et al., 2013). It was also recognised that wider work could be done to 
educate the cisgender population and foster a more tolerant attitude that would 
consequentially allow for a more supportive social environment. 
 
7.2.2 Study 2 
 
The next study (Chapter 4) focused on interpersonal problems. Given 
that the trans population are known to have high rates of depression, in addition 
to the evidence that interpersonal problems often play a key role in depression, 
it was surprising that interpersonal functioning among trans individuals had not 
been previously examined. The aims were to measure and compare 
interpersonal problems among trans and cisgender groups, and to investigate 
potential differences in interpersonal problems between trans women and trans 
men. A further aim was to explore the role of depression by observing whether 
significant differences remained after controlling for levels of depression. The 
findings demonstrated that, compared to the cisgender group, the trans group 
had significantly elevated interpersonal problems overall. Specifically, trans 
individuals displayed greater difficulties in the areas of being sociable, 
supportive, and involved with others, and being less open. While levels of 
depression explained the significant differences between the trans and 
cisgender groups on global interpersonal problems and also being open with 
others, the differences relating to being sociable, supportive and involved 
remained after accounting for depression. In terms of gender differences, after 
controlling for depression, trans women reported similar levels of interpersonal 
problems to cisgender individuals whereas trans men continued to have higher 
levels. As interpersonal difficulties did not appear to be linked to depression 
among trans men, it was suggested that anticipated and actual experiences of 
rejection and transphobia could cause trans men to be inhibited around others 
and less trusting, resulting in less adequate interpersonal skills. For trans 
women, the link between depression and interpersonal problems may indicate 
either that interpersonal problems can increase trans women’s vulnerability to 
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depression or that interpersonal functioning can be negatively affected by the 
onset of depression.  
 
7.2.3 Study 3 
 
Study 3 (Chapter 5) observed that there is substantial evidence that 
trans individuals are at high risk of mental health problems and of suicide, but 
strikingly little evidence on rates of self-injury in this group. Therefore, the aim 
was to measure the prevalence rate of non-suicidal self-injury (NSSI) among 
treatment-seeking trans individuals and compare this to the rate among control 
cisgender individuals. It further aimed to draw comparisons between those who 
currently engage in NSSI and those with no history of NSSI, with regards to 
psychological wellbeing, self-esteem, body dissatisfaction, social support, and 
demographic factors. The study identified that trans individuals had a 
significantly higher risk of current NSSI than cisgender individuals, with 19% of 
the trans group reporting current NSSI in spite of engaging with a gender 
identity clinic (GIC) and being on the treatment pathway. Regarding gender 
differences, it was found that trans men, but not trans women, were more at risk 
of NSSI than both cisgender men and women. When compared to those who 
had never engaged in NSSI, trans individuals who currently self-injured 
reported significantly greater psychopathology, lower body satisfaction, lower 
self-esteem, lower social support, and tend to be younger in age. This high risk 
of NSSI, especially among trans men and notably in a treatment seeking 
population, points to a need for health professionals who work with trans 
individuals to be vigilant for NSSI. As part of supporting trans individuals who 
engage in NSSI, it may be beneficial to work on developing healthier coping 
mechanisms, building supportive networks, and improving psychological 
wellbeing, particularly in areas of body image and self-esteem, to reduce the 
need for NSSI behaviour. 
 
7.2.4 Study 4  
 
The fourth and final study (Chapter 6) applied findings from the above 
studies and observations within the existing literature to propose a testable 
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model of predictors of psychological wellbeing among trans individuals. The 
literature has clearly identified the trans community as a vulnerable population, 
demonstrating several negative outcomes, including high rates of mood 
disorders, self-injury, suicide, depression, and low quality of life. However, in 
terms of identifying risk factors of poor psychological wellbeing, the evidence to 
date is lacking. The majority of the research into trans wellbeing only goes as 
far as to measure associations, falling short of exploring predictive 
relationships. The limited research that has investigated risk factors tends to 
lack statistical power and has primarily measured depression as an outcome.  
 
In order to conduct a more thorough investigation into potential predictors, it 
was considered valuable to take a more comprehensive view of psychological 
wellbeing. Therefore, within the model put forward for testing, psychological 
wellbeing was indicated by levels of psychopathology (including depression) 
and quality of life. The predictors selected for testing were drawn from the 
collated evidence in the trans literature, the general literature, and the thesis’ 
findings so far. The literature on trans individuals demonstrated that younger 
age and experiences of transphobic victimisation are associated with poor 
psychological wellbeing. The general (non-trans specific) literature illustrated 
the importance of low self-esteem and body dissatisfaction in wellbeing - each 
of which have been identified as typical difficulties among trans individuals. 
Chapter 4 demonstrated that trans individuals tend to have elevated 
interpersonal problems, which raised the question of what impact this has on 
their psychological wellbeing. The findings in Chapter 3 eliminated social 
support from the model as a predictor, as it failed to predict global 
psychopathology and depression. However, social support, together with self-
esteem, was considered a potential mediator that may account for some of the 
associations between the predictive factors and psychological wellbeing. 
 
Subsequently, there were four aims for formulating and fully testing the model. 
First, to replicate previous findings that trans individuals report greater 
psychopathology, greater interpersonal problems, higher body dissatisfaction, 
lower quality of life, and lower self-esteem, in comparison to cisgender 
individuals. Second, to test which of these factors (with the added factor of age) 
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significantly predict psychopathology, and third, which factors significantly 
predict quality of life. Fourth, to investigate whether either self-esteem or social 
support mediated any significant effects of predictors on psychological 
wellbeing variables.  
 
Findings from study 4 demonstrated that trans individuals report greater levels 
of psychopathology, body dissatisfaction, and interpersonal problems, and 
lower levels of self-esteem and quality of life than their cisgender peers. Higher 
levels of psychopathology among trans individuals were predicted by younger 
age, lower levels of self-esteem, greater body dissatisfaction, and greater 
interpersonal problems, whereas only lower self-esteem and greater overall 
interpersonal problems were significant predictors among cisgender individuals. 
Regarding lower quality of life among trans individuals, lower self-esteem and 
greater interpersonal problems were significant predictors. Unusually, higher 
body dissatisfaction was not related to lower quality of life. This could be due to 
recruiting a treatment population of trans individuals. It is possible that for 
individuals who are already in the process of physically aligning their bodies 
more closely with their experienced gender, body dissatisfaction may not have 
as big an impact on psychological wellbeing. Among cisgender individuals, 
lower quality of life was predicted by younger age, lower self-esteem, and 
greater overall interpersonal difficulties. The non-significant findings in relation 
to transphobic victimisation and each of the psychological wellbeing variables 
could be attributed to a floor effect of few reported incidents of such 
experiences. If individuals reported a higher incidence of being victim to verbal 
and physical transphobia, it is likely there would emerge a strong link to poorer 
psychological wellbeing, as has been identified in other research (e.g., Boza & 
Nicholson Perry, 2014; Nemoto et al., 2011). 
 
In terms of the predictive models tested, among the trans group, the models 
significantly predicted 54% of the variance in psychopathology and 49% of the 
variance in quality of life. While social support was not entered as a mediator, 
due to not meeting the necessary criteria, self-esteem mediated several 
relationships, including those between body dissatisfaction and 
psychopathology and depression; age of referral and psychopathology; and 
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interpersonal problems and psychopathology, depression and quality of life. 
Taking into account this evidence, Figure 7.1 depicts the final model of 
predictors. 
 
In light of these findings, it would be beneficial to focus interventions on 
bolstering self-esteem, reducing interpersonal problems and alleviating body 
dissatisfaction, with a view to improve overall psychological wellbeing among 
trans individuals. This is likely to be especially important when working with 
younger trans individuals, who may lack more developed coping mechanisms 
compared to older trans individuals. As self-esteem is developed in early age 
and influenced by family and social factors, it is likely that the high levels of 
bullying reported by trans individuals (e.g., Grossman & D’Augelli, 2007; 
Toomey et al., 2010) impacts their self-esteem. Interventions aimed at 
preventing the development of low self-esteem among this population could 
include working with schools to reduce bullying and promote more positive 
attitudes to differences between people. 
 
  
172 
Figure 7.1. Final model of predictors of psychological wellbeing among trans 
individuals 
 
7.3 General limitations & future directions 
 
Studying individuals when they are in the midst of undergoing treatment 
and transitioning is an especially interesting and valuable undertaking. This is 
because there is great potential for individuals’ wellbeing to improve 
dramatically during this time. First, the clinical environment is able to validate a 
person’s sense of gender identity and lived experience without prejudice, 
perhaps for the first time, and represents a vital source of support and expert 
knowledge. This experience when attending a gender clinic may benefit 
individuals’ wellbeing. Second, evidence shows that the initiating cross-sex 
hormone treatment can have a fundamental impact on individuals’ 
psychological wellbeing (e.g., Gómez-Gil et al., 2012). Physical changes to the 
body brought on by cross-sex hormones aligns the body more closely with a 
person’s experienced gender and therefore is likely alleviate a considerable 
↓ Self-esteem 
↓ Age 
↑ Interpersonal problems 
hard to be assertive 
hard to be sociable 
hard to supportive 
hard to be involved 
too dependent 
  
↑ Body dissatisfaction 
↑ Psychopathology 
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↑ Psychopathology 
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degree of dysphoria. Third, other steps included in this period are obtaining 
legal recognition of one’s chosen gender and making changes to formal 
documents, such as a passport or driving licence. Achieving this formal 
recognition may serve to validate individual’s self-image and represent a mark 
of progress towards the life individuals wish to live, thus enhancing individuals’ 
wellbeing. 
 
Despite these potential gains which individuals may experience, this period can 
also introduce significant challenges. For example, individuals may have to 
make difficult decisions regarding the future of their fertility when commencing 
hormone treatment (e.g., Richards & Seal, 2014; Tʼsjoen, Van Caenegem, & 
Wierckx, 2013). Close relationships may be negatively affected by the 
emotional journey of an individual’s transition. Individuals may have to live 
openly in their experienced gender in spheres where this aspect of themselves 
may have previously been hidden, such as the workplace or college, which can 
additionally increase their exposure to rejection and discrimination. These 
challenges could adversely affect individuals’ wellbeing. This is why it was 
important to investigate individuals in the treatment phase rather than simply 
before or after treatment was completed. In this sample, there was not the 
opportunity to compare individuals at differing stages of treatment/transition. 
However, the knowledge that this thesis has contributed to the field could offer 
a valuable starting point to for future research to pursue such an enquiry.   
 
Whilst this research adds valuable evidence to our understanding of trans 
wellbeing, it is not without limitations in terms of design, recruitment, method 
generalisability, potential for confounding factors, and data analysis. This body 
of research was cross-sectional in design. This may appear not to lend itself to 
the final aim of examining predictors of psychological wellbeing. However, from 
the literature review presented in the introduction chapter, it was found that 
there was little existing evidence of what factors might impact trans’ wellbeing 
other than treatment. Examining the associations between proposed predictors 
and the wellbeing variables at a cross-sectional level was vital starting point for 
this question. Having discovered which parts of the model were significant, in 
Chapter 6, longitudinal research could proceed and confirm whether these are 
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truly predictive relationships or simply associations. Longitudinal research 
requires considerable investment and cannot be conducted without firm 
scientific grounding. This research goes some way into providing the 
groundwork for such investigation. 
 
In terms of recruitment, the research relied on volunteer participants to 
complete the questionnaires and offered no monetary incentive. The potential 
for volunteer bias means that those who chose to participate may have had a 
particular interest in the topic or may collectively have had similar 
characteristics, such as high motivation and desire for social approval (e.g., 
Bell, 1962). This could have affected the representativeness of the sample. 
Given that the main focus was psychological wellbeing, the potential for a 
greater number of high functioning participants (those who had the time and 
motivation to complete a survey on wellbeing) could have skewed the data. 
With regard to recruitment sources for control participants, a significant portion 
of the control sample were consequently made up of university students and 
individuals from voluntary organisations, which would have implications for 
participants’ educational level and socio-economic advantage. This may have 
further diminished the representativeness of the control sample and its 
comparative value within the research. 
 
When administering questionnaires and relying on self-report data, there is the 
possible presence of social desirability bias. Within this research, this may be 
especially pertinent to the trans group. Despite assurances of confidentiality 
and that their responses would have no bearing on the care they received at 
the GIC, trans participants may have perceived a need to respond in ways that 
would give clinicians a certain representation of their wellbeing. For example, 
some individuals may have thought that by masking poorer psychological 
wellbeing or interpersonal problems, and appearing well-adjusted in their 
answers to the questionnaires, they may advance their treatment. Equally, the 
opposite may have been true, that some participants may have over-reported 
indicators of poor psychological wellbeing to ensure the receipt of care and 
emphasising its necessity. 
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The generalisability of the findings presented in this thesis is limited to trans 
individuals in contact with GIC services. This is in part due to the decision to 
make a diagnosis of Transsexualism a core criterion for eligibility with a view to 
enhancing the rigor of the research. It is acknowledged that this subgroup is not 
necessarily representative of the general trans population. There may be 
particular reasons why some trans individuals either have not yet approached 
GICs or actively chose not to seek treatment through a GIC. These reasons 
may relate to differences in the psychological wellbeing of those in contact with 
gender clinics and those not. This is an area where little investigation has been 
conducted, likely due in part to the conflicts of recruiting undiagnosed trans 
individuals and the difficulties of accessing a hidden population. A further 
limitation, with regards to generalisability, it that this research was specific to 
people living in the UK and the experience of being trans will inevitably differ 
cross-culturally, not least due to differences in access to medical treatment and 
legislation that protects the rights of trans people. The opportunity to safely 
transition for those who wish to do so, and an accepting social environment in 
which to express one’s gender, will unquestionably have positive implications 
for the wellbeing of trans people.  
 
As highlighted in earlier chapters, there were notable differences in 
demographic characteristics between the trans group and cisgender group, in 
relation to employment, civil status, and living situation. These differences have 
the potential to bias the findings as some differences between groups may be 
better accounted for by differences in demographic background. This weakness 
could be addressed by further matching or applying a stratified sampling 
technique. However, it should also be considered that as a population trans 
individuals may generally be more likely to be unmarried/divorced, live alone or 
with non-partners, and experience unemployment than the general population. 
There is evidence to suggest that transitioning carries the risk of losing 
relationships, housing, and employment, as a consequence of the stigma that 
surrounds being trans (e.g., Factor & Rothblum, 2007; Whittle et al., 2007).  
 
Lastly, there are statistical limitations to consider, namely that the data were not 
normally distributed. As there are no non-parametric equivalents for the 
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regression analyses required in studies 1 and 4, it was advised for these results 
to be interpreted with caution. A further weakness of the regression analyses is 
that the data were cross-sectional, and therefore, true predictive effects could 
not be determined. However, as discussed above, these findings still have 
value. Looking more broadly at the research, a larger sample size would have 
been desirable, though the response rate achieved (40% for the trans group) 
was reflective of that typical for surveys. The total sample size would have been 
sufficient for analysis using an alpha level of .05, but was less than 
recommended for using the more conservative alpha level of .01. 
 
7.4 Clinical recommendations 
 
One of the major drivers for this research was to produce clinical 
recommendations that identify which areas need to be targeted in order to 
improve the psychological wellbeing of trans individuals, and suggest how this 
could be possible. Bringing together what has been observed over the course 
of this research, the recommendations that have been generated are divided 
into those appropriate at a prevention level and those appropriate at a 
management level. While recommendations primarily aimed at clinicians and 
health professionals are considered, there are also wider implications for social 
work included (see Figure 7.1). 
 
7.4.1 Prevention of psychopathology 
 
The following recommendations are intended to be implemented in the 
form of early invention to prevent problems, such as low self-esteem, 
developing. The prevention of the development of poor psychological wellbeing 
in the trans population can equate to preventing the development of 
psychopathology. This could be achieved in the following ways: 
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1) Reducing the development of interpersonal problems and preserving social 
support 
 
Most of the interpersonal difficulties reported by trans individuals in 
Chapter 4 were linked to socialising and engaging with others. A lack of trust 
could play a major role in these difficulties. Additionally, it was found that 
perceived social support is often lacking from family members. By working with 
families and significant others from the beginning of the treatment process to 
increase understanding and communication, existing relationships may not only 
suffer less but also have the opportunity to grow and develop. On a broader 
level, targeting bullying and transphobia that currently takes place within 
schools, colleges, universities, and work organisations (e.g., Grossman & 
D’Augelli, 2007; McGuire et al., 2010; Pitts et al., 2006) could help foster a 
more tolerant and accepting social environment.  
 
2) Reducing the development of low self-esteem 
 
Living with a physical appearance and body that is incongruent with 
one’s gender identity can be emotionally distressing and it is understandable 
that this would impact self-esteem. By intervening early and increasing access 
to appropriate services, for example by reducing waiting times, trans individuals 
may be able to move on with their lives sooner. 
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Figure 7.2. Recommendations and strategies to improve psychological wellbeing among the trans population 
Offering family 
therapy within GICs 
Increasing social 
support 
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significant others in the 
treatment process 
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3) Reducing the development of poor body image 
 
Trans individuals usually present to gender services with high body 
dissatisfaction. As suggested above, improving access to treatment so that 
individuals can achieve a physical appearance more congruent with their 
experienced gender identity is likely to have a positive impact on body image, in 
addition to self-esteem. However, it is not sufficient to exact change on an 
individual level, societal change is also needed. Living within societies where 
there is a rigid gender binary and where unconventional representations of 
gender can attract ridicule is likely to fuel body dissatisfaction among trans 
individuals. Therefore, challenging public attitudes to be more accepting of 
varying physical and social expressions of gender could serve to promote more 
positive body image among those who do not easily fit within the current gender 
binary. 
 
4) Reducing the risk of NSSI 
 
One of the most common functions of NSSI is affect-regulation (Klonsky, 
2007). Teaching more adaptive coping mechanisms among young trans 
people, who are known to be more at risk of NSSI, to help them manage how 
they feel could help to reduce this risk. Trans individuals often report 
involvement with supportive LGBT communities (e.g., Levitt & Ippolito, 2014), 
therefore working with these communities to teach their members how to 
manage emotional distress in healthier ways may be a useful way to help 
young trans people. An additional consideration is that as NSSI in this 
population is known to be associated with poor body image, low self-esteem 
and low social support, it is possible that by implementing the above strategies, 
individuals’ need for NSSI will also be subsequently reduced.  
 
7.4.2 Management of psychopathology 
 
Where individuals may already experience poor psychological wellbeing 
(rendering prevention strategies null), there is critical work to do to reduce 
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factors that exacerbate or contribute to the maintenance of poor psychological 
wellbeing. The following strategies should be considered: 
 
1) Increasing social support 
 
Families can often feel to blame for their child’s gender dysphoria (Lantz, 
1999) and may struggle to accept an individual in their experienced gender 
identity. To help families come to terms with their loved ones’ gender 
experience and decisions regarding transitioning, and to be more supportive, 
offering family therapy within GICs may be beneficial. 
 
2) Improving interpersonal skills 
 
Evidence demonstrates that interpersonal psychotherapy (IPT) can be 
an effective treatment for depression by helping individuals to manage 
interpersonal difficulties (e.g., Hara, Stuart, Gorman, & Wenzel, 2000; Klerman 
et al., 1984; Mufson, Weissman, Moreau, & Garfinkel, 2013). However, the 
unique experiences of trans individuals and the higher risk of interpersonal 
problems in this group may necessitate the development of IPT which is 
specifically tailored for trans people. IPT has previously been adapted to 
specific populations, for example in eating disorders (Arcelus et al., 2009), and 
a tailored IPT approach could benefit trans individuals. 
 
3) Reducing NSSI behaviour 
 
As part of supporting trans individuals within GICs as they undergo the 
transitional process, clinicians may need to focus on helping individuals to 
develop healthy coping mechanisms and reduce reliance on NSSI to manage 
emotional distress. This is important as certain stressors, such as transphobia, 
may persist after treatment is completed and after individuals achieve the 
bodies that better align with their gender identity. 
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4) Focusing on young people 
 
Younger trans individuals are more vulnerable to poor psychological 
wellbeing so targeting this demographic is vital. Collaborating with schools, 
colleges, universities, and community groups to encourage peer support, 
promote self-worth, and create environments that are more accommodating to 
the needs of trans individuals would be valuable. 
 
7.5 Conclusions 
 
This thesis draws attention to the importance of working with trans 
individuals to increase social support. This may be through improving 
interpersonal skills as trans individuals, as a group, report difficulties in 
socialising and engaging with others. Social support and interpersonal 
functioning are critical areas to work on as they are clearly associated with 
psychopathology and quality of life, as demonstrated by this research and the 
wider literature (e.g., Boza & Perry, 2014; Hoffman, 2014; Nemoto et al., 2011). 
Family relationships, in particular, are often perceived as lacking in support, 
especially by trans women. Therefore, the inclusion of families when working 
clinically with this population may be valuable (Ahmad et al., 2013; Wylie et al., 
2014). Clinicians may consider aiming to improve understanding and 
communication within families and thereby increase support for the trans 
individual. In spite of difficulties reported with regard to interpersonal 
functioning, trans individuals perceive relatively good support from friends and 
partners (or families of choice), on par with the cisgender population. This may 
be an important indication that the formation of new relationships is more 
successful for trans individuals than maintaining existing relationships, at least 
at the point of receiving treatment. 
 
While these findings hold significance for working with trans individuals, further 
research is required. This thesis has usefully contributed to what is understood 
of psychological wellbeing among trans individuals undergoing treatment. 
However, it remains critical to know how treatment influences the variables 
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investigated here: social support, interpersonal problems, NSSI, self-esteem, 
body dissatisfaction, experiences of transphobia, and psychological wellbeing. 
Future research into how these factors/variables may change in the long term 
or when individuals complete their final phase of treatment (or desire no further 
treatment) is important. For example, examining whether trans individuals 
continue to engage in unhealthy coping mechanisms, such as NSSI, once 
discharged from GICs is an exigent line of enquiry. Trans individuals who 
undergo treatment not only experience great physical changes but also 
emotional, social and psychological adjustment as well. This process of 
adjustment could extend well beyond the completion of treatment and is likely 
to influence each of the factors studied.  
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_____________________________________________________________________
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Title: Predictors of psychological wellbeing among transgender patients 
Applicant: Prof C Meyer, Prof J Arcelus, A Davey 
Department:  SSEHS 
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Comments of the Committee: 
 
The Committee agreed to issue clearance to proceed subject to the following 
conditions: 
 
• That confirmation of NHS approval was confirmed once obtained. 
• That confirmation was provided as to whether or not Participants could leave the online 
questionnaires part-completed and return to it at a later date. 
• That the Participant Information Sheet was amended to remove the duplicated 
sentence (‘Your participation is greatly appreciated…) 
 
 
  
215 
 
 
 
  
216 
 
 
 
217 
 
  
218 
 
Appendix II: Clinical participant information sheet 
 
 
 
 
Research Participant 
Information Sheet 
(Please retain this information sheet for your own reference) 
 
Predictors of Psychological Wellbeing Among Transgender Patients 
 
 
Introduction 
 
You are invited to take part in our research project. This is a collaborative project 
between the Nottingham Gender Clinic and Loughborough University.  
 
Please read this information sheet carefully. It is important for you to understand why 
the research is being done and what it would involve if you agree to take part. If you 
have any questions please contact the researcher – contact details are at the end of 
this sheet. Please take time to consider whether or not you wish to take part. 
 
What is the purpose of this study? 
 
The purpose of this research study is to identify what factors predict psychological 
wellbeing among patients with gender dysphoria. People who have gender dysphoria 
face a number of difficulties unique to their gender identity or gender presentation. 
These difficulties can negatively impact people’s sense of wellbeing. This study will 
help researchers and clinicians better understand factors associated with wellbeing 
and how they might provide more effective support for patients. 
 
Why have I been chosen? 
 
All patients attending the Nottingham Gender Clinic will be invited to take part in this 
research project. We are interested in recruiting patients who have been given a formal 
diagnosis of Gender Identity Disorder by their clinician and who may be at any stage of 
their transition or the treatment programme. Participants must be over 16 years of age. 
 
You have been invited to take part because you meet the recruitment criteria for the 
research project. 
 
Who is organising the study? 
 
This research is being organised by Professor Caroline Meyer, Professor Jon Arcelus 
and Miss Amanda Davey from Loughborough University, in collaboration with Dr 
Walter Pierre Bouman, Clinical Director at Nottingham Gender Clinic. 
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Do I have to take part? 
 
Your help in the study is entirely voluntary. If you do not want to take part, you do not 
have to give a reason. If you do take part and later decide to withdraw from the study, 
you have the right to have your data withdrawn and destroyed at any time up until 
publication. You do not have to give a reason to withdraw.  
 
What do I have to do? 
 
If you have any questions or concerns, please don’t hesitate to contact the researcher 
before proceeding (contact details are provided at the end of this sheet).   
 
If you are interested in taking part and have no further questions, you will first need to 
sign the consent form enclosed in this pack. The pack also contains a set of 
demographic questions and several questionnaires related to wellbeing for you to 
complete. This should take you approximately one hour and 15 minutes. To return your 
questionnaire pack, please use the stamped and addressed envelope provided or 
hand it in to your clinician in person.  
 
What are the possible disadvantages of taking part? 
 
These questionnaires should not cause you any discomfort or distress. However if you 
do feel distressed at any point during the study we would strongly advise you to talk to 
your clinician. Alternatively you may wish to speak to your local GP or The Samaritans 
(telephone no. 08457 909090). 
 
If you decide not to take part in the study, your decision will in no way affect your care 
at Nottingham Gender Clinic. 
 
What are the possible benefits of taking part? 
 
Your participation in this study will help clinicians and researchers understand what 
factors most influence wellbeing in those with gender dysphoria. Identifying which 
factors are important will help tailor interventions that aim to support patients and 
improve their sense of wellbeing.  
 
If you wish to receive a summary of the study’s findings on completion of the project, 
you may request this from the researcher via email. 
 
Will my taking part in this study be kept confidential? 
 
All information given will be kept strictly confidential and will only be accessible to the 
clinical team at Nottingham Gender Clinic and the research team from Loughborough 
University. All questionnaire data entered onto the research database will be assigned 
a unique identifier code to achieve anonymity. Completed questionnaire packs and 
consent forms will be separated and stored in a locked filing cabinet at the Gender 
Clinic. These will be stored for ten years following completion of the study and 
destroyed thereafter, in accordance with Loughborough University guidelines. The 
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procedure for handling, processing, storage and destruction of your data will be 
compliant with the Data Protection Act 1998.  
 
What happens if I don’t want to carry on with the study? 
 
You can withdraw from the study at any time without giving a reason for doing so. If 
you wish to withdraw, your data will be discarded from the study and subsequently 
destroyed. Again this decision will not affect your care at Nottingham Gender Clinic. 
 
What will happen to the results of the research study? 
 
Data from this study will be used in a doctoral research project undertaken by the 
researcher at Loughborough University. The study’s findings will be shared with the 
clinical team at Nottingham Gender Clinic and may be published in academic journals 
and presented at research conferences. Also a summary of the study’s findings will be 
made available on request to participants on completion of the study.  
 
Who has reviewed the study? 
 
This study has been reviewed and was given a favourable ethical opinion for conduct 
by the regional NHS Research and Ethics Committee.  
 
What if I have any other questions or concerns? 
 
If you have any questions or concerns about this study, please contact the researcher:  
 
Miss Amanda Davey 
L1.18 Wavy Top Building 
Loughborough University 
Leicestershire 
LE11 3TU 
Tel: 01509 228168 
Email: a.davey@lboro.ac.uk 
 
 
 
 
 
If you would like independent advice about taking part in research, you may wish to 
contact Patient Advice Liaison Service (PALS): 
Tel: 0800 015 3367 
Website: www.pals.nhs.uk (for general information only) 
 
 
Thank you for taking the time to read this information sheet and for considering 
taking part in the study. Please retain this information sheet for future reference. 
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Appendix III: Clinical consent form 
 
 
 
 
INFORMED CONSENT 
(to be completed after Participant Information Sheet has been read) 
 
Please read the following carefully. Please initial each box and sign at the 
bottom to show you have read and understood what is expected of you. 
 
I hereby give my consent to participate in the questionnaire study on predictors of 
psychological wellbeing. I confirm that: 
 
The purpose and details of the study have been explained to me. I understand 
that this study is designed to further scientific knowledge and that all procedures 
have been approved by the regional NHS Research Ethics Committee. 
 
I have read and understood the Participant Information Sheet, dated 06/06/2012, 
and have had an opportunity to ask the researcher questions regarding the 
procedures of the study. 
 
I have been informed that my participation in the study will involve completing a 
set of questionnaires and that my responses will be kept anonymous and 
confidential. 
 
I understand that relevant sections of my medical notes and data collected during 
this study may be looked at by individuals from Nottingham Gender Clinic or from 
the NHS Trust, where it is relevant to my taking part in this research. I give 
permission for these individuals to have access to my records.  
 
I understand that I am under no obligation to take part in the study; I have the 
right to withdraw at any stage for any reason; and that I will not be required to 
explain my reasons for withdrawing. 
 
                    Your name 
 
              Your signature 
 
Signature of investigator 
 
                               Date 
  
ID code:  
Date 06/06/2012 
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Appendix IV: Clinical questionnaire pack 
  
Questionnaire Pack 
Section 1: Demographic Information 
 
 
Age:………………………                                     
 
Chosen gender: (please tick the appropriate box)
  Male 
  Female 
Ethnic origin: (please tick the appropriate box)
  White 
  Black Caribbean 
  Black African 
  Black Other 
  Indian 
  Pakistani 
  Bangladeshi 
  Chinese 
  Other Ethnic Group………………… 
 
 
 
Employment status: (please tick the appropriate box) 
  Employed full-time 
  Employed part-time 
  Student 
  Volunteer work 
  Housewife/husband 
  Disabled 
  Unemployed 
  Other…………………
        If in work, please state how many weekly hours undertaken:………………… 
 
Civil status: (please tick the appropriate box) 
  Single, never married 
  Married 
  Civil partnership 
  Separated 
  Divorced 
  Widowed 
  Other……………….. 
 
 
 
 
Living situation: (please tick the appropriate box) 
  With family of origin 
  Alone 
  Shares with non-partner/s 
  With partner only 
  With partner and child/ren 
  With child/ren only 
  Other……………… 
 
 
 
 
Do you have any current physical health problems? (please list in the box below)  
 
 
 
ID code:________ 
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Age of coming out:……………………   Not applicable 
Age of transition:………………………   Not applicable 
Age when you were first referred to a gender clinic:................................... 
 
Current stage of gender programme: (please circle answer) 
 
Assessment          Real Life Experience          Post-surgery 
 
Use of hormone treatment: (please circle answer) 
 
Current use of hormones               Previous use of hormones               None at all 
 
Have you undergone any sex reassignment surgery? (please list in the box below) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Section 2: Questionnaires 
 
Experiences of transphobia 
 
The following questions ask you about your experiences of discrimination or victimisation on the 
basis of your gender identity or gender presentation. Please circle the answer that best 
describes your experiences. 
 
1. Have you ever been fired from a job due to your gender identity or presentation?  
Never          Once          A few times          Several times 
2. Have you ever experienced problems getting a job due to your gender identity or 
presentation?  
Never          Once          A few times          Several times 
3. Have you ever experienced problems getting health or medical services due to your 
gender identity or presentation?  
Never          Once          A few times          Several times 
4. Have you ever been verbally abused or harassed due to your gender identity or 
presentation?  
Never          Once          A few times          Several times 
5. Have you ever been physically abused or beaten due to your gender identity or 
presentation?  
Never          Once          A few times          Several times 
 
 
 
 
 
Type of surgery:                                      Date (month/year): 
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SCL-90-R 
 
Below is a list of problems and complaints that people sometimes have. Please read each one 
carefully, and circle the number to the right that best describes how much that problem has 
bothered or distressed you during the past 7 days including today. Circle only one number 
for each problem and do not skip any items. If you change your mind, erase your first answer 
carefully. Read the example below before beginning. 
 
 
 
 
 
EXAMPLE: 
In the past 7 days, how much 
were you distressed by:  
 N
ot
 a
t a
ll 
A 
lit
tle
 b
it 
M
od
er
at
el
y 
Q
ui
te
 a
 b
it 
Ex
tre
m
el
y 
1. Body aches 0 1 2 (3) 4 
 
 
How much were you distressed by: 
 
N
ot
 a
t a
ll 
A 
lit
tle
 b
it 
M
od
er
at
el
y 
Q
ui
te
 a
 b
it 
Ex
tre
m
el
y 
1. Headaches 0 1 2 3 4 
2. Nervousness or shakiness inside      0 1 2 3 4 
3. Repeated thoughts that won’t leave your mind 0 1 2 3 4 
4. Faintness or dizziness 0 1 2 3 4 
5. Loss of sexual interest or pleasure 0 1 2 3 4 
6. Feeling critical of others 0 1 2 3 4 
7. The idea that someone else can control your thoughts 0 1 2 3 4 
8. Feeling others are to blame for most of your troubles 0 1 2 3 4 
9. Trouble remembering things 0 1 2 3 4 
10. Worried about sloppiness or carelessness 0 1 2 3 4 
11. Feeling easily annoyed or irritated 0 1 2 3 4 
12. Pains in heart or chest 0 1 2 3 4 
13. Feeling afraid in open spaces or on the streets 0 1 2 3 4 
14. Feeling low in energy or slowed down 0 1 2 3 4 
15. Thoughts of ending life 0 1 2 3 4 
16. Hearing voices that other people do not hear 0 1 2 3 4 
17. Trembling 0 1 2 3 4 
18. Feeling that most people cannot be trusted 0 1 2 3 4 
19. Poor appetite 0 1 2 3 4 
20. Crying easily 0 1 2 3 4 
21. Feeling shy or uneasy with the opposite sex 0 1 2 3 4 
22. Feeling of being trapped or caught 0 1 2 3 4 
23. Suddenly scared for no reason 0 1 2 3 4 
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How much were you distressed by: 
 
N
ot
 a
t a
ll 
A 
lit
tle
 b
it 
M
od
er
at
el
y 
Q
ui
te
 a
 b
it 
Ex
tre
m
el
y 
24. Temper outbursts that you could not control 0 1 2 3 4 
25. Feeling afraid to go out of your house alone 0 1 2 3 4 
26. Blaming yourself for things 0 1 2 3 4 
27. Pains in lower back 0 1 2 3 4 
28. Feeling blocked in getting things done 0 1 2 3 4 
29. Feeling lonely 0 1 2 3 4 
30. Feeling blue 0 1 2 3 4 
31. Worrying too much about things 0 1 2 3 4 
32. Feeling no interest in things 0 1 2 3 4 
33. Feeling fearful 0 1 2 3 4 
34. Your feelings being easily hurt 0 1 2 3 4 
35. Other people being aware of your private thoughts 0 1 2 3 4 
36. Feeling others do not understand you or are unsympathetic 0 1 2 3 4 
37. Feeling that people are unfriendly or dislike you 0 1 2 3 4 
38. Having to do things very slowly to ensure correctness 0 1 2 3 4 
39. Heart pounding or racing 0 1 2 3 4 
40. Nausea or upset stomach 0 1 2 3 4 
41. Feeling inferior to others 0 1 2 3 4 
42. Soreness of your muscles 0 1 2 3 4 
43. Feeling that you are watched or talked about by others 0 1 2 3 4 
44. Trouble falling asleep 0 1 2 3 4 
45. Having to check and double check what you do 0 1 2 3 4 
46. Difficulty making decisions 0 1 2 3 4 
47. Feeling afraid to travel on buses, subways or trains 0 1 2 3 4 
48. Trouble getting your breath 0 1 2 3 4 
49. Hot or cold spells 0 1 2 3 4 
50. Having to avoid certain things, places or activities because they 
frighten you 
0 1 2 3 4 
51. Your mind going blank 0 1 2 3 4 
52. Numbness or tingling in parts of your body 0 1 2 3 4 
53. A lump in your throat 0 1 2 3 4 
54. Feeling hopeless about the future 0 1 2 3 4 
55. Trouble concentrating 0 1 2 3 4 
56. Feeling weak in parts of your body 0 1 2 3 4 
57. Feeling tense or keyed up 0 1 2 3 4 
58. Heavy feelings in your arms or legs 0 1 2 3 4 
 226 
 
 
  
 
 
How much were you distressed by: 
 
N
ot
 a
t a
ll 
A 
lit
tle
 b
it 
M
od
er
at
el
y 
Q
ui
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 a
 b
it 
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tre
m
el
y 
59. Thoughts of death or dying 0 1 2 3 4 
60. Overeating 0 1 2 3 4 
61. Feeling uneasy when people are watching or talking about you 0 1 2 3 4 
62. Having thoughts that are not your own 0 1 2 3 4 
63. Having urges to beat, injure or harm someone 0 1 2 3 4 
64. Awakening early in the morning 0 1 2 3 4 
65. Having to repeat the same actions such as touching, counting or 
washing 
0 1 2 3 4 
66. Sleep that is restless or disturbed 0 1 2 3 4 
67. Having urges to break or smash things 0 1 2 3 4 
68. Having ideas or beliefs that others do not share 0 1 2 3 4 
69. Feeling very self-conscious with others 0 1 2 3 4 
70. Feeling uneasy in crowds, such as shopping or at a movie 0 1 2 3 4 
71. Feeling everything is an effort 0 1 2 3 4 
72. Spells of terror or panic 0 1 2 3 4 
73. Feeling uncomfortable about eating or drinking in public 0 1 2 3 4 
74. Getting into frequent arguments 0 1 2 3 4 
75. Feeling nervous when you are left alone 0 1 2 3 4 
76. Others not giving you proper credit for your achievements 0 1 2 3 4 
77. Feeling lonely even when you are with people 0 1 2 3 4 
78. Feeling so restless you couldn’t sit still 0 1 2 3 4 
79. Feelings of worthlessness 0 1 2 3 4 
80. The feeling that something bad is going to happen to you 0 1 2 3 4 
81. Shouting or throwing things 0 1 2 3 4 
82. Feeling afraid you will faint in public 0 1 2 3 4 
83. Feeling that people will take advantage of you if you let them 0 1 2 3 4 
84. Having thoughts about sex that bother you a lot 0 1 2 3 4 
85. The idea that you should be punished for your sins 0 1 2 3 4 
86. Thoughts and images of a frightening nature 0 1 2 3 4 
87. The idea that something serious is wrong with your body 0 1 2 3 4 
88. Never feeling close to another person 0 1 2 3 4 
89. Feelings of guilt 0 1 2 3 4 
90. The idea that something is wrong with your mind 0 1 2 3 4 
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SF-36v2 
 
Please answer every question. Some questions may look like others, but each one is different. Please 
take the time to read and answer each question carefully by circling the number that best represents 
your response. 
 
EXAMPLE: How strongly do you agree or disagree with each of the following statements? 
                                                  Strongly agree       Agree       Uncertain       Disagree       Strongly disagree 
a) I enjoy listening to music             1                  2                3                  4                      5 
b) I enjoy reading magazines          1                  2                3                  4                      5 
 
1. In general, would you say your health is: 
Excellent Very good Good Fair Poor 
1 2 3 4 5 
 
2. Compared to one year ago, how would you rate your health in general now? 
Much better now 
than one year 
ago 
Somewhat better 
now than one 
year ago 
About the same 
as one year ago 
Somewhat 
worse now than 
one year ago 
Much worse now 
than one year 
ago 
1 2 3 4 5 
 
3. The following questions are about activities you might do during a typical day. Does 
your health now limit you in these activities? If so, how much? 
 Yes, limited a 
lot 
Yes, limited a 
little 
No, not limited 
at all 
a) Vigorous activities, such as running, 
lifting heavy objects, participating in 
strenuous sports 
1 2 3 
b) Moderate activities, such as moving a 
table, pushing a vacuum cleaner, 
bowling, or playing golf 
1 2 3 
c) Lifting or carrying groceries 1 2 3 
d) Climbing several flights of stairs 1 2 3 
e) Climbing one flight of stairs 1 2 3 
f) Bending, kneeling or stooping 1 2 3 
g) Walking more than one mile 1 2 3 
h) Walking several hundred yards 1 2 3 
i) Walking one hundred yards 1 2 3 
j) Bathing or dressing yourself 1 2 3 
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4. During the past 4 weeks, how much of the time have you had any of the following 
problems with your work or other regular daily activities as a result of your physical 
health? 
 
 
5. During the past 4 weeks, how much of the time have you had any of the following 
problems with your work or other regular daily activities as a result of any emotional 
problems (such as feeling depressed or anxious)? 
 
6. During the past 4 weeks, to what extent has your physical health or emotional 
problems interfered with your normal social activities with family, friends, neighbours 
or groups? 
Not at all Slightly Moderately Quite a bit Extremely 
1 2 3 4 5 
 
7. How much bodily pain have you had during the past 4 weeks? 
None Very mild Mild Moderate Severe Very severe 
1 2 3 4 5 6 
 
8. During the past 4 weeks, how much did pain interfere with your normal work (including 
both work outside the home and housework)? 
Not at all A little bit Moderately Quite a bit Extremely 
1 2 3 4 5 
 
 
 All of 
the 
time 
Most of 
the 
time 
Some 
of the 
time 
A little 
of the 
time 
None of 
the 
time 
a) Cut down on the amount of time you 
spent on work or other activities 
1 2 3 4 5 
b) Accomplished less than you would like 1 2 3 4 5 
c) Were limited in the kind of work or other 
activities 
1 2 3 4 5 
d) Had difficulty performing the work or 
other activities (for example, it took extra 
effort) 
1 2 3 4 5 
 All of 
the 
time 
Most of 
the 
time 
Some 
of the 
time 
A little 
of the 
time 
None of 
the 
time 
a) Cut down on the amount of time you 
spent on work or other activities 
1 2 3 4 5 
b) Accomplished less than you would like 1 2 3 4 5 
c) Did work or other activities less carefully 
than usual 
1 2 3 4 5 
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9. These questions are about how you feel and how things have been with you during the 
past 4 weeks. For each question, please give the one answer that comes closest to the 
way you have been feeling. How much of the time during the past 4 weeks… 
 
10. During the past 4 weeks, how much of the time has your physical health or emotional 
problems interfered with your social activities (like visiting friends, relatives, etc.)? 
All of the time Most of the time Some of the time A little of the 
time 
None of the time 
1 2 3 4 5 
 
11. How TRUE or FALSE is each of the following statements for you? 
 
 
  
 All of 
the 
time 
Most of 
the 
time 
Some 
of the 
time 
A little 
of the 
time 
None of 
the 
time 
a) Did you feel full of life? 1 2 3 4 5 
b) Have you been very nervous? 1 2 3 4 5 
c) Have you felt so down in the dumps that 
nothing could cheer you up? 
1 2 3 4 5 
d) Have you felt calm and peaceful? 1 2 3 4 5 
e) Did you have a lot of energy? 1 2 3 4 5 
f) Have you felt downhearted and 
depressed? 
1 2 3 4 5 
g) Did you feel worn out? 1 2 3 4 5 
h) Have you been happy? 1 2 3 4 5 
i) Did you feel tired? 1 2 3 4 5 
 Definitely 
true 
Mostly 
true 
Don’t 
know 
Mostly 
false 
Definitely 
false 
a) I seem to get sick a little easier than 
other people 
1 2 3 4 5 
b) I am as healthy as anybody I know 1 2 3 4 5 
c) I expect my health to get worse 1 2 3 4 5 
d) My health is excellent 1 2 3 4 5 
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PWI 
The following questions ask how satisfied you feel, on a scale from zero to 10. Zero means you feel 
completely dissatisfied, 10 means you feel completely satisfied, and the middle of the scale is 5, 
which means you feel neutral, neither satisfied nor dissatisfied. Please tick the box that best describes 
your answer. 
 
Part 1 
1. Thinking about your own life and personal circumstances, how satisfied are you with your 
life as a whole? 
Part 2 
1. How satisfied are you with your standard of living? 
2. How satisfied are you with your health? 
3. How satisfied are you with what you are achieving in life? 
4. How satisfied are you with your personal relationships? 
5. How satisfied are you with how safe you feel? 
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6. How satisfied are you with feeling part of your local community*? 
7. How satisfied are you with your future security? 
8. How satisfied are you with your spirituality or religion? 
 
*This question refers ONLY to your local community; it does NOT refer to the transgender 
community.  
 
 
 
 
RSE 
 
Below is a list of statements dealing with your general feelings about yourself. 
 
If you strongly agree, circle SA.  
If you agree with the statement, circle A.  
If you disagree, circle D.  
If you strongly disagree, circle SD. 
 
1. On the whole, I am satisfied with myself……….……….SA       A       D       SD  
2. At times, I think am no good at all……..………..……….SA       A       D       SD 
3. I feel that I have a number of good qualities......……….SA       A       D       SD 
4. I am able to do things as well as most other people..…SA       A       D       SD 
5. I feel I do not have much to be proud of…. …………….SA       A       D       SD 
6. I certainly feel useless at times. ……………….…………SA       A       D       SD 
7. I feel that I’m a person of worth, at least on an 
equal plane with others. …………………………….…….SA       A       D       SD 
8. I wish I could have more respect for myself. ……...…...SA       A       D       SD 
9. All in all, I am inclined to feel that I am a failure. …....…SA       A       D       SD 
10. I take a positive attitude toward myself. ………….……..SA       A       D       SD 
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SIQ-TR 
 
A1 How long ago did you SCRATCH yourself until it bled? 
  A week                          (--> go to question A2) 
  A month                         (--> go to question A2) 
  Several months             (--> go to question B1) 
  More than a year           (--> go to question B1) 
  Never                             (--> go to question B1) 
A2 Which body parts did you injure most of the time? 
  Head, neck 
  Arms, hands, fingers, nails 
  Torso, belly, buttocks 
  Legs, feet, toes 
  Breasts, genitals 
A3 On how many days did this occur during the last month? 
  From 1 to 5 days 
  Between 6 and ten days 
  Between 11 and 15 days 
  More than 15 days 
A4 How many times a day did this occur on average? 
  Less than 1 time a day 
  1 to 2 times a day 
  3 to 4 times a day 
  5 or more times a day 
A5 How often did you feel pain during this act? 
  Never 
  Now and then 
  Often 
  Always 
A6 To what degree did you feel pain during this act? 
  None 
  Mild 
  Moderate 
  Strong 
  Very strong 
 
A7 When this act occurred, then… 
 Never Sometimes Often Always 
It had been clearly planned beforehand 1 2 3 4 
I realised how it had come about 1 2 3 4 
I took care of the wound(s) 1 2 3 4 
I hid the act from other people 1 2 3 4 
 
 
A8 How did you feel shortly BEFORE this act occurred? 
 Not at 
all 
A bit Moderately Much Very 
much 
Glad 1 2 3 4 5 
Relieved 1 2 3 4 5 
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Nervous 1 2 3 4 5 
Bored 1 2 3 4 5 
Angry at myself 1 2 3 4 5 
Angry at others 1 2 3 4 5 
Anxious 1 2 3 4 5 
Sad 1 2 3 4 5 
Guilty 1 2 3 4 5 
Other feeling (describe):……………………. 1 2 3 4 5 
 
A9 How did you feel shortly AFTER this act occurred? 
 Not at 
all 
A bit Moderately Much Very 
much 
Glad 1 2 3 4 5 
Relieved 1 2 3 4 5 
Nervous 1 2 3 4 5 
Bored 1 2 3 4 5 
Angry at myself 1 2 3 4 5 
Angry at others 1 2 3 4 5 
Anxious 1 2 3 4 5 
Sad 1 2 3 4 5 
Guilty 1 2 3 4 5 
Other feeling (describe):……………………. 1 2 3 4 5 
 
A10 Why did you perform this act? 
 Not at 
all 
A bit Moderately Much Very 
much 
To avoid or suppress negative feelings 1 2 3 4 5 
To avoid or suppress painful images or 
memories 
1 2 3 4 5 
To get into a twilight or numb state 1 2 3 4 5 
To get attention from others 1 2 3 4 5 
To escape from a twilight or numb state 1 2 3 4 5 
To punish myself 1 2 3 4 5 
To make myself unattractive 1 2 3 4 5 
To avoid or suppress suicidal thoughts 1 2 3 4 5 
To show myself how strong I am 1 2 3 4 5 
To show others how strong I am 1 2 3 4 5 
To avoid doing something unpleasant, you 
don’t want to do 
1 2 3 4 5 
To avoid school, work, or other activities 1 2 3 4 5 
To avoid being with people 1 2 3 4 5 
Another reason (describe):………………… 1 2 3 4 5 
 
B1 How long ago did you BRUISE yourself? 
  A week                          (--> go to question B2) 
  A month                         (--> go to question B2) 
  Several months             (--> go to question C1) 
  More than a year           (--> go to question C1) 
  Never                             (--> go to question C1) 
 
B2 Which body parts did you injure most of the time? 
  Head, neck 
  Arms, hands, fingers, nails 
  Torso, belly, buttocks 
  Legs, feet, toes 
  Breasts, genitals 
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B3 On how many days did this occur during the last month? 
  From 1 to 5 days 
  Between 6 and ten days 
  Between 11 and 15 days 
  More than 15 days 
B4 How many times a day did this occur on average? 
  Less than 1 time a day 
  1 to 2 times a day 
  3 to 4 times a day 
  5 or more times a day 
B5 How often did you feel pain during this act? 
  Never 
  Now and then 
  Often 
  Always 
B6 To what degree did you feel pain during this act? 
  None 
  Mild 
  Moderate 
  Strong 
  Very strong 
 
B7 When this act occurred, then… 
 Never Sometimes Often Always 
It had been clearly planned beforehand 1 2 3 4 
I realised how it had come about 1 2 3 4 
I took care of the wound(s) 1 2 3 4 
I hid the act from other people 1 2 3 4 
 
B8 How did you feel shortly BEFORE this act occurred? 
 Not at 
all 
A bit Moderately Much Very 
much 
Glad 1 2 3 4 5 
Relieved 1 2 3 4 5 
Nervous 1 2 3 4 5 
Bored 1 2 3 4 5 
Angry at myself 1 2 3 4 5 
Angry at others 1 2 3 4 5 
Anxious 1 2 3 4 5 
Sad 1 2 3 4 5 
Guilty 1 2 3 4 5 
Other feeling (describe):……………………. 1 2 3 4 5 
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B9 How did you feel shortly AFTER this act occurred? 
 Not at 
all 
A bit Moderately Much Very 
much 
Glad 1 2 3 4 5 
Relieved 1 2 3 4 5 
Nervous 1 2 3 4 5 
Bored 1 2 3 4 5 
Angry at myself 1 2 3 4 5 
Angry at others 1 2 3 4 5 
Anxious 1 2 3 4 5 
Sad 1 2 3 4 5 
Guilty 1 2 3 4 5 
Other feeling (describe):……………………. 1 2 3 4 5 
 
B10 Why did you perform this act? 
 Not at 
all 
A bit Moderately Much Very 
much 
To avoid or suppress negative feelings 1 2 3 4 5 
To avoid or suppress painful images or 
memories 
1 2 3 4 5 
To get into a twilight or numb state 1 2 3 4 5 
To get attention from others 1 2 3 4 5 
To escape from a twilight or numb state 1 2 3 4 5 
To punish myself 1 2 3 4 5 
To make myself unattractive 1 2 3 4 5 
To avoid or suppress suicidal thoughts 1 2 3 4 5 
To show myself how strong I am 1 2 3 4 5 
To show others how strong I am 1 2 3 4 5 
To avoid doing something unpleasant, you 
don’t want to do 
1 2 3 4 5 
To avoid school, work, or other activities 1 2 3 4 5 
To avoid being with people 1 2 3 4 5 
Another reason (describe):………………… 1 2 3 4 5 
 
C1 How long ago did you CUT yourself? 
  A week                          (--> go to question C2) 
  A month                         (--> go to question C2) 
  Several months             (--> go to question D1) 
  More than a year           (--> go to question D1) 
  Never                             (--> go to question D1) 
 
C2 Which body parts did you injure most of the time? 
  Head, neck 
  Arms, hands, fingers, nails 
  Torso, belly, buttocks 
  Legs, feet, toes 
  Breasts, genitals 
C3 On how many days did this occur during the last month? 
  From 1 to 5 days 
  Between 6 and ten days 
  Between 11 and 15 days 
  More than 15 days 
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C4 How many times a day did this occur on average? 
  Less than 1 time a day 
  1 to 2 times a day 
  3 to 4 times a day 
  5 or more times a day 
C5 How often did you feel pain during this act? 
  Never 
  Now and then 
  Often 
  Always 
C6 To what degree did you feel pain during this act? 
  None 
  Mild 
  Moderate 
  Strong 
  Very strong 
 
C7 When this act occurred, then… 
 Never Sometimes Often Always 
It had been clearly planned beforehand 1 2 3 4 
I realised how it had come about 1 2 3 4 
I took care of the wound(s) 1 2 3 4 
I hid the act from other people 1 2 3 4 
 
C8 How did you feel shortly BEFORE this act occurred? 
 Not at 
all 
A bit Moderately Much Very 
much 
Glad 1 2 3 4 5 
Relieved 1 2 3 4 5 
Nervous 1 2 3 4 5 
Bored 1 2 3 4 5 
Angry at myself 1 2 3 4 5 
Angry at others 1 2 3 4 5 
Anxious 1 2 3 4 5 
Sad 1 2 3 4 5 
Guilty 1 2 3 4 5 
Other feeling (describe):……………………. 1 2 3 4 5 
 
C9 How did you feel shortly AFTER this act occurred? 
 Not at 
all 
A bit Moderately Much Very 
much 
Glad 1 2 3 4 5 
Relieved 1 2 3 4 5 
Nervous 1 2 3 4 5 
Bored 1 2 3 4 5 
Angry at myself 1 2 3 4 5 
Angry at others 1 2 3 4 5 
Anxious 1 2 3 4 5 
Sad 1 2 3 4 5 
Guilty 1 2 3 4 5 
Other feeling (describe):……………………. 1 2 3 4 5 
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C10 Why did you perform this act? 
 Not at 
all 
A bit Moderately Much Very 
much 
To avoid or suppress negative feelings 1 2 3 4 5 
To avoid or suppress painful images or 
memories 
1 2 3 4 5 
To get into a twilight or numb state 1 2 3 4 5 
To get attention from others 1 2 3 4 5 
To escape from a twilight or numb state 1 2 3 4 5 
To punish myself 1 2 3 4 5 
To make myself unattractive 1 2 3 4 5 
To avoid or suppress suicidal thoughts 1 2 3 4 5 
To show myself how strong I am 1 2 3 4 5 
To show others how strong I am 1 2 3 4 5 
To avoid doing something unpleasant, you 
don’t want to do 
1 2 3 4 5 
To avoid school, work, or other activities 1 2 3 4 5 
To avoid being with people 1 2 3 4 5 
Another reason (describe):………………… 1 2 3 4 5 
 
D1 How long ago did you BURN yourself? 
  A week                          (--> go to question D2) 
  A month                         (--> go to question D2) 
  Several months             (--> go to question E1) 
  More than a year           (--> go to question E1) 
  Never                             (--> go to question E1) 
 
D2 Which body parts did you injure most of the time? 
  Head, neck 
  Arms, hands, fingers, nails 
  Torso, belly, buttocks 
  Legs, feet, toes 
  Breasts, genitals 
D3 On how many days did this occur during the last month? 
  From 1 to 5 days 
  Between 6 and ten days 
  Between 11 and 15 days 
  More than 15 days 
D4 How many times a day did this occur on average? 
  Less than 1 time a day 
  1 to 2 times a day 
  3 to 4 times a day 
  5 or more times a day 
D5 How often did you feel pain during this act? 
  Never 
  Now and then 
  Often 
  Always 
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D6 To what degree did you feel pain during this act? 
  None 
  Mild 
  Moderate 
  Strong 
  Very strong 
 
D7 When this act occurred, then… 
 Never Sometimes Often Always 
It had been clearly planned beforehand 1 2 3 4 
I realised how it had come about 1 2 3 4 
I took care of the wound(s) 1 2 3 4 
I hid the act from other people 1 2 3 4 
 
D8 How did you feel shortly BEFORE this act occurred? 
 Not at 
all 
A bit Moderately Much Very 
much 
Glad 1 2 3 4 5 
Relieved 1 2 3 4 5 
Nervous 1 2 3 4 5 
Bored 1 2 3 4 5 
Angry at myself 1 2 3 4 5 
Angry at others 1 2 3 4 5 
Anxious 1 2 3 4 5 
Sad 1 2 3 4 5 
Guilty 1 2 3 4 5 
Other feeling (describe):……………………. 1 2 3 4 5 
 
D9 How did you feel shortly AFTER this act occurred? 
 Not at 
all 
A bit Moderately Much Very 
much 
Glad 1 2 3 4 5 
Relieved 1 2 3 4 5 
Nervous 1 2 3 4 5 
Bored 1 2 3 4 5 
Angry at myself 1 2 3 4 5 
Angry at others 1 2 3 4 5 
Anxious 1 2 3 4 5 
Sad 1 2 3 4 5 
Guilty 1 2 3 4 5 
Other feeling (describe):……………………. 1 2 3 4 5 
 
D10 Why did you perform this act? 
 Not at 
all 
A bit Moderately Much Very 
much 
To avoid or suppress negative feelings 1 2 3 4 5 
To avoid or suppress painful images or 
memories 
1 2 3 4 5 
To get into a twilight or numb state 1 2 3 4 5 
To get attention from others 1 2 3 4 5 
To escape from a twilight or numb state 1 2 3 4 5 
To punish myself 1 2 3 4 5 
To make myself unattractive 1 2 3 4 5 
To avoid or suppress suicidal thoughts 1 2 3 4 5 
To show myself how strong I am 1 2 3 4 5 
To show others how strong I am 1 2 3 4 5 
To avoid doing something unpleasant, you 
don’t want to do 
1 2 3 4 5 
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To avoid school, work, or other activities 1 2 3 4 5 
To avoid being with people 1 2 3 4 5 
Another reason (describe):………………… 1 2 3 4 5 
 
E1 How long ago did you BITE yourself? 
  A week                          (--> go to question E2) 
  A month                         (--> go to question E2) 
  Several months             (--> go to question F1) 
  More than a year           (--> go to question F1) 
  Never                             (--> go to question F1) 
 
E2 Which body parts did you injure most of the time? 
  Head, neck 
  Arms, hands, fingers, nails 
  Torso, belly, buttocks 
  Legs, feet, toes 
  Breasts, genitals 
E3 On how many days did this occur during the last month? 
  From 1 to 5 days 
  Between 6 and ten days 
  Between 11 and 15 days 
  More than 15 days 
E4 How many times a day did this occur on average? 
  Less than 1 time a day 
  1 to 2 times a day 
  3 to 4 times a day 
  5 or more times a day 
E5 How often did you feel pain during this act? 
  Never 
  Now and then 
  Often 
  Always 
E6 To what degree did you feel pain during this act? 
  None 
  Mild 
  Moderate 
  Strong 
  Very strong 
 
E7 When this act occurred, then… 
 Never Sometimes Often Always 
It had been clearly planned beforehand 1 2 3 4 
I realised how it had come about 1 2 3 4 
I took care of the wound(s) 1 2 3 4 
I hid the act from other people 1 2 3 4 
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E8 How did you feel shortly BEFORE this act occurred? 
 Not at 
all 
A bit Moderately Much Very 
much 
Glad 1 2 3 4 5 
Relieved 1 2 3 4 5 
Nervous 1 2 3 4 5 
Bored 1 2 3 4 5 
Angry at myself 1 2 3 4 5 
Angry at others 1 2 3 4 5 
Anxious 1 2 3 4 5 
Sad 1 2 3 4 5 
Guilty 1 2 3 4 5 
Other feeling (describe):……………………. 1 2 3 4 5 
 
E9 How did you feel shortly AFTER this act occurred? 
 Not at 
all 
A bit Moderately Much Very 
much 
Glad 1 2 3 4 5 
Relieved 1 2 3 4 5 
Nervous 1 2 3 4 5 
Bored 1 2 3 4 5 
Angry at myself 1 2 3 4 5 
Angry at others 1 2 3 4 5 
Anxious 1 2 3 4 5 
Sad 1 2 3 4 5 
Guilty 1 2 3 4 5 
Other feeling (describe):……………………. 1 2 3 4 5 
 
E10 Why did you perform this act? 
 Not at 
all 
A bit Moderately Much Very 
much 
To avoid or suppress negative feelings 1 2 3 4 5 
To avoid or suppress painful images or 
memories 
1 2 3 4 5 
To get into a twilight or numb state 1 2 3 4 5 
To get attention from others 1 2 3 4 5 
To escape from a twilight or numb state 1 2 3 4 5 
To punish myself 1 2 3 4 5 
To make myself unattractive 1 2 3 4 5 
To avoid or suppress suicidal thoughts 1 2 3 4 5 
To show myself how strong I am 1 2 3 4 5 
To show others how strong I am 1 2 3 4 5 
To avoid doing something unpleasant, you 
don’t want to do 
1 2 3 4 5 
To avoid school, work, or other activities 1 2 3 4 5 
To avoid being with people 1 2 3 4 5 
Another reason (describe):………………… 1 2 3 4 5 
 
F1 OTHER form of self-injury:………………………..(please specify) 
     How long ago did you last display this behaviour? 
  A week                          (--> go to question F2) 
  A month                         (--> go to question F2) 
  Several months             (--> end of questionnaire) 
  More than a year           (--> end of questionnaire) 
  Never                             (--> end of questionnaire) 
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F2 Which body parts did you injure most of the time? 
  Head, neck 
  Arms, hands, fingers, nails 
  Torso, belly, buttocks 
  Legs, feet, toes 
  Breasts, genitals 
F3 On how many days did this occur during the last month? 
  From 1 to 5 days 
  Between 6 and ten days 
  Between 11 and 15 days 
  More than 15 days 
F4 How many times a day did this occur on average? 
  Less than 1 time a day 
  1 to 2 times a day 
  3 to 4 times a day 
  5 or more times a day 
F5 How often did you feel pain during this act? 
  Never 
  Now and then 
  Often 
  Always 
F6 To what degree did you feel pain during this act? 
  None 
  Mild 
  Moderate 
  Strong 
  Very strong 
 
F7 When this act occurred, then… 
 Never Sometimes Often Always 
It had been clearly planned beforehand 1 2 3 4 
I realised how it had come about 1 2 3 4 
I took care of the wound(s) 1 2 3 4 
I hid the act from other people 1 2 3 4 
 
F8 How did you feel shortly BEFORE this act occurred? 
 Not at 
all 
A bit Moderately Much Very 
much 
Glad 1 2 3 4 5 
Relieved 1 2 3 4 5 
Nervous 1 2 3 4 5 
Bored 1 2 3 4 5 
Angry at myself 1 2 3 4 5 
Angry at others 1 2 3 4 5 
Anxious 1 2 3 4 5 
Sad 1 2 3 4 5 
Guilty 1 2 3 4 5 
Other feeling (describe):……………………. 1 2 3 4 5 
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F9 How did you feel shortly AFTER this act occurred? 
 Not at 
all 
A bit Moderately Much Very 
much 
Glad 1 2 3 4 5 
Relieved 1 2 3 4 5 
Nervous 1 2 3 4 5 
Bored 1 2 3 4 5 
Angry at myself 1 2 3 4 5 
Angry at others 1 2 3 4 5 
Anxious 1 2 3 4 5 
Sad 1 2 3 4 5 
Guilty 1 2 3 4 5 
Other feeling (describe):……………………. 1 2 3 4 5 
 
F10 Why did you perform this act? 
 Not at 
all 
A bit Moderately Much Very 
much 
To avoid or suppress negative feelings 1 2 3 4 5 
To avoid or suppress painful images or 
memories 
1 2 3 4 5 
To get into a twilight or numb state 1 2 3 4 5 
To get attention from others 1 2 3 4 5 
To escape from a twilight or numb state 1 2 3 4 5 
To punish myself 1 2 3 4 5 
To make myself unattractive 1 2 3 4 5 
To avoid or suppress suicidal thoughts 1 2 3 4 5 
To show myself how strong I am 1 2 3 4 5 
To show others how strong I am 1 2 3 4 5 
To avoid doing something unpleasant, you 
don’t want to do 
1 2 3 4 5 
To avoid school, work, or other activities 1 2 3 4 5 
To avoid being with people 1 2 3 4 5 
Another reason (describe):………………… 1 2 3 4 5 
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HBDS 
 
How satisfied are you at this moment with the following body characteristics?  
 
Please give each body part one of the following scores:  
1 = Very satisfied, 2 = Satisfied, 3 = Average, 4 = Dissatisfied, 5 = Very dissatisfied, NA = Not 
Applicable 
 
 
  
1. Hair 
2. Ears 
3. Beard 
4. Jaw 
5. Shoulder 
6. Armpit hair 
7. Arm 
8. Pubic hair 
9. Hands 
10. Feet 
11. Forehead 
12. Nose 
13. Chin 
14. Adam’s apple 
15. Upper arm 
t  
16. Chest or breasts 
17. Stomach 
18. Waist 
19. Hips 
20. Bottom 
21. Thighs 
22. Calves 
23. Height 
24. Weight 
25. Clitoris 
26. Vagina 
27. Inner labia 
28. Outer labia 
29. Testicles 
30. Penis 
31. Body hair 
32. Skin  
33. Voice 
34. Other (please state) __________ 
35. Satisfaction with your whole body 
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MSPSS 
 
We are interested in how you feel about the following statements. Read each statement carefully. 
Indicate how you feel about each statement. 
 
Circle 1 if you very strongly disagree 
           2 if you strongly disagree 
           3 if you mildly disagree 
           4 if you are neutral 
           5 if you mildly agree 
           6 if you strongly agree 
           7 if you very strongly agree 
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1. There is a special person who is around when I am in 
need. 
1 2 3 4 5 6 7 
2. There is a special person with whom I can share my 
joys and sorrows. 
1 2 3 4 5 6 7 
3. My family really tries to help. 1 2 3 4 5 6 7 
4. I get the emotional help and support I need from my 
family. 
1 2 3 4 5 6 7 
5. I have a special person who is a real source of comfort 
to me. 
1 2 3 4 5 6 7 
6. My friends really try to help me. 1 2 3 4 5 6 7 
7. I can count on my friends when things go wrong. 1 2 3 4 5 6 7 
8. I can talk about my problems with my family. 1 2 3 4 5 6 7 
9. I have friends with whom I can share my joys and 
sorrows. 
1 2 3 4 5 6 7 
10. There is a special person in my life who cares about 
my feelings. 
1 2 3 4 5 6 7 
11. My family is willing to help me make decisions. 1 2 3 4 5 6 7 
12. I can talk about my problems with my friends. 1 2 3 4 5 6 7 
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IIP-32 
 
Here is a list of problems that people report in relating to other people. Please read the list below and 
for each item, select the number that describes how distressing that problem has been for you. 
Then circle that number. 
EXAMPLE: How much have you been distressed by this problem? 
It is hard for me to:       
                                                Not at all     A little bit     Moderately     Quite a bit     Extremely      
Get along with my relatives             0               1                   2                    3                  4 
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It is hard for me to:      
1. Join in on groups 0 1 2 3 4 
2. Be assertive with another person 0 1 2 3 4 
3. Make friends 0 1 2 3 4 
4. Disagree with other people 0 1 2 3 4 
5. Make a long-term commitment to another person 0 1 2 3 4 
6. Be aggressive toward other people when the situation 
calls for it 
0 1 2 3 4 
7. Socialise with other people 0 1 2 3 4 
8. Show affection to people 0 1 2 3 4 
9. Feel comfortable around other people 0 1 2 3 4 
10. Tell personal things to other people 0 1 2 3 4 
11. Be firm when I need to be 0 1 2 3 4 
12. Experience a feeling of love for another person 0 1 2 3 4 
13. Be supportive of another person’s goals in life 0 1 2 3 4 
14. Really care about other people’s problems 0 1 2 3 4 
15. Put somebody else’s needs before my own 0 1 2 3 4 
16. Take instructions from people who have authority over 
me 
0 1 2 3 4 
17. Open up and tell my feelings to another person 0 1 2 3 4 
18. Attend to my own welfare when somebody else is 
needy 
0 1 2 3 4 
19. Be involved with another person without feeling 
trapped 
0 1 2 3 4 
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Thank you for completing these questionnaires. 
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The following are things that you do too much:      
20. I fight with other people too much 0 1 2 3 4 
21. I get irritated or annoyed too easily 0 1 2 3 4 
22. I want people to admire me too much 0 1 2 3 4 
23. I am too dependent on other people 0 1 2 3 4 
24. I open up to people too much 0 1 2 3 4 
25. I put other people’s needs before my own too much 0 1 2 3 4 
26. I am overly generous to other people 0 1 2 3 4 
27. I worry too much about other people’s reactions to me 0 1 2 3 4 
28. I lose my temper too easily 0 1 2 3 4 
29. I tell personal things to other people too much 0 1 2 3 4 
30. I argue with other people too much 0 1 2 3 4 
31. I am too envious and jealous of other people 0 1 2 3 4 
32. I am affected by another person’s misery too much 0 1 2 3 4 
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Appendix V: Control participant information sheet  
 
 
 
 
 
 
Predictors of Psychological Wellbeing Among Transgender Patients 
 
Information Sheet for Non-Transgender Participants 
 
 
You are invited to take part in our research project. This is a collaborative project 
between Loughborough University and Nottingham Gender Clinic. 
 
Please read this information sheet carefully. It is important for you to understand why 
the research is being done and what it would involve if you agree to take part. If you 
have any questions please contact the researcher – contact details are at the end of 
this sheet. Please take time to consider whether or not you wish to take part. 
 
What is the purpose of the study? 
 
The purpose of this research study is to identify what factors predict psychological 
wellbeing among transgender persons and to compare these findings to a control 
sample of non-transgender adults. Transgender people, or people with gender 
dysphoria, feel that their gender identity is different from the sex they were born with; 
many describe it as being born in the wrong body. Living as transgender often 
means people have to face a number of difficulties in everyday life which negatively 
impact their sense of wellbeing, such as discrimination, harassment, family rejection, 
and low self-esteem. Exploring what factors impact transgender patients’ wellbeing 
and how they differ to non-transgender individuals will help enhance patient care. 
 
Who is doing this research and why? 
 
This study is being undertaken as part of a doctoral research project by Miss 
Amanda Davey within the School of Sport, Exercise and Health Sciences at 
Loughborough University. The study has been organised in collaboration with Dr 
Walter Pierre Bouman, Clinical Director at Nottingham Gender Clinic, and is being 
supervised by Professor Caroline Meyer and Professor Jon Arcelus at 
Loughborough University. 
 
Why have I been chosen? 
 
We are looking for people aged 18 and over, who do not identify as transgender and 
who do not feel they have (or have ever had) gender dysphoria (a condition where 
you experience your gender identity as different to the sex you were born with), to 
take part in the control sample.  
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What will I be asked to do? 
 
If you agree to take part, you will be asked to complete a consent form before 
proceeding to the questionnaire pack. The pack contains a set of demographic 
questions followed by several questionnaires related to different aspects of 
wellbeing. You will have the option of completing a paper version of this pack or 
completing it online at [insert web address, tbc]. If you choose to complete the online 
survey, you don’t have to fill it in all at once; you will able to answer some of the 
questions and return to it later if you wish. 
 
How long will it take? 
 
Questionnaires should take between 30 and 45 minutes to complete. 
 
Who should I send the questionnaire back to? 
 
If you complete a paper copy of the questionnaire pack, please return it to the 
researcher (see contact details at the end of this sheet).  
 
Do I have to take part? 
 
Your help in the study is entirely voluntary. If at any time you wish to withdraw from 
the study, please contact the researcher.  You can withdraw at any time, for any 
reason and you will not be asked to explain your reasons for withdrawing. 
 
Are there any risks in participating? 
 
This study should not cause you any discomfort or distress. However if you do feel 
distressed at any point during the study, we would strongly advise you contact one of 
the following: 
 
• Your local GP. 
• The Samaritans – tel: 08457 909090. 
 
If you are a student or staff member of Loughborough University, you may wish to 
contact:  
 
• University Counselling Service - tel: 01509 222148, email: ucs@lboro.ac.uk 
• Student2Student – email: Student2Student@lborosu.org.uk 
 
Will my taking part in this study be kept confidential? 
 
All information given will be kept strictly confidential and anonymous. Paper 
questionnaire packs will be assigned a unique identifier code to achieve anonymity 
and stored separately from consent forms. Consent forms and anonymous 
questionnaires will be stored in locked filing cabinets at Loughborough University. 
Online questionnaires may be completed anonymously and all electronic data will be 
stored on a password-protected computer at Loughborough University. Only the 
research team will have access to the data. 
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The procedure for handling, processing, storage and destruction of your data will be 
compliant with the Data Protection Act 1998. Consent forms and questionnaires will 
be stored in their original form at Loughborough University for ten years from the 
completion of the study and destroyed after this time. 
 
What will happen to the results of the study? 
 
Data from this study will be used in a doctoral research project undertaken by the 
main investigator at Loughborough University. The study’s findings may be 
presented at research conferences and published in academic journals. Also a 
summary of the findings will be made available to participants.  
 
What do I get for participating? 
 
Your participation is greatly appreciated and you will have the opportunity to request 
a summary of the research findings on completion of the study. 
 
I have some more questions who should I contact? 
 
If you have any questions or concerns about this study, please contact the 
researcher:  
 
Miss Amanda Davey 
School of Sport, Exercise and Health Sciences 
Loughborough University 
Leicestershire 
LE11 3TU 
Tel: 01509 228168 
Email: A.Davey@lboro.ac.uk 
 
Supervisors: 
Prof. Caroline Meyer, email: C.Meyer@lboro.ac.uk  
Prof. Jon Arcelus, email: J.Arcelus@lboro.ac.uk 
 
 
Thank you for taking the time to read this information sheet and for 
considering taking part in the study. Please retain this sheet for future 
reference. 
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Appendix VI: Control consent form 
 
ID no.__________ 
 
 
Predictors of Psychological Wellbeing 
 
 
DECLARATION OF INFORMED CONSENT 
(to be completed after Participant Information Sheet has been read) 
 
 
Please read the following carefully. Please initial each box and sign at the 
bottom to show you have read and understood what is expected of you. 
 
I hereby give my consent to participate in the questionnaire study on predictors of 
psychological wellbeing. I confirm that: 
 
The purpose and details of the study have been explained to me. I understand 
that this study is designed to further scientific knowledge and that all 
procedures have been approved by the Loughborough University Ethical 
Advisory Committee. 
 
I have read and understood the Participant Information Sheet and have had 
an opportunity to ask the researcher questions regarding the procedures of 
the study. 
 
I have been informed that my participation in the study will involve completing 
a set of questionnaires and that my responses will be kept anonymous and 
confidential. 
 
I understand that I am under no obligation to take part in the study; I have the 
right to withdraw at any stage for any reason; and that I will not be required to 
explain my reasons for withdrawing. 
 
 
                    Your name 
 
 
 
              Your signature 
 
 
 
Signature of investigator 
 
 
 
                               Date 
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Appendix VII: Control questionnaire pack 
Questionnaire Pack 
Section 1: Demographic Information 
 
 
Age:………………………                                     
 
Gender: (please tick the appropriate box)
  Male 
  Female 
Ethnic origin: (please tick the appropriate box)
  White 
  Black Caribbean 
  Black African 
  Black Other 
  Indian 
  Pakistani 
  Bangladeshi 
  Chinese 
  Other Ethnic Group………………… 
 
 
Employment status: (please tick the appropriate box) 
  Employed full-time 
  Employed part-time 
  Student 
  Volunteer work 
  Housewife/husband 
  Disabled 
  Unemployed 
  Other…………………
        If in work, please state how many weekly hours undertaken:………………… 
 
Civil status: (please tick the appropriate box) 
  Single, never married 
  Married 
  Civil partnership 
  Separated 
  Divorced 
  Widowed 
  Other……………….. 
 
 
Living situation: (please tick the appropriate box) 
  With family of origin 
  Alone 
  Shares with non-partner/s 
  With partner only 
  With partner and child/ren 
  With child/ren only 
  Other……………… 
 
ID code:________ 
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Do you have any current physical health problems? (please list in the box below)  
 
From this page onwards, the questionnaire pack for control participants replicates 
exactly the measures in Appendix IV (starting with SCL-90-R) 
 
